A cikin shekara ta 1914, an yi amfani da wannan alama don ya nuna cewa ba a taɓa yin kome ba.
Kuma wannan shine yadda ake bi da duk cututtukan kirji, musamman a shekarunku.
Kuma yana da zazzabi.
Kuma dole ne a bincika hawan jini na jikinka
Kuma yanzu kana da zazzabi?
Yanzu kana da wannan ciwon kirji?
Kuma kana da matsalar numfashi.
Kuma za ku iya gaya mini waɗanne alamun da kuke da su a wannan batun?
Kuma zazzabinka ya yi yawa
Kuma ina da
Ina da zazzabi da tari
A yau, ina fama da ciwon kirji mai tsanani.
Kuma yanzu ne lokacin da ya dace don zafin jiki na musamman
Kuma ya sãmi ciwon kirjinsa.
Kuma ina jin zafi kaɗan
Kuma ina so in sami bayani game da abin da ciwon ciki yake da shi.
Kuma suna da zazzabi.
Kuma kuna da ciwon sukari a baya.
Kuma ka san, ina jin kamar kirjina na kasa.
Kuma mutane sun san cewa za su yi mini dariya kullum
Kuma a wannan lokacin kuna jin ciwon kirji
Kuma ya ce wannan ba shi da wani matsin lamba a kirjinku.
Idan kana da wani a iyalinka da ke fama da ciwon zuciya, ciwon zuciya, ciwon zuciya, yawan cholesterol, da kuma hawan jini
Shin akwai wasu alamun cututtukan da kake gani game da ciwon tsoka?
Shin akwai wasu da suke da cututtuka kamar naka a gida?
Shin, akwai wasu alamun da za su iya sa ka ji rauni?
Shin kana bukatar ka yi numfashi?
Har ila, kana da ciwon kirji.
Domin wannan lokacin na mura ne.
Amma bai kamata mu bar ciwon zuciya ba.
Amma yanzu, ciwon kirji ne ya fi tsanani.
Amma ina da matsalar numfashi.
Amma na san cewa mutane da yawa suna yi mini dariya
Amma, dole ne mu kula da kowace cuta ta ciki.
Amma yanzu suna numfashi sosai, ko ba haka ba?
Na manta da shi sosai saboda wannan ciwon kirji.
Kana jin kamar wani yana matsa maka kirji
Za ka iya jin numfashi har yanzu
Shin suna nuna alamun cutar ɗaya?
Shin kana da hawan jini ko kuma wata irin cuta ta kullum?
Shin kana da wata cuta ta kullum kamar ciwon sukari?
Shin kana bukatar ka yi numfashi mai tsawo idan kana da ciwon ciki?
Shin kana da hawan jini?
Shin kana da numfashi mai kyau?
Ta yi mamaki sosai, amma ta yi mamaki sosai.
Shin kuna ganin hoton?
Ka sha ruwa da yawa a yau
Amma na yi gwajin ciwon sukari
Amma, akwai alamun da suka yi kama da na
Yaya girman harbinka yake?
Ta yaya za ka iya samun hawan jini?
Idan zazzabi ya ci gaba da ƙaruwa
Idan kana da zazzabi mai tsanani ko fiye da haka
Idan kana ganin cewa alamun da ke damunka suna bukatar ƙarin tabbaci don su bayyana
Na yi zazzabi jiya
Ina da zazzabi kaɗan
Na yi zazzabi jiya
Ina da ciwo mai tsanani a kirji a nan
Ina da matsalar numfashi.
Zan aiko maka da hoto
A yau, ina fama da ciwon kirji.
A yau, ina da ciwon kai da zazzabi.
A ganina, zazzabin cizon sauro ne.
A ganina, wannan zazzabi ne mai sauƙi.
Shin kana kama da wani da ya yi nauyi a kirjinka?
Na soma ciwon kai da zazzabi a lokaci guda.
Na yi baƙin ciki sosai a ciki.
Amma, ba a taɓa yin hakan ba.
A cikin ƙirjina
Na yi baƙin ciki sosai.
Yana cikin ƙirjin
Na yi ciwo a ƙirjina
Ina da ciwon kirji mai tsanani.
Ina son a bayyana mini wannan ciwon kirji
Amma, akwai wasu cututtuka da suka shafi jini.
Na yi tunani sosai game da wannan batun.
Yanzu za ka iya yin amfani da tatapiarina don yin amfani da ita
Yanzu Mary, kwana nawa ne ka fara ganin wadannan alamun?
Yanzu sun ce kana da ciwon kirji
A wasu lokatai, ina fama da ciwon kirji.
Da kyau, sai dai idan kun sami wata alama da ta zo tare da wannan,
Ko kuma wani ya zauna a kirjinka?
Yana kama da ciwon kai da ciwon tsoka da kuma ciwon daji da kuma ciwon daji.
Na yi tunani sosai game da wannan batun.
Ka nuna mini a wannan hoton yadda kake ji da shi
Idan kana da zazzabi
Saboda haka, kana ganin akwai alamun da ke nuna cewa kana da ciki?
Saboda haka, yaranku suna nuna irin waɗannan alamun?
Ka gaya mini game da ciwon kirjinka
A cikin dare, zafin jiki ya ƙaru
Na yi fama da zazzabi na kwanaki biyu da suka shige
A daren jiya, zafin ya fara ƙaruwa.
Wannan likitan ne mai suna Porter, wanda ke cikin sashen gaggawa na Cibiyar Trigger.
Za ku iya gaya mani game da ciwon kirjinku?
Yanzu ina jin zafi a kirji a jikin na na gaba
Na yi ciwo mai tsanani a kirji.
"Sa'ad da na ji ciwon kirji a cikin kirji,
Wane irin ciwo ne kake da shi a kirjinka?
Yaushe ne wannan ciwon kirji ya fara?
A wane wuri ne kake ciwo a kirjinka?
Wannan shi ne abin da ke sa ka ji kamar kana ciwon kirji.
Za ka ji kamar kana da ƙarfi a kirjinka
Na yi fama da ciwon sukari, kuma na yi irin wannan rashin lafiya.
Ya ce yana da ciwon kirji.
Daga 1 ga Janairu zuwa 15 ga Maris, 2020, yawan kamuwa da cutar coronavirus (COVID-19) a cikin Turai ta Turai / Yankin Tattalin Arzikin Turai yana ƙaruwa cikin sauri.
Yawan adadin cututtukan cutar coronavirus (COVID-19) yana nuna irin wannan yanayin a cikin Tarayyar Turai / Yankin Tattalin Arzikin Turai da Burtaniya, wanda ke tabbatar da cewa cutar COVID-19 ta duniya tana yaduwa cikin sauri a duk ƙasashe, duk da cewa tana da matakan daban-daban na ƙasa.
Bisa ga kwarewar Italiya, ƙasashe, asibitoci da dakunan kula da lafiya na musamman suna buƙatar haɓaka shirye-shiryen su don tsammanin yawan marasa lafiya na COVID-19 da ke buƙatar kulawa mai ƙarfi.
A ranar 31 ga watan Disamba na shekarar 2019, an samu rahoton wasu cututtukan cutar samba da ba a san dalilinsu ba a Wuhan, lardin Hubei, kasar Sin.
A ranar 9 ga Janairu, 2020, Cibiyar Kula da Cututtuka da Rigakafin Cutar kasar Sin ta ba da rahoton cewa cutar ta haifar da cutar coronavirus ta hanyar Agent Novel, wanda ake kira cutar ta Coronavirus ta 2 (SARS-CoV-2).
Tun daga wannan lokacin, an sake kiran cutar ta coronavirus (COVID-19) da ke haifar da kamuwa da cutar SARS-CoV-2.
Shaidar da aka samu har yanzu ta nuna cewa kashi 80% na marasa lafiya da ke fama da COVID-19 suna da wani abu mai tsanani, wato kamuwa da cutar numfashi tare da ko ba tare da cutar ba, kuma yawancin suna warkewa.
A cikin kashi 14% na masu cutar kansa, COVID-19 ya ci gaba zuwa matakin da ya fi tsanani kuma yana buƙatar yin asibiti, yayin da sauran kashi 6% na lokuta suna fama da mummunan ciwo wanda ke buƙatar kulawa mai tsanani.
Kashi 4% na marasa lafiya da ke asibiti sun mutu saboda COVID-19.
A cikin wannan binciken, za mu kwatanta yanayin COVID-19 a kowace ƙasa ta EU / Yankin Tattalin Arzikin Turai da kuma a cikin Burtaniya (UK) da lardin Hubei na China.
A halin yanzu, mun kwatanta adadin shari'o'in COVID-19 a cikin EU / Yankin Tattalin Arzikin Turai da Burtaniya da waɗanda ke cikin Italiya daga 31 ga Janairu zuwa 15 ga Maris, 2020.
Kasashen EU/Yankin Tattalin Arzikin Turai da Burtaniya sun kamu da cutar COVID-19
COVID-19 ya bazu daga China zuwa wasu yankuna, kuma annobar COVID-19 a halin yanzu tana nuna ƙasar a duniya.
A ranar 11 ga Maris, 2020, babban darektan Hukumar Lafiya ta Duniya (WHO) ya bayyana COVID-19 a matsayin annoba ta duniya.
Spiteri et al. a cikin Eurosurveillance 2020 da aka buga a ranar 5 ga Maris sun ba da rahoton farkon shari'o'in COVID-19 na Turai bisa ga ma'anar WHO.
A cikin Tarayyar Turai/Yankin Tattalin Arzikin Turai, Faransa ce ta fara bayar da rahoton sabbin cututtuka uku na farko a ranar 24 ga Janairu, 2020, kuma mutane sun fito ne daga Wuhan, lardin Hubei, China.
Ya zuwa 15 ga Maris, 2020, an sami shari'o'in COVID-19 a cikin ƙasashen 30 na Tarayyar Turai / Yankin Tattalin Arzikin Turai da Burtaniya, tare da sabbin shari'o'i 39,768 da mutuwar 1,727 a tsakanin 31/2020 zuwa wannan ranar, daga cikinsu 17,750 da mutuwar 1,441 an rubuta su ne daga Italiya kawai.
Sanin yawan adadin shari'o'in COVID-19 da kuma yawan abubuwan da suka faru
Lambar cutar COVID-19 a kowace ƙasa ta duniya, kamar yadda aka bayyana a Cibiyar Tarayyar Turai don Rigakafin Cututtuka da Kulawa (ECDC), ta samo asali ne kawai daga kafofin hukuma kamar Ma'aikatar Lafiya ta ƙasashen, hukumomin kiwon lafiya na ƙasa da na yanki da WHO, wanda ake sabuntawa kowace safiya da karfe 8:00.
Waɗannan bayanan sun yi amfani da su don auna yanayin COVID-19 a cikin ƙasashen EU / Yankin Tattalin Arzikin Turai da Burtaniya da kuma kwatanta shi da Italiya.
A matsayin wakili na kasancewar shari'o'in COVID-19 masu aiki, mun gabatar da jimlar kwanaki 14 na shari'o'in COVID-19, saboda haka muna la'akari da yanayin COVID-19 na kowane EU / Kasashen Yankin Tattalin Arziki na Turai da Burtaniya daga Janairu 1-Maris 15, 2020.
Bugu da ƙari, mun kwatanta yawan adadin da aka samu a kowace ƙasa zuwa karfe 8:00 na safe na ranar 15 ga Maris, 2020, da yanayin da ke Italiya daga 31 ga Janairu zuwa 15 ga Maris, 2020.
COVID-19 a cikin Tarayyar Turai/Ƙasar Tattalin Arzikin Turai da kuma yanayin Burtaniya
A cikin kwanaki 14 na al'amuran COVID-19, yanayin da aka nuna a cikin EU/Yankin Tattalin Arzikin Turai da Burtaniya an bi shi a duk faɗin lardin Hubei (China) (Hoto na 1).
Ga EU/EEA da Burtaniya gabaɗaya, ƙaruwar yanayin COVID-19 ya fara ne a kusa da ranar 21 ga Fabrairu, sannan ya karu sosai zuwa 28 ga Fabrairu/2020 (Kayan Taimako).
Wannan ya kasance ne saboda saurin karuwa a cikin shari'o'in da aka ruwaito daga Italiya, amma, sauran ƙasashen EU / Yankin Tattalin Arzikin Turai da Burtaniya sun nuna irin wannan karuwar yanayin COVID-19 (Kayan taimako).
Hoto na 2 ya nuna yawan adadin shari'o'in COVID-19 a cikin Tarayyar Turai / Kasashen Yankin Tattalin Arzikin Turai da Burtaniya idan aka kwatanta da adadin da aka samu a Italiya daga Janairu 31-Maris 15, 2020.
A karfe 8:00 na safe na ranar 15 ga Maris, wasu kasashe 15 na Tarayyar Turai/Yankin Tattalin Arzikin Turai da Burtaniya sun yi rikodin jimlar adadin shari'o'in da aka yi a Italiya makonni uku ko ƙasa da haka.
Sakamakonmu ya nuna cewa adadin shari'o'in COVID-19 da aka ruwaito sun karu cikin sauri a cikin Tarayyar Turai / Yankin Tattalin Arzikin Turai da Burtaniya.
Hanyoyin da aka gani game da yanayin COVID-19 gabaɗaya sun nuna cewa annobar ta duniya tana ƙaruwa da sauri a duk ƙasashe.
Wannan yana faruwa yayin da ƙasashe ke kan matakai daban-daban, da bambance-bambance a cikin martani na lafiyar al'umma na ƙasa, kuma wataƙila akwai ma'anar shari'a daban-daban da ladabi daban-daban a cikin ƙasashe daban-daban don zaɓar marasa lafiya waɗanda za a bincika don gano idan akwai COVID-19.
A farkon watan Maris na 2020, likitoci a jihohin Italiya da suka kamu da cutar sun bayyana cewa kashi 10% na marasa lafiya na COVID-19 suna buƙatar kulawa ta musamman, kuma kafofin watsa labarai sun ruwaito cewa asibitoci da dakunan kula da lafiya a waɗannan jihohin sun isa su kula da su.
A halin yanzu, a cikin EU / Yankin Tattalin Arzikin Turai, akwai bayanai game da shari'o'in COVID-19 da ake bi da su a asibiti da / ko cibiyar kula da lafiya mai tsanani don kashi 6% da 1% na shari'o'in bi da bi (ba a nuna bayanai ba).
Duk da haka, dole ne a tattara bayanan da suka dace don ƙarfafa bayanan kulawa na yanzu game da yawan wadanda aka ruwaito da yawan mutuwar.
Wani bincike a shekara ta 2010-11 ya nuna cewa a Turai akwai bambanci tsakanin gado mai tsawo da kuma gado na yau da kullum, daga 29.2 a Jamus zuwa 4.2 a Fotigal ga mutum 100,000.
Wannan yana nufin cewa ƙasashe na iya samun ƙarin ko ƙasa da Italiya (12.5 gadaje na kulawa mai girma da matsakaici a kowace mutum 100,000, a 2010-11).
Matsalolin samfurin da suka shafi haɗakar ƙarfin tallafi na kiwon lafiya suna haifar da haɗarin haɗari a cikin gado na marasa lafiya na musamman sama da 90 don kowace ƙasa ta EU / EEA da Burtaniya, ƙididdigar yaduwar shari'o'in COVID a cikin asibiti, an gabatar da shi a cikin sabuntawar ECDC ta shida a cikin saurin COVID-19 kimantawa.
Saboda akwai wasu cututtuka a cikin EU/Yankin Tattalin Arzikin Turai da kuma Birtaniya, kuma asibitoci da dakunan kula da lafiya na musamman galibi suna ba da sabis ga wani ɓangare na al'umma, dole ne a bayyana bayanai game da cututtuka da gadon kula da lafiya a matakin Statistics 2 (NUTS-2).
Kwarewa daga Italiya da sauran abubuwan da ke faruwa a wasu ƙasashe sun nuna cewa annobar COVID-19 ta duniya tana gudana cikin sauri a cikin Tarayyar Turai / Yankin Tattalin Arzikin Turai da Burtaniya.
Saboda haka, dole ne kasashe, asibitoci da cibiyoyin kula da lafiya na musamman su kasance a shirye don sanin cewa SARS-CoV-2 na ci gaba da yaduwa a cikin al'umma kuma yawan marasa lafiya na COVID-19 suna buƙatar kulawa ta kiwon lafiya, musamman ma kulawar likita mai ƙarfi, misali a yankunan Italiya da suka kamu da cutar.
Kamar yadda aka nuna a cikin binciken gaggawa na ECDC na kwanan nan, yana da mahimmanci a bi hanyar sauri da ta gama gari don rage yaduwar SARS-COV-2, kuma ya kamata a canza hanyar daga riƙe cutar zuwa ragewa, saboda ƙaruwar da ake tsammani za ta faru a cikin adadin shari'o'in da ba a aiwatar da su ba da lokaci mai yawa ga masu yanke shawara da asibitoci don fahimtar, karɓa da daidaita amsar su.
Ana yin saurin tantance haɗari don rage matakan kiwon lafiyar jama'a, wanda aka yi niyya don rage tasirin cutar ta duniya.
Kasashe ba su da damar ƙara ƙoƙari na sarrafawa don rage nauyin kiwon lafiya ta hanyar jinkirta yaduwar SARS-CoV-2.
Idan ba haka ba, tsarin kula da lafiya na sauran kasashen EU / Yankin Tattalin Arzikin Turai zai zama mai yawa ga marasa lafiya da ke buƙatar ƙarin kulawa ta likita a cikin kwanaki ko makonni masu zuwa.
Cutar coronavirus ta 2019 (COVID-19) ta zama annoba saboda cutar ta SARS (Cov-2), wadda ta kai ga cutar ta cutar ta COVID-19 da ta shafi mutane fiye da 80,000 a kasar Sin da sauran kasashen duniya, inda ta kashe fiye da 3,000.
Kamar yadda cutar ta SARS-CoV ta yi wa dubban mutane a shekara ta 2003, ana iya samun cutar ta SARS-CoV-2 daga tsuntsaye da dare kuma ta haifar da irin wannan alamun.
Koyaya, COVID-19 yana da ƙananan nauyi da yawan mutuwa fiye da SARS, amma yawan kamuwa da cutar ya fi yawa kuma yana shafar tsofaffi fiye da matasa da maza fiye da mata.
Da yake an samu karuwar labarai game da sabon cuta, wannan labarin zai yi ƙoƙari ya ba da cikakken bayani game da aikin bincike mai sauri.
Muna rufe batutuwan asali game da cututtukan cututtuka, ilimin halayyar mutum, ilimin ƙwayoyin cuta, ganowa, magani da rigakafi.
Ko da yake har yanzu akwai tambayoyi da yawa da za a amsa, muna fatan cewa wannan binciken zai taimaka wajen fahimtar cutar da ke da haɗari da kuma kawar da ita.
Bikin bazara na 25 ga Janairu, 2020, ya bar wani abin tunawa da ba a taɓa mantawa da shi ba ga duk Sinawa, saboda an gargaɗe su kada su fita gidajensu a lokacin bikin da bayan bikin saboda sabon kamuwa da cutar.
Wannan cutar tana kama da cutar coronavirus (Cov) da ta haifar da cutar ta hanyar numfashi mai tsanani a shekara ta 2003, saboda haka, a ranar 11 ga Fabrairu, 2020, Hukumar Lafiya ta Duniya (WHO) ta sake sanya sunan SARS-CoV-2 kuma an sake sanya sunan cutar ta COVID-19 (COVID-19).
Cutar ta fara ne a birnin Wuhan, China, kuma da sauri ta bazu a duk ƙasar, ta kai kusan ƙasashe 50 na duniya.
A ranar 2 ga Maris, 2020, an samu karin mutane 80,000 da suka kamu da cutar COVID-19, fiye da mutane 40,000 sun bar asibiti, fiye da 3,000 sun mutu.
WHO ta yi gargadin cewa, COVID-19 shine makiyin jama'a na 1 kuma yana da damar cutar da ta'addanci.
A cewar PubMed (https://www.ncbi.nlm.nih.gov/pubmed/), a cikin ƙasa da watanni biyu da suka gabata bayan fitowar rahoton farko a ranar 7 ga Janairu, 2020, an buga labarai sama da 200 game da COVID-19, gami da ilimin cututtuka, cututtuka, ilimin lissafi, ilimin lissafi, kamuwa da cuta da magani, waɗanda suka ƙayyade jerin ƙwayoyin cuta daga marasa lafiya daban-daban.
Wannan binciken zai yi ƙoƙari ya taƙaita sakamakon binciken da muke yi a kan sabon batun nazari da ke saurin canzawa.
Idan za ta yiwu, za mu gwada COVID-19 da SARS da wani cuta na CoV, cuta ta numfashi ta Gabas ta Tsakiya (Meres, annoba ta 2012).
Za mu tattauna wasu tambayoyi masu muhimmanci da suka rage, kamar yadda muka koya game da rigakafin cutar da kuma sanin tarihinta.
Ana ɗaukar CoVs a matsayin masu cutar da ba su haifar da mutuwa a cikin ɗan adam ba, kuma sune manyan abubuwan da ke haifar da cutar mura kusan kashi 15 cikin ɗari.
Duk da haka, a wannan karni, mun sami manyan cututtukan CoVs (SARS-CoV da MERS-CoV) sau biyu; waɗannan ƙwayoyin sun fara faruwa a China a 2003 da Saudi Arabia a 2012, sannan suka bazu cikin sauri zuwa wasu ƙasashe da yawa kuma sun sami mummunan ci gaba da cutar da mutuwar.
Saboda haka, COVID-19 na yanzu shine annoba ta uku ta CoV da aka rubuta a tarihin ɗan adam.
Kamar yadda aka nuna a hoto na 1, an fara bayar da rahoton cutar samba da ba a san asalinta ba daga Hunan zuwa Hukumar Lafiya ta Kasa ta kasar Sin a ranar 31 ga Disamba, 2019.
Bayan kwana bakwai, an saki abokin aikin Cove.
Ranar 15 ga Janairu, 2020, an yi rahoton mutuwar farko a cikin ruwa.
A halin yanzu, cutar ta bazu cikin sauri zuwa garuruwan makwabta, yankuna da ƙasashe.
A ranar 20 ga Janairu, an ba da rahoton cewa masu kula da lafiya sun kamu da cutar, wanda ke nuna cewa cutar tana yaduwa daga mutum zuwa mutum.
A ranar 23 ga Janairu, duk hanyoyin sufuri na jama'a sun tsaya a birnin Wuhan kuma an rufe ayyukan birnin.
Nazarin farko na asibiti da aka gudanar a ranar 24 ga Janairu ya nuna cewa daga cikin marasa lafiya 41 da ke da cutar da aka tabbatar, 21 ne kawai suka kasance a cikin tuntuɓar kai tsaye da kasuwar abincin teku na ruwa, wanda ake tsammanin asalin dabba ne wanda ba a san asalin cutar ba.
A ranar 30 ga Janairu, WHO ta bayyana cewa annobar ta zama gaggawa ga lafiyar duniya.
A lokacin da aka shirya wannan rahoton, cutar ta riga ta bazu a kasar Sin da kuma wasu ƙasashe kusan 50 (Hoto (Hoto 2).
Da yake yanayin yana canjawa cikin sauri, za a iya sanin ko wane irin annoba ce za a yi a ƙarshe da kuma yadda za a yi ta a nan gaba.
A ranar 11 ga Fabrairu, 2020, an gudanar da binciken cibiyoyin bincike da yawa a kan marasa lafiya 8,866, daga cikinsu marasa lafiya 4,021 da suka tabbatar da COVID-19 suna nuna sabon yanayin annobar (https://mp.weixin.qq.com/s/UlBi-HX_rHPXa1qHA2bhdA).
SARS-CoV-2 yana shafar mutane na kowane zamani, amma ya fi shafar mutanen da ke tsakanin shekaru 30 zuwa 65.
Rabin wadanda suka kamu da cutar (47.7%) sun fi shekaru 50, kuma kaɗan ne kawai ke ƙasa da shekaru 20, kuma 14 ne kawai ke da shekaru 10 ko ƙasa da haka.
Yawan maza da ke fama da cutar SARS-CoV-2 (0.31/100,000) ya fi na mata (0.27/100,000).
COVID-19 ya bazu ne a Hubei da kewaye da shi.
Ana ɗaukar matsakaita kwanaki 5 (2-9) kafin a gano COVID-19 daga ranar kamuwa da cutar.
A matsakaita, mutum yana nuna alamun cutar a cikin kwanaki 4.8 (3.0-7.2).
A matsakaita, an yi shekaru 9.5 (4.8-13) kafin a mutu.
Matsayin haihuwa na asali (R0) 3.77 (95% CI: 3.51-4.05) ne, kuma daidaitaccen R0 2.23-4.82.
Yawan masu kamuwa da cutar ya karu sosai kafin 23 ga Janairu, 2020, lokacin jigilar kayayyaki don bikin bazara a China.
Yawan mutuwar marasa lafiya da ke da cutar da aka tabbatar da cutar ya kai 1.44% (95% CI: 1.10-1.86%) kuma adadin mutuwar da aka daidaita na dukan marasa lafiya ya kai 3.06% (95% CI: 2.02-4.59%).
Abubuwa uku da suka fi haifar da COVID-19 sune jinsi (maza), shekaru (≥60) da kuma cutar sankara mai tsanani.
CoVs ƙananan ƙwayoyin cuta ne masu yawa da ke da rukuni na RNA.
Ana iya rarraba su zuwa sassa hudu: alpha, beta, gamma da delta, kuma an san cewa alpha da beta CoVs suna cutar da mutane.
Envelope Spike (S) glycoprotein yana haɗuwa da enzymes 2 (ACE2) da dipeptidyl peptidase 4 (DPP4) na SARS-CoV da MERS-CoV daga mai karɓar ƙwayoyin cuta kuma ana ƙirƙirar haɗin ƙwayoyin halitta.
Ana sakin kwayoyin RNA na kwayar cutar zuwa cytoplasm; bayan an lalata kwayoyin kwayar cutar, RNA na kwayar halitta da glicoproteins da nucleocapside sun haifar da kwayar cutar a ciki ko waje, wanda ke haɗuwa da kwayar cutar ta hanyar haɗuwa da ƙwayar plasma.
An bayar da rahoton farko na SARS-CoV-2 a ranar 10 ga Janairu, 2020.
Lokacin da aka gano cewa SARS-CoV-2 sabon nau'in beta-CoV ne, an gano cewa fiye da 99.98% na samfurori 10 daga kasuwar abincin teku ta Hunan, a cikin ruwan da cutar ta fara.
SARS-CoV-2 yana da kamanceceniya da SARS-CoV maimakon MERS-CoV.
Ta hanyar microscopy na lantarki, an gano ƙananan abubuwa na SARS-CoV-2 a cikin ƙananan sassan numfashi na mutum.
An gano cewa ɗan adam ACE2 mai karɓar SARS-CoV-2 da SARS-CoV.
Koyaya, haɗin S-protein a cikin SARS-CoV-2 tare da ACE2 na ɗan adam ya rage ƙarfin SARS-CoV, wanda ke haifar da ƙananan kamuwa da cutar SARS-CoV-2 a cikin marasa lafiya fiye da SARS-CoV.
SARS-CoV-2 shine furotin mai gajeren ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar
Kwayar SARS-CoV-2 orf3b na iya taka rawa wajen kamuwa da cutar kuma ya hana bayyanar IFNβ, amma, ba a san wani aiki ko dalili na orf8 ba.
A ranar 18 ga Fabrairu, 2020, Zhu da abokan aikinsa sun ba da rahoton cewa cikakken tsawon ɗan adam ACE2 shine ƙudurin 2.9 Å na tsarin CREO EM, wanda ya fito ne daga mahaɗan amino acid mai ɗaukar nauyin B0AT1.
Bayanai masu buɗewa da rufewa sun tabbatar da cewa kwayar halitta ta sake haɗuwa da dimer kuma kwayar ACE2-B0AT1 na iya haɗa sunadarai biyu na S, wanda ke ba da shaida ga ganowa da kamuwa da cutar CoV.
B0AT1 na iya zama manufa ga maganin maganin rigakafi don hana kamuwa da cutar SARS-CoV-2.
A cikin wannan labarin, an rubuta wasu littattafai da suka nuna cewa ba a taɓa samun su ba.
An gano cewa SARS-CoV da MERS-CoV sun fito ne daga tsuntsayen dare kuma an watsa su ga mutane ta hanyar tsutsotsi da raƙuma, bi da bi.
Ta hanyar kwatanta asalin jinsin SARS-CoV-2 da sauran CoVs, an yi tunanin cewa tsuntsayen dare sune farkon masu karɓar SARS-CoV-2 saboda, sabon kwayar cutar bat-SL-CoVZX45 da bat-SL-CoVZX21 sun kasance 96% kama da CoVs biyu na SARS-like waɗanda suka fito daga tsuntsayen dare.
Amma, har yanzu ba a san wanda ya kai cutar ba kuma ba a bayyana hanyar da za ta kai ta ba.
G da abokansa sun nuna cewa macijin ne ya sa aka samu cutar daga tsuntsaye zuwa mutane, kuma hakan ya bukaci sake haɗa shi da furotin S.
A cewar wani bincike, masu bincike a Guangzhou, China sun gano cewa, dabbobi masu shayarwa masu dogon hanci da suke cin tsutsa, da ake amfani da su a yawancin lokaci a maganin gargajiya na kasar Sin, sune masu karɓar SARS-CoV-2, bisa ga kwatancen 99% na amsar jinsi tsakanin CoV da aka samu a kan pangolin da SARS-CoV-2.
Amma, bambancin kashi 1 cikin 100 a cikin jinsunan biyu da kansa ya bambanta sosai, saboda haka, ana jiran sakamako mai kyau don tabbatar da gaskiyar.
Har yanzu ba a san yawancin halaye na jiki da sunadarai na SARS-CoV-2 ba.
SARS-CoV da MERS-CoV suna rayuwa har zuwa awanni 48 a cikin yanayin bushe, har zuwa kwanaki 5 a ƙasa da 20 °C da kuma 40%-50% danshi.
SARS-CoV-2 na iya samun irin wannan fasalin.
An ruwaito SARS-CoV-2 yana da ƙwarewa ga hasken ultraviolet da zafin jiki na 56 °C zuwa 30 °C. Ethers, 75% ethanol, antibacterial chlorine, peroacetic acid, chloroform da sauran kayan shafawa masu narkewa zasu iya lalata kwayar cutar sosai ba tare da ƙara chloroxycin ba.
Yawancin mutane suna da rauni a cikin rigakafin SARS-CoV-2 kuma suna da haɗari ga sabon kwayar cutar.
A halin yanzu, babu cikakken bincike da aka bayar game da yadda cutar SARS-CoV-2 ta shafi rigakafin cutar.
Saboda haka, za mu iya ambata wasu bincike na baya a kan wasu cocoves, musamman Sars-Cov da Mers-Cov (Hoto na 4).
A gabaɗaya, ana gano kwayar cutar ta farko bayan ta kai wa mai masaukin baki ta hanyar masu karɓar kwayar cutar (PRRs) a cikin tsarin rigakafin mai masaukin baki, waɗanda suka haɗa da masu karɓar irin na C-type lectin, mai karɓar irin na Toll (TLR), mai karɓar irin na NOD (NLR), da mai karɓar RIG-I (RLR).
Kwayar cutar tana amfani da hanyoyi daban-daban don haifar da kumburi, ƙwayoyin cuta na antigen, da kuma haɗuwa da Interferons na nau'in I (IFNs), yana hana yaduwar kwayar cutar ta hanzarta haɓakar ƙwayoyin cuta na ƙwayoyin cuta.
Koyaya, furotin SARS-CoV N na iya taimakawa kwayar cutar ta tsere daga tsarin rigakafi.
Ba da daɗewa ba, maganin rigakafin cutar zai shiga cikin aikin yaƙi da cutar.
T lymphocytes, ciki har da CD4+ da CD8+ T cells, suna taka muhimmiyar rawa wajen hana cutar.
CD4+ T ƙwayoyin halitta suna kunna ƙwayoyin halitta na B don samar da rigakafin ƙwayar cuta, kuma CD8+ T ƙwayoyin halitta suna kashe ƙwayoyin da suka kamu da cutar kai tsaye.
T-cell na taimaka wajen samar da cytokines na proinflammatory don taimakawa kwayoyin rigakafi.
Koyaya, CoV na iya saurin mutuwar T-cell don hana aikin T-cell.
Hakanan, rigakafin ruwa kamar C3a da C5a da antibodies suna da mahimmanci don hana kamuwa da cutar.
Alal misali, an gano maganin rigakafi na MERS-CoV daga mai haƙuri da ya warke kuma ya sa ya zama mara amfani.
A wani ɓangare kuma, idan tsarin rigakafi ya yi aiki sosai, zai iya haifar da mummunan lalacewa ga ƙwayar cuta da sauran sassan jiki, kuma a mafi muni, zai iya haifar da mutuwa ta hanyar hana wasu sassan jiki aiki.
Ana iya kamuwa da cutar SARS-CoV-2 ga tsofaffi da mata masu ciki da ke fama da cututtuka daban-daban.
Mutane da ke da ƙarancin kamuwa da ƙwayoyin cuta ko kuma waɗanda ke da rashin ƙarfi suna da mafi yawan haɗarin kamuwa da cutar fiye da sauran.
Matsakaicin lokacin haihuwa na SARS-CoV-2 ya kasance kwanaki 1-14 kuma a cikin binciken da aka yi akan mutane 425 na farko a cikin ruwa, mafi yawan kwanaki 3-7 ne.
Amma, wani bincike da aka yi a kan mutane 1,099 ya nuna cewa a matsakaita, lokacin da aka yi maniyyi yana da kwanaki 3 kuma yana tsakanin kwanaki 0 zuwa 24.
Kamar yadda aka ambata a sama, binciken da aka yi kwanan nan ya nuna cewa, a cikin mutane 8,866 da aka yi wa kamuwa da cutar, lokacin haifuwa na kwanaki 4.8 (3.0-7.2) ne.
Don haka, zai zama da muhimmanci a daidaita lokacin warewa da kyau bisa ga lokacin haihuwa, kuma hakan zai hana mutane da ba su da alamun cutar watsawa.
A matsayinsu na al'ada, ana bukatar a ware mutanen da suka kamu da cutar ko kuma suka kamu da ita har tsawon kwanaki 14.
Shin ya kamata a ware mutane na kwana 24?
Babban alamun farko na COVID-19 zazzabi ne, wanda ba a iya lura da shi ba, ko kuma wasu alamun kamar tari, numfashi mai ƙyama, ciwon tsoka, kumburi, ciwon kai, ciwon wuya, ciwon kirji, kumburi da kuma kumburi.
Wasu marasa lafiya sun sami raguwar numfashi da kuma/ko rage yawan oxygen a cikin jini tun daga ranar da suka kamu da cutar.
A cikin yanayin da ya fi tsanani, marasa lafiya suna nuna ciwon numfashi mai tsanani, tsokoki na tsakiya, ƙwayar cuta da kuma coagulopathy.
Idan akwai zazzabi da kuma/ko cututtukan numfashi da kuma zazzabi mai tsanani, dole ne a yi musu gwajin cutar kafin su gano cutar, ko da ba su da matsala a yin hotunan samba.
Binciken da aka gudanar a ƙarshen Disamba na 2019, ya nuna cewa kashi 98% na bayyanar cututtuka sun kasance na kumburi, 76% na tari, 55% na numfashi da 3% na kumburi, kuma 8% na marasa lafiya suna buƙatar taimakon na'urar numfashi.
Kwanan nan, an gano irin wannan binciken a cikin nazarin da aka yi a kan wasu iyalai biyu da kuma waɗanda suka kamu da cutar da ba su da alamun cutar.
A wani bincike na shekara ta 2012, an gano cewa, zazzabi (98%), tari mai zafi (47%) da kuma numfashi mai tsawo (55%) sune manyan alamun marasa lafiya na MERS-CoV.
Koyaya, kashi 80% na marasa lafiya na COVID-19 suna buƙatar injin numfashi fiye da yadda suke buƙata, saboda mutuwar MERS ya fi COVID-19 girma.
An lura da ciwon kumburi (26%) da kuma raunuka a cikin wuya (21%) a cikin marasa lafiya na MERS.
A cikin marasa lafiya na SARS, zazzabi (99%-100%), tari (29%-75%), rashin numfashi (40%-42%), zazzabi (20-25%), da kuma ciwon wuya (13-25%) sune manyan alamun bayyanar cututtuka, kuma 14%-20% na marasa lafiya suna buƙatar taimakon numfashi.
A ranar 14 ga Fabrairu, yawan mutuwar COVID-19 ya kai 2% kuma adadin shari'o'in da aka tabbatar a duniya ya kai 66,576.
A matsakaici, adadin mutuwar SARS ya kai kashi 10% na shari'o'in 8,096 da aka tabbatar a watan Nuwamba na 2002.
A cikin binciken da aka gudanar a watan Yuni na 2012, na Mars, yawan mutuwar mutane daga cikin mutane 2,494 da aka tabbatar da cutar ya kai 37%.
Wani bincike na farko ya nuna cewa SARS-CoV-2 R0 ya kasance mafi girma zuwa 6.47, kuma kashi 95% na Interval na Aminci (CI) ya kasance 5.71-7.23, yayin da SARS-CoV R0 ya kasance daga 2 zuwa 4.
An kwatanta SARS-CoV-2 da MERS-CoV da kuma SARA-CoV a cikin tebur 1.1 dangane da alamun, yawan mutuwa da R0.
Bayanan da aka ambata a sama sun nuna cewa SARS-CoV-2 na da damar yadawa fiye da MERS-CoV da SARS-CoV, amma yana da ƙarancin kisa.
Saboda haka, sarrafa cutar SARS-CoV-2 ya fi kalubale fiye da sarrafa MERS-CoV da SARS-CoV.
Sau da yawa ana samun kamuwa da cutar a cikin iyali ɗaya ko kuma a cikin rukuni ɗaya ko kuma a cikin motar motsa jiki.
Yawancin lokaci, marasa lafiya suna da tarihin tafiya ko zama a cikin ruwa ko wasu yankunan da cutar ta shafa ko kuma sun taɓa tuntuɓar mutane ko marasa lafiya kai tsaye a cikin makonni biyu kafin cutar ta fara.
Amma, rahotanni sun nuna cewa mutane za su iya ɗaukar cutar fiye da makonni biyu ba tare da bayyanar cututtuka ba kuma marasa lafiya da suka tsira daga asibiti za su iya sake ɗaukar cutar.
A farkon cututtukan cutar, marasa lafiya suna da ƙananan ƙwayoyin jini (musamman lymphocytes) ko kuma ƙarancin adadin su.
Alal misali, an gano cutar lymphophenia da yawan fararen kwayar jini, 4×109/L, da yawan lymphocytes, 1×109/L, da yawan aspartate aminotransference da kuma viriemia 1,099 a cikin marasa lafiya na COVID-19.
A wasu marasa lafiya, an samu karuwar ƙwayar ƙwayar cuta da ƙwayar ƙwayar cuta da kuma ƙwayar myoglobin a cikin jini, kuma a yawancin marasa lafiya, an samu karuwar furotin mai aiki da C da kuma rage ƙwayar erythrocytes.
A cikin marasa lafiya masu ƙarancin ƙwayar cuta, yawan D-dimer, wanda ke rage yawan fiber a cikin jini ya ƙaru kuma adadin ƙwayoyin fari na jini na rigakafi ya ragu.
A yawancin marasa lafiya na COVID-19, sakamakon radiography na kirji ya nuna rashin lafiya, wanda ya nuna cewa an sami matsi a bangarorin biyu ko kuma ɓangarorin hazo a cikin samfurori.
Yawancin lokaci, marasa lafiya suna fama da ciwon hanci na yau da kullum, ciwon hanci mai tsanani, da kuma ciwon cutar numfashi mai tsanani (ARDS).
A lokacin da ARDS ta faru, ɓarkewar jiki, ƙwayoyin ruwa da kuma ciwon da ke ci gaba da girma suna haifar da matsala mai tsanani ga gas.
Kwayoyin alveoli na nau'i na I da na II suna rage haɓakar lipid da furotin, suna ƙara matsa lamba, suna sa naman gwari su yi nauyi kuma suna ƙara haɗarin ƙwanƙwasa naman gwari.
Saboda haka, yawanci ana yin bincike a kan cutar ta kirji da ta fi tsanani.
Binciken farko na binciken cutar COVID-19 da aka gudanar a ranar 18 ga Fabrairu, 2020, ya nuna cutar kwayar cutar, ƙwayoyin cuta na Haelin, ƙwayar cuta mai shiga cikin samba da ƙwayoyin da aka samo daga mai cutar da ya mutu, wanda ya dace da binciken cutar kwayar cutar da ARDS kuma ya yi kama da marasa lafiya na SARS da MERS.
Gano SARS-CoV-2 RNA ta hanyar hanyar aikin dakin gwaje-gwaje mai suna reverse-transcriptase polymerase chain reaction (RT-PCR) ya zama muhimmin mahimmanci ga bayyanar COVID-19.
Amma, saboda karuwar sakamakon rashin inganci wanda zai kara hanzarta barkewar cutar, an fara amfani da siginan asibiti don gano cutar a China a ranar 13 ga Fabrairu, 2020 (wanda ba zai dogara da RT-PCR kawai ba).
An gano cutar SARS a cikin wani abu mai kama da haka.
Saboda haka, haɗuwa da tarihin cutar, nunawa na asibiti, gwaje-gwajen dakin gwaje-gwaje da kuma binciken radiological yana da mahimmanci don gano cutar mai tasiri.
A ranar 14 ga Fabrairu, 2020, Feng Zhang Group ta kafa yarjejeniya ta gano SARS-CoV-2 ta hanyar gwaji ta amfani da fasaha ta CRISPR-based SHERLOCK, wanda ke samar da RNA RNA mai kwakwalwa ta hanyar amfani da dipstick a cikin ƙasa da awa ɗaya ba tare da buƙatar ƙarin kayan aiki ba, ta hanyar amfani da yarjejeniya ta samar da sassan RNA na SARS-CoV-2 a cikin 20 × 10-18 mol / L zuwa 200 × 10-18 mol / L (10-100 kwafi a cikin shigarwar microlitre).
Muna fatan cewa sabon fasaha zai iya inganta ƙoshin lafiya da jin dadi sosai idan ana iya tabbatar da shi ta hanyar gwajin asibiti.
Saboda rashin kwarewa game da COVID-19, likitoci za su iya ba da kulawa ta tallafi ga COVID-19, kuma za su gwada wasu magunguna daban-daban da aka yi amfani da su ko kuma an tsara su don magance wasu cututtukan cuta kamar SARS-CoV da MERS-CoV (tebur 2).
Waɗannan sun haɗa da maganin rigakafi, maganin rigakafi, steroids, ƙwayar jini, magani na kasar Sin, da kuma hanyoyin da za a yi amfani da su a nan gaba.
An kuma ba da shawarar yin amfani da jini daga marasa lafiya da suka warke.
Kamfanonin magunguna suna gaggauta samar da alluran rigakafin cutar.
SARS-CoV-2 ya fara kai hari ga naman sauro, amma ya rage yawan cutar da ke shafar sauran sassan jiki kamar na'urar narkewa da koda.
Amma, rashin numfashi da kuma rashin aiki sune manyan abubuwan da ke jawo mutuwa ga marasa lafiya.
Saboda haka, taimakon numfashi yana da muhimmanci wajen rage alamun cutar da kuma ceton rai. Yana haɗa da maganin oxygen gaba ɗaya, oxygen mai gudana sosai, iska mai hana jiki shiga da iska mai shiga da kuma iska ta inji bisa ga nauyin ƙanshi.
Masu fama da cututtukan rashin lafiyar numfashi na musamman suna bukatar a yi musu maganin oxygenation na ECMO, wani fasaha mai zurfi na zuciya da huhu wanda ake amfani da shi wajen magance rashin aiki na zuciya ko na numfashi.
Bugu da ƙari, kula da daidaiton electrolyte, rigakafi da magani na kamuwa da cuta na biyu da kuma bugun jini na ƙwayar cuta da kuma kula da ayyukan jikin mutum na SARS-CoV-2 suna da mahimmanci ga marasa lafiya.
An san dalilin da ya sa ake fama da cutar cytokine shine yawan yawan rigakafin jikin mutum a cikin marasa lafiya na SARS da MERS.
Cytocin Storm yana nunawa a matsayin amsa mai kyau ga hana haɓakar jiki, wanda ya ƙunshi sakin jerin cytokines, ciki har da TNFα, IL-1β, IL-2, IL-6, IFNα, IFNβ, IFNγ, da MCP-1.
Waɗannan kwayoyin cutar suna haifar da yawan kwayoyin da ke fitowa daga cikin kwayoyin cutar, wanda ke haifar da dakatar da ARDS da sauran sassan jiki.
Maganin rigakafi yana da muhimmanci wajen magance ciwon cytocin, musamman ga marasa lafiya masu tsanani.
An yi amfani da cortisteroids da toshilizumab, magungunan rigakafin IL6 na monoclonal, don magance cytocin.
Sauran magunguna don maganin cytokine storm sun haɗa da motsawar ƙwayar garkuwar jiki zuwa ƙwayoyin T; hana IFN-γ, IL-1, da TNF; hana JAK; blinatomab; siginar siginar cytokine; 4; da kuma masu hana HDAC.
Ana amfani da steroids a maganin ciwon daji don rage cutar da ke hana mutum yin rigakafi.
Koyaya, steroids masu yawa ba su da amfani sosai wajen rage mummunan lalacewar ƙwayar cuta a cikin marasa lafiya na SARS da COVID-19.
Maimakon haka, zai iya haifar da mummunan sakamako, musamman mutuwar ƙwayoyin ƙashi, kuma ya shafi ƙididdigar ci gaban cutar sosai.
Koyaya, an ba da shawarar cewa a ba da maganin cortisteroid na ɗan gajeren lokaci, mai ƙarancin zuwa matsakaici, yadda ya kamata ga marasa lafiya masu ƙwarewa na COVID-19.
A lokacin da ake rubuta wannan labarin, har yanzu ba a tabbatar da cewa akwai maganin rigakafi na cutar da zai iya magance cutar ba.
Koyaya, an sami sakamako a cikin wani mai haƙuri na COVID-19 na Amurka wanda aka karɓa ta hanyar jini, wanda shine analog na nucleotide, Remdesivir.
An yi amfani da Remdesivir a matsayin sabon maganin rigakafi na ƙwayoyin cuta a Gilead, wanda aka yi niyya a dā don magance cututtuka da suka shafi ƙwayoyin cuta na Ebola da na Marburg.
Daga baya, an nuna cewa Remdesvir yana hana ayyukan ƙwayoyin cuta na RNA guda ɗaya, gami da ƙwayoyin cutar Mars da SARS.
A cewar wannan, Gilead ta kawo sinadarin zuwa kasar Sin domin a gudanar da gwaje-gwaje a kan mutane da ke fama da cutar SARS-CoV-2, kuma ana sa ran sakamakon.
Bugu da ƙari, an ba da shawarar yin amfani da baritinib, interferon-α, lopinavir/ritonavir, da ribavirin a matsayin magani ga marasa lafiya da ke fama da cututtukan numfashi.
Ana iya haifar da ciwon ciki, kumburi, kumburi, cutar hanta da sauran mummunan halayen magana ta hanyar maganin hada-hadar Lopinavir / Rithonavir.
Dole ne a lura sosai da alaƙar da ke tsakanin waɗannan magunguna da sauran magunguna da ake amfani da su a cikin marasa lafiya.
A lokacin da aka yi amfani da maganin, an yi amfani da maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin cutar.
Hakazalika, an daɗe ana amfani da jini daga mutanen da suka warke daga cututtuka masu yaduwa don a yi wa waɗanda suke da cututtuka magani ko kuma don a hana mutane lafiya kamuwa da cutar.
Hakika, marasa lafiya da suka warke suna da ƙwayoyin rigakafi masu yawa a cikin jininsu.
Anboids sune immunoglobulins (Ig) waɗanda kwayoyin B suke samarwa, waɗanda ke yaki da cututtuka da sauran kwayoyin halitta, kuma suna amfani da su kai tsaye ta hanyar gano kwayoyin da ke cikin kwayoyin cutar.
A cewar wannan, an karɓi jini daga cikin marasa lafiya da suka warke daga COVID-19 kuma an yi wa marasa lafiya 10 da ke fama da cutar allurar rigakafi.
A cikin sa'o'i 24, an inganta alamun cutar, an rage kumburi da ƙwayoyin cuta, kuma an inganta yawan iskar oxygen a cikin jini.
Amma, idan ana son a yi amfani da wasu hanyoyin magani, ana bukatar a tabbatar da cewa akwai wasu hanyoyin da za a iya yin amfani da su sosai.
Bugu da ƙari, ya kamata a yi la'akari da wasu lahani da ke tattare da jini, saboda sakamakon da ke tattare da maganin.
Alal misali, maganin rigakafi zai iya hana rigakafin mutum ya kamu da cutar, kuma ya haifar da cutar cytokine mai guba.
Yawancin lokaci, ƙwayar ƙwayar ƙwayar cuta a cikin jini ba ta da yawa, kuma ana bukatar jini sosai don kula da marasa lafiya.
Yana da wuya a yi sauri kuma a samar da wasu kwayoyin rigakafi da ke da ikon yaƙi da annoba ta duniya.
Saboda haka, a cikin marasa lafiya da suka warke, dole ne a gano nau'ikan kwayoyin halitta da ake buƙata don cire ƙwayoyin B da kuma samar da maganin rigakafi mai inganci, ko kuma a bincika sunadarai masu mahimmanci na cutar don su zama maganin rigakafi mai inganci.
Ta wannan hanyar, za mu iya ƙara yawan kwayoyin cutar.
An yi amfani da TCM a kasar Sin na shekaru dubbai don magance cututtuka iri-iri.
Amma, sakamakon ya dogara ne da haɗuwa da sassan da ke cikin tsari guda, wanda ya bambanta dangane da yanayin cutar bisa ga bukatun TCM.
Yawancin sassan da suka dace sun kasance ba a sani ba ko kuma ba a sani ba, saboda yana da wuya a gano da kuma tabbatar da irin waɗannan sassan ko haɗin su.
A halin yanzu, TCM ya zama ɗayan manyan hanyoyin zaɓin magani ga marasa lafiya waɗanda ke da alamun rashin lafiya na sauƙi zuwa matsakaici ko kuma waɗanda suka dawo daga rashin lafiya saboda rashin ingantaccen magani na musamman don COVID-19.
Misali, an gano cewa magungunan Shu Feng Jie Du da Lian Hua Qing Wen sun yi tasiri wajen magance COVID-19.
Yawancin jihohin da ke China da suka yi amfani da TCM a cikin kashi 87% na marasa lafiya sun sami mafi yawan ceto a cikin marasa lafiya na COVID-19, daga cikinsu akwai Gansu (63.7%), Niza (50%) da Hunan (50%). Jihar Hubei, wanda kawai ya yi amfani da TCM a cikin kusan 30% na marasa lafiya na COVID-19, ta sami ƙarancin ceto (13%).
Amma, wannan kwatancin bai da zurfi, domin akwai wasu abubuwa da yawa da za su iya shafan yanayin da ake yi, kamar yawan marasa lafiya da kuma yanayin rashin lafiya.
A ranar 18 ga Fabrairu, 2020, Boli Zhang da abokan aikinsa sun buga wani binciken da ya kwatanta maganin Magungunan Yammacin Turai (WM) da maganin WM da TCM a hade.
Sun tabbatar da cewa lokacin da ake buƙatar dawo da zafin jiki, lokacin da alamun suka ɓace da lokacin da ake kula da shi a asibiti sun ragu sosai a cikin ƙungiyar WM+TCM fiye da a cikin ƙungiyar WM kawai.
Abin mamaki, yawan cututtukan cututtuka (daga sauki zuwa mai tsanani) ya ragu sosai a cikin WM+TCM fiye da na WM kawai (7.4% akan 46.2%); kuma mutuwar ta ragu sosai a cikin WM+TCM fiye da na WM kawai (8.8% akan 39%).
Amma, TCM za ta kasance mai jiran sakamako na gwaje-gwaje masu tasiri da aminci a kan manyan sikelin da kuma cibiyoyin da yawa.
Bayyana matakan da za a bi da su da kuma bayyana abubuwan da ke cikin maganin TCM ko kuma haɗuwa da su idan ya yiwu, na iya zama abin sha'awa.
Marasa lafiya da ake zargi ko kuma waɗanda aka tabbatar da COVID-19 suna tsoron kamuwa da cutar mai yaduwa da kuma kisa, kuma waɗanda ke keɓewa suna jin ƙyama, kaɗaici da fushi.
Ƙari ga haka, rashin jin daɗi da kuma rashin jin daɗi da ake samu daga cututtuka kamar zazzabi, rashin numfashi, da tari, kamar rashin barci da ake samu daga cututtukan da ake amfani da su a jiki, zai iya sa mutum ya yi rashin lafiya da kuma damuwa.
A farkon barkewar cutar SARS, an bayar da rahoton rashin lafiyar kwakwalwa daban-daban, ciki har da ci gaba da bugun jini, damuwa, tashin hankali, rashin hankali, alamun rashin hankali, lalata da tunanin kashe kansa.
Kulawa da keɓaɓɓu da keɓaɓɓu, ɗayan matakan lafiyar jama'a don hana cutar COVID-19, na iya haifar da damuwa da laifi ga mutane game da cutar, sakamakon keɓaɓɓu da keɓaɓɓu ga iyalansu da abokai.
Saboda haka, dole ne a kula da lafiyar hankali ga marasa lafiya na COVID-19, mutane masu shakku da waɗanda suka tuntube su da kuma waɗanda suke buƙatar su gaba ɗaya.
Abubuwan da za a bayar da tallafi na tunani sun haɗa da kafa ƙungiyoyin kula da lafiyar hankali da yawa, isar da daidaitattun bayanai na yau da kullun game da annobar SARS-CoV-2 da shirye-shiryen magani, da kuma amfani da na'urorin lantarki da aikace-aikacen ƙwararru don guje wa tuntuɓar juna.
Bugu da ƙari, allurar rigakafi mai tasiri tana da muhimmanci wajen kawar da hanyar watsawa daga gidajen kiwo da kuma mutanen da suka kamu da cutar zuwa wuraren da ke da haɗari, maganin rigakafi na iya taimakawa wajen sarrafa cututtukan da ke haifar da sababbin ƙwayoyin cuta.
An yi ƙoƙari don samar da alluran rigakafin S-protein wanda zai iya ƙarfafa rigakafin cutar da / ko rigakafin cutar a cikin yanayin SARS-CoV.
An gwada alluran rigakafin da aka samar daga ƙwayoyin cuta na SARS a cikin samfurin dabba.
Amma, ana bukatar a ƙayyade ko waɗannan alluran rigakafi za su iya shafar tsofaffi, ko kuma su iya hana su mutuwa, ko kuma su iya hana su kamuwa da ƙwayoyin cuta da ke yaduwa daga dabbobi kafin a fara binciken asibiti.
Wataƙila saboda SARS ya ragu shekaru 17 da suka gabata kuma ba a sami sabon kamuwa da cutar ba tun daga wannan lokacin.
A akasin haka, a Gabas ta Tsakiya, cutar ta ci gaba da ƙaruwa sosai, kuma ta yadu zuwa wasu yankuna.
An yi amfani da ƙwayoyin cuta marasa aiki, plasmids na DNA, vectors na kwayar cuta, nanoparticles, abubuwa masu kama da kwayar cuta da kuma ƙananan sinadarai masu ƙwayoyin cuta na dakin gwaje-gwaje don tsara allurar rigakafin Mars, wasu kuma an gwada su a kan samfurin dabba.
Samar da allurar rigakafi mai aminci da inganci don rigakafin SARS-CoV-2 ga mutane marasa ƙarfi aiki ne na gaggawa da kuma gaggawa don sarrafa annobar da ke gudana.
Duk da haka, yin aiki da wannan matsalar yana da wuya saboda tsawon lokacin da ake bukata don samar da allurar rigakafi (kimanin watanni 18) da kuma yanayin CoVs.
Saboda COVID-19 sabon cuta ne, an fara nuna cikakken aikin asibiti a dubban marasa lafiya.
A yawancin lokuta, marasa lafiya suna iya warkewa a hankali ba tare da yin wani lahani ba.
Koyaya, kamar SARS da MERS, COVID-19 yana haifar da mummunan ciwo da mutuwa ga waɗanda ke fama da rashin lafiya.
Saboda haka, yana da muhimmanci a gina tsarin tsinkaya na ci gaban wannan cuta don hukumomin kiwon lafiya su iya tsara ayyukansu musamman a yankunan da ake fama da rashin lafiya.
Bisa ga binciken asibiti da aka ruwaito zuwa yanzu, waɗannan batutuwan masu zuwa na iya shafar ko kuma suna da alaƙa da tarihin marasa lafiya na COVID-19 (tebur (tebur33):
Shekaru: Shekaru sun kasance masu mahimmanci wajen gano tarihin cutar SARS, kuma wannan yana aiki kamar yadda yake tare da COVID-19.
Kamar yadda aka ambata a sama, a cikin binciken da aka yi a kan shari'o'i 8,866, kashi 47.7% na marasa lafiya sama da shekaru 50 da haihuwa sun kamu da COVID-19 a tsakanin shekaru 30 zuwa 65.
Gaskiyar cewa marasa lafiya da ke buƙatar kulawa mai ƙarfi sun fi tsofaffi fiye da waɗanda ke da cututtuka da matsalolin lafiya da ba su da matsala ta yanzu (ƙimar shekaru 66 zuwa 51 a matsakaici) yana nuna cewa shekaru suna da alama ga masu haƙuri na COVID-19 don kimanta yiwuwar warkewa daga cutar.
jinsi: Kamar yadda aka ambata a sama, SARS-CoV-2 ya fi kamuwa da maza fiye da mata (0.31/100,000 maza, 0.27/100,000 mata).
Rashin lafiya da cututtuka masu maimaitawa: Marasa lafiya na COVID-19 da ke buƙatar kulawa ta musamman suna da haɗarin kamuwa da cututtukan zuciya da rashin numfashi.
Matsalolin cututtukan zuciya sune manyan abubuwan da ke haifar da mutuwar marasa lafiya na SARS.
An ruwaito cewa SARS-CoV-2 yana da alaƙa da colangiocytes na ACE2-positive kuma yana iya haifar da matsalolin lafiyar hanta a cikin marasa lafiya na COVID-19.
Ya kamata a fahimci cewa shekaru da kuma cututtuka suna da alaƙa sosai kuma suna iya tsoma baki.
Abubuwan da aka gano a dakin gwaje-gwaje ba su da lafiya: matakan furotin mai aiki na C (CRP) a cikin jini suna nuna yawan kumburi ko lalacewar jijiyoyin jini, kuma an ba da shawarar amfani da shi don gano tarihin cutar, amsa ga magani da kuma dawo da ƙarshe.
An kuma gabatar da wata dangantaka tsakanin matakan CRP da kuma hasashen nauyin COVID-19 da yanayin ci gaba.
Bugu da ƙari, haɓakar lactate dehydrogenase (LDH), aspartate aminotransferase (AST), alanine aminotransferase (ALT), da creatine kinase (CK) na iya taimakawa wajen hango sakamakon.
Ana samun waɗannan enzymes a wurare dabam-dabam na jiki, musamman a zuciya da hanta, kuma ana sakin su sa'ad da aka lalata ƙwayoyin halitta.
Saboda haka, cututtukan zuciya ko na hanta alamun alamun yau da kullum ne.
Dole ne a yi amfani da manyan alamun asibiti, radiography na kirji da kuma tsawon lokacin bayyanar cututtuka na asibiti tare da sauran dalilai don hango sakamakon COVID-19 da matsalolin kiwon lafiya.
Amfani da Steroids: Kamar yadda aka ambata a sama, ana amfani da steroids a matsayin magani na taimako ga cututtukan cututtuka don rage rigakafin mutum da kuma cutar da numfashi.
Ana amfani da kwayoyin cuta masu yawa a cikin marasa lafiya masu ciwon SARS, kuma yawancin waɗanda suka tsira daga cutar sun sami mutuwar ƙwayoyin ƙashi da rauni na dindindin da rashin rayuwa.
Saboda haka, idan ya cancanta, yakamata a yi amfani da steroids a ƙananan adadi da gajeren lokaci a cikin marasa lafiya na COVID-19.
Rashin damuwa: Kamar yadda aka ambata a sama, yawancin marasa lafiya suna fuskantar damuwa da rashin tabbas saboda an ware su na dogon lokaci a lokacin annobar COVID-19, suna ganin danginsu da sauran marasa lafiya sun mutu.
Idan kana so ka taimaka wa marasa lafiya su warke daga damuwa kuma su koma rayuwa ta yau da kullum, yana da muhimmanci ka ba su shawara da kuma taimako na dindindin.
A cewar binciken da aka yi a yanzu, COVID-19 na da halaye na yaduwar cutar daban da SARS.
Baya ga ninka kansa a cikin ƙananan numfashi, SARS-CoV-2 ya ninka kansa a cikin numfashi na sama kuma ba ya nuna sauƙi ko alamun bayyanar cututtuka a farkon matakin kamuwa da cutar, kamar sauran CoVs da ke haifar da mura.
Saboda haka, mutane da suka kamu da cutar za su iya samar da ƙwayoyin cuta masu yawa a farkon matakin ko kuma lokacin yaduwar cutar, saboda aikin yau da kullun, wanda ke sa ya zama da wuya a sarrafa cutar.
Koyaya, an gano cewa SARS-CoV ana watsawa ne lokacin da marasa lafiya suka yi rashin lafiya sosai kuma yawancin yaduwar ba ta faru a farkon farkon cutar ba.
Saboda haka, annobar COVID-19 ta yanzu ta fi ta SARS tsanani kuma ta fi wahala a sarrafa.
Ana yin manyan ƙoƙari a China don dakatar da yaduwar SARS-CoV-2, gami da ƙuntata ayyukan a cikin ruwa da garuruwan da ke kewaye da shi da kuma sanya al'umma gaba ɗaya cikin yanayin keɓewa.
Duk da cewa wadannan matakan suna shafar tattalin arziki da sauran bangarorin kasar, rage yawan sabbin cututtuka na nuna cewa annobar ta ragu.
Ana tsammanin cewa cutar za ta ƙare a watan Maris kuma za a rage yaduwar cikin watanni 3-4.
Amma, wasu masana ba su da wannan tabbacin.
A cewar Inne Paul Hunter, COVID-19, wanda ya fi SARS kamuwa da cuta, ba zai ƙare a shekarar 2020.
Kuma Ira Longini ya kirkiro wani tsari na hango ko hasashen sakamakon annobar, inda ya nuna cewa SARS-CoV-2 na iya kaiwa kashi biyu bisa uku na yawan duniya hari.
Wani rukuni na Kanada ya ruwaito cewa an gano SARS-CoV-2 a cikin samfurori na hanci da wuyan marasa lafiya da suka bar asibiti makonni biyu da suka gabata, wanda ke nuna cewa cutar da aka gano kwanan nan, kamar mura, tana iya faruwa sau da yawa.
Amma, a kasar Sin, an nuna alamun da za su nuna cewa an yi kasa a kan dabarun da ake amfani da su yanzu, saboda ƙarancin adadin sababbin cututtuka.
Da farko an kiyasta cewa cutar Ebola za ta kashe mutane miliyan ɗaya, kuma hakan zai kashe rabin miliyan.
Amma, da sannu-sannu, an daina cutar saboda rashin lafiyan da ake yi da kuma warewa.
Kamar SARS-CoV, SARS-CoV-2 na iya zama ƙarancin ƙarfi kuma ya mutu a cikin tsari ko kuma ya kasance tare da mutane kuma yana da ƙarancin ƙwayar cuta.
A ƙasa akwai kwatancen cutar COVID-19 da SARS da MERS (Hotuna 55):
Ana watsa SARS-CoV-2 ta hanyar tsutsa ko tsutsa, da kuma ta hanyar tuntuɓar kai tsaye da kayan da ke da cutar.
An gano cutar a cikin hanji kuma hakan ya nuna cewa tana da damar watsawa daga hanji zuwa baki.
Wani bincike na kwanan nan da aka yi kan shari'o'i 138 ya nuna cewa kashi 41% na shari'o'in sun kasance sakamakon kamuwa da cuta a wani wuri, ciki har da marasa lafiya 17 da masu kula da lafiya 40 da ke da cututtuka na yanzu.
Saboda haka, dole ne a yi hankali sosai don a kāre mutane, musamman ma masu kula da lafiya, ma'aikatan kula da jama'a, 'yan uwa, abokan aiki, da kuma waɗanda suka yi hulɗa da marasa lafiya ko waɗanda suka kamu da cutar.
Hanyar farko da za mu iya amfani da ita don rage haɗarin kamuwa da cuta ita ce yin abin rufe fuska; yin abin rufe fuska na tiyata da abin rufe fuska na numfashi na N95 (sunan samfurin 1860s) yana taimakawa wajen sarrafa yaduwar cutar.
Masks na tiyata suna hana saukad da cutar daga mutum ya tashi zuwa iska ko kuma ya rataye a kan kayan don ya hana shi watsawa ga wasu mutane.
Koyaya, kawai N95 masks (Lambar lamba 1860s) ne ke hana ɗaukar ƙwayoyin cuta masu girma daga 10 zuwa 80 nm; kawai 5% na ƙwayoyin cuta masu ƙarancin ƙarfi suna iya shiga cikin numfashi; SARS-CoV-2 ya yi kama da SARS-CoV, dukansu suna da kusan 85 nm.
Masks biyar na tiyata suna cikin ruwa, amma ƙananan abubuwa na iya shiga cikin ruwa, saboda haka masu kula da lafiya da ke da kai tsaye lamba da marasa lafiya ba za su sanya N95 (lambar alama 1860s) da masks na tiyata ba.
Baya ga abin rufe fuska, dole ne masu kula da lafiya su sa tufafin da aka shirya da kansu don rage haɗuwa da cutar.
Kwayar cuta tana iya cutar da mutum a idanunsa.
A ranar 22 ga Janairu, 2020, wani likita ya kamu da cutar SARS-CoV-2 a cikin abin rufe fuska na N95, wanda ƙila ya shiga jikinsa ta hanyar idanunsa.
Saboda haka, masu kula da lafiya suna bukatar su saka abin rufe fuska ko abin rufe fuska da ke nuna bayyanar idan suna aiki da marasa lafiya.
Ga dukan mutanen da ke zaune a wuraren da cutar ta shafa ko kuma za ta iya shafawa, ana ba da shawarar kowa ya wanke hannayensa da sabulu fiye da yadda ya saba, ya kasance a gida a ware, kuma ya rage tuntuɓar waɗanda suke zaune tare da waɗanda ke da damar kamuwa da cutar.
Dole ne mutane su kasance a nesa da mai haƙuri a ƙafa uku.
Waɗannan matakan suna da tasiri wajen rage haɗarin kamuwa da cuta da kuma hana yaduwar cutar.
Kodayake SARS-CoV-2 ya bayyana a matsayin sabon kwayar cutar ga ɗan adam, babban kamanceceniya da SARS-CoV, kamar yadda aka ruwaito a ranar 7 ga Janairu, 2020, ya kamata ya zama babban ƙararrawa saboda mummunan ƙwaƙwalwar ƙwaƙwalwar cutar SARS da China ta fuskanta a 2003.
Duk da haka, darektan Cibiyar Kula da Cututtuka ta Watana ya ci gaba da ƙarfafa jama'a har zuwa 19 ga Janairu, 2020, yana bayyana cewa sabon kwayar cutar tana da ƙarancin yiwuwar watsawa daga mutum zuwa mutum da kuma iyakantaccen yiwuwar haifuwa, kuma ba shi da wahalar hanawa da sarrafa cutar.
Musamman a lokacin da duk ƙasar ke shirin bikin bazara, wannan saƙon ya ƙara faɗakar da jama'a sosai, kuma ya zama muhimmin lokaci don sarrafa cutar yayin da ta kasance a cikin ruwa.
Hukumomin kula da cututtuka a kasar Sin za su iya yin gyara mai girma a nan gaba ta hanyar koyi da wannan darasi mai wuya.
Alal misali, waɗannan hukumomi suna bukatar su (1) yi hankali sosai wajen bayar da shawarwari na jama'a domin suna ɗaukan kowane kalma da muhimmanci kuma suna iya canja ra'ayinsu da shawarwarin da suka yanke; (2) su kasance masu saurin saurara da kuma amsa ga bayanai na yau da kullum daga asibitoci maimakon jiran rahotanni na yau da kullum daga likitoci ko jami'ai; (3) su kasance masu saurin ba da shawara don hana mutane sanin cewa annoba ta faru; da kuma (4) su ba da lokaci mai yawa don yin ayyukan da suka dace da kuma tasiri da za su taimaka wa jama'a su fahimci cututtuka da kuma inganta tsarin zabe na al'umma a wani lokaci.
Cutar COVID-19, wanda ya faru ne saboda cutar coronavirus SARS-CoV-2, ya fara ne a ƙarshen Disamba 2019.
A cikin ƙasa da watanni biyu, an yi amfani da shi a dukan ƙasar Sin kuma a kusan ƙasashe 50 a lokacin da ake wallafa wannan labarin.
Saboda cutar ta yi kama da SARS-CoV da kuma alamun COVID-19 da SARS suna kama, an yi tunanin cewa cutar COVID-19 za ta sake faruwa.
Duk da haka, akwai wasu bambance-bambance masu mahimmanci tsakanin COVID-19 da SARS, waɗanda ke da mahimmanci don sarrafa cutar da kuma kula da marasa lafiya.
COVID-19 yana shafar tsofaffi fiye da matasa, maza fiye da mata, kuma yana ƙara yawan kamuwa da cutar da yawan mutuwa a cikin tsofaffi fiye da matasa.
Yawan mutuwar da SARS ke haifarwa ya fi na COVID-19 girma (10.91% idan aka kwatanta da 1.44%).
Masu cutar COVID-19 suna watsa kwayar cutar ko da ba su da alamun cutar, amma masu cutar SARS galibi suna watsa cutar a lokacin da suke cikin mummunan yanayi, wanda hakan ke sa ya zama da wahala a sarrafa yaduwar COVID-19 fiye da SARS.
Wannan yana ba da wani bayani game da dalilin da ya sa SARS-CoV-2 ya zama mafi sauri da kuma yadu fiye da SARS-CoV.
Gwajin RNA na yau da kullun don SARS-CoV-2 na iya zama mara kyau ga wasu marasa lafiya na COVID-19.
A gefe guda kuma, marasa lafiya da suka tsira za su iya sake samun cutar.
Wadannan binciken sun kara barazanar yaduwar cutar.
Tunda bincike kan COVID-19 yana samun ci gaba cikin sauri, akwai wasu mahimman batutuwa da ake buƙatar warwarewa, kamar:
Daga ina ne SARS-CoV-2 ya fito?
Kodayake an gano 96% na kamanceceniya tsakanin SARS-CoV-2 da CoVs na SARS na tsuntsaye biyu, har yanzu ba za mu iya yanke shawarar cewa SARS-CoV-2 ya fito ne daga tsuntsaye na dare ba.
Wane irin dabba ne ya fara watsa cutar daga tsuntsayen dare zuwa mutane?
Idan ba mu san amsoshin tambayoyin 1 da 2 ba, ba za mu iya dakatar da yaduwar cutar ba, kuma annobar na iya kai ka hari a kowane lokaci.
Ko da yake an gano cewa SARS-CoV-2 yana da alaƙa da ACE2 ta hanyar samfurin kwayoyin halitta da kuma nazarin halittu, ta yaya cutar ta shiga cikin ƙwayoyin bututun iska kuma ta haifar da cutar?
Shin kwayar cutar tana da alaƙa da ƙwayoyin ACE2 a wasu sassan jiki?
Idan ba a ba da amsoshin waɗannan tambayoyin ba, ba za mu iya gano cututtuka da sauri ba kuma mu yi maganin da ya dace ba.
A cikin shekara ta 1914, an yi amfani da cutar ta kamuwa da cuta ta kamuwa da cuta ta hanyar amfani da kwayoyin cuta.
Ta yaya za a iya ganin cewa an haifi ƙwayoyin cuta a lokacin da ake watsa su?
Shin zai zama annoba ta duniya, ko kuwa zai zama kamar cutar SARS ko kuma zai zama kamar mura?
Ko da yake yana da muhimmanci mu sami amsoshin waɗannan tambayoyin da kuma wasu, yana iya ɗaukan lokaci.
Amma, duk da haka, ba mu da wani zaɓi sai dai mu daina cutar nan da nan kuma mu koma rayuwarmu ta yau da kullum.
A cikin wannan labarin, an gano cewa cutar ta kamu da cutar coronavirus a duniya.
Canji da daidaitawa sun kasance tushen tushen cutar coronavirus da masu ɗaukar ta har da mutum na dubban shekaru.
Kafin 2003, an tabbatar da cewa kwakwalwan mutum biyu suna haifar da ƙananan cututtuka kamar mura.
Cutar cutar ta hanyar numfashi mai tsanani (SARS) da cutar ta hanyar numfashi ta Gabas ta Tsakiya (MERS) ta nuna cewa kamuwa da cutar HCVC na da haɗari da haɗari ga rayuwa.
Yunƙurin SARS-CoV-2 a tsakiyar China a ƙarshen 2019 ya sa Covuses suka sake ɗaukar hankali kuma ya ba mu mamaki da ƙarfin watsawa, duk da haka, yawan kamuwa da cutar ya ragu idan aka kwatanta da SARS-CoV.
HCV cutar dabba ce, saboda haka fahimtar tushen dabba na HCV yana da amfani sosai.
Yawancin HCoVs sun fito ne daga tsuntsaye na dare kuma ba su haifar da cututtuka a cikinsu ba.
Ana kuma san su da manyan masu ɗaukar wasu HKovs.
Zaɓin dabbobi masu ɗaukar hoto yana da alaƙa kai tsaye da hana cututtuka.
Binciken hulɗar masu ɗaukar Cove a cikin dabbobi na iya ba da ƙarin haske game da ƙwayoyin cuta na Cove a cikin mutane.
A cikin wannan bita, za mu taƙaita bayanan da ke akwai game da HCV bakwai, tarihin gano su, da kuma tushen asali da kuma hanyar sadarwa.
Abu mai mahimmanci, idan muka kwatanta HCoVs daban-daban, za mu iya kwatanta yadda cutar ta samo asali da kuma yadda aka sake tsara kwayoyin halitta.
An tattauna a cikin wannan mahallin game da annobar COVID-19 na yanzu na 2019.
Bugu da ƙari, an kuma nuna cewa akwai buƙatar canjin mai ɗaukar hoto mai nasara da tasirin yanayin kwayar cutar a cikin nauyin cutar.
Kwayar cutar korona ta kasance cikin rukuni na kwayoyin cutar da ake kira coronaviruses, wanda ke da rukuni na kwayoyin cutar masu kyau da kuma RNA guda.
Wadannan ƙwayoyin cuta suna da babban jini daga 26 zuwa 32 kilobes na ƙwayoyin RNA, kuma an kira su Kovacs because saboda siffarsu ta zama kamar kambi a ƙarƙashin microscope na lantarki.
A cikin tsarin, ƙananan ƙwayoyin cuta suna da kwayoyin halitta waɗanda ke da tsari iri ɗaya wanda ba a rarraba su ba.
Kimanin kashi biyu bisa uku na nau'in kwayar cutar suna da manyan masu karantawa biyu (ORF1a da ORF1b), kuma yawancin furotin da aka ninka zuwa pp1a da pp1ab suna canzawa.
Abubuwan da ke cikin polyproteins suna aiki akai-akai don ƙirƙirar furotin 16 na musamman, nsp1 ~ 16.
Sauran sassan suna da ORFs na spike (S), ovulope (E), membrane (M) da nucleotide (N) don tsarin furotin.
Ana kuma rubuta wasu nau'ikan furotin masu canzawa a cikin nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'i na nau'ikan nau'u.
Dangane da bambancin tsari a cikin furotin, ana rarraba cocoves zuwa rukuni huɗu (alpha-cove, beta-cove, gamma-cove da delta-cove); daga cikin waɗannan, beta-cove genus yana da yawa da yawa na hCoVs kuma an rarraba su zuwa ƙananan ƙananan ƙananan biyar (A, B, C da D).
Shaidar iri ta nuna cewa tsuntsaye da berayen da ke cikin dare suna amfani da asalin zuriya don yawancin alpha-CoVs da beta-CoVs, yayin da tsuntsaye sune babban adana gamma-CoVs da delta-CoVs.
A cikin shekaru dubbai, an yi amfani da su wajen ƙetare iyakar jinsuna kuma wasu daga cikinsu suna da muhimmanci wajen jawo cututtuka ga 'yan Adam.
Har yanzu an san mutane bakwai da ke kai hari.
Daga cikin su, HCoV-229E da HCoV-NL63 sune Alpha-Cov.
Sauran beta-CoV guda biyar sun ƙunshi HCoV-OC43, HCoV-HQ, cutar coronavirus mai tsanani ta numfashi (SARS-CoV), cutar coronavirus ta numfashi ta Gabas ta Tsakiya (MERS-CoV) da SARS-CoV-2.
HCoV-229E, HCoV-OC43, HCoV-HQ1 da HCoV-NL63 galibi suna haifar da ƙananan alamun cututtuka kamar mura da/ko mura.
A akasin haka, SARS-CoV, MERS-CoV da kuma sabon SARS-CoV-2 sun zama manyan cututtuka, wanda ke haifar da cututtuka na rashin numfashi mai tsanani (ARDS) da kuma bayyanar cututtuka na extrasperimentary a cikin marasa lafiya da yawa.
An gano samfurin B814, samfurin HCoV-229E na farko, daga ruwan hanci na marasa lafiya masu mura a tsakiyar shekarun 1960.
Tun daga wannan lokacin, an sami ƙarin bincike a kan HCoV-229E da HCoV-OC43, duka biyu suna haifar da alamun ƙuntatawa.
A gaskiya ma, an yarda da ra'ayin cewa kamuwa da cutar HCoVs ba zai haifar da cutar ba har sai an fara barkewar cutar SARS.
Cutar SARS ta 2003 ita ce mafi munin cutar a tarihin kwanan nan. Ta shafi mutane sama da 8,000, kuma kashi 10% na su na cikin mafi muni.
Shekaru goma bayan haka, cutar ta cutar MERS ta Gabas ta Tsakiya ta bazu a cikin ƙasar da ake magana da yaren Larabawa kuma ta bazu cikin sauri zuwa wasu sassan duniya.
An sake sanya sunan SARS-CoV-2 na 2019 (2019-nCoV), wanda shine tushen cutar ta 2019 (COVID-19), wanda ya haifar da cutar ta 2019 (COVID-19), wanda ya shafi mutane sama da 91,000 kuma ya kashe mutane sama da 3,120 a tsakanin 3 zuwa 3 ga Maris 2020.
Tun da ake kara karawa, dole ne duniya ta shirya don barkewar cutar SARS-CoV-2.
Dukkanin waɗannan 'yan fashi bakwai suna fitowa daga tsuntsaye, beraye ko dabbobi.
Yawancin bayanai sun nuna cewa dukkanin cutar ta fito ne daga tsuntsayen dare, inda ƙwayoyin cuta ke da kyau kuma ba su haifar da cututtuka ba, amma suna nuna bambancin zuriya mai girma.
Cutar COVID-19 ta kawo manyan kalubalen kiwon lafiya, kimiyya, zamantakewa da ɗabi'a a China da kuma duniya.
Nazarin asalin Kovch ya ba mu ra'ayin sanin tarihin yanayi, matsin lamba da kuma abubuwan da ke hana rarraba jinsuna.
Wannan na iya jagorantar ko inganta binciken manyan, matsakaici da masu ɗaukar SARS-CoV-2 tare da shawarwari masu mahimmanci don hana yaduwar gaba.
A cikin wannan binciken, za mu ba da cikakken bayani game da asalin zoonotic, rarraba tsakanin jinsuna, da kuma dalilin cutar HCV.
Musamman, za mu tattauna da kuma nuna cewa cutar HCoV da ke da alaƙa da juna ta lalace sosai a cikin wuraren ajiyarsu na halitta, amma bayan sabon ƙwayar cuta ta kamu da cutar, za su zama masu cutarwa.
Mun kuma bincika yanayin juyin halitta na HCoV, wanda yawanci yana ƙaruwa tare da rage yawan cututtuka.
An kuma tattauna sakamakon ci gaba da yaduwar SARS-CoV-2 a wannan mahallin.
An san dabbobi masu ƙuƙwalwa tun daga ƙarshen shekarun 1930.
Kafin a fara gano kwayar cutar HCoV-229E B814 daga cikin ramin hanci na marasa lafiya da ke fama da cutar, an gano kwayar cutar daga dabbobi daban-daban, ciki har da turkey, beraye, saniya, cats da karnuka.
A cikin shekaru goma da suka shige, an gano nau'i bakwai na echovaks.
An tsara jigon tarihin binciken Hkovch a cikin tabula (1) a hankali.
An gano cutar ta farko ta HCoV-229E a cikin yanayin numfashi na sama a cikin 1966 daga yanayin numfashin marasa lafiya, sannan aka ci gaba da haɓaka ta hanyar WI-38 na ƙwayoyin huhu.
A cikin marasa lafiya da ke fama da cutar HCoV-229E, an sami zazzabi da tari a cikin 10 zuwa 20% na lokuta, ciki har da ciwon kai, numfashi, jin zafi da ciwon wuya, wanda shine kumburi da kumburi.
Daga baya, a 1967, an gano yaduwar HCoV-OC43 a cikin jerin kwayoyin halitta da kuma kwakwalwa a cikin jaririn linzamin kwamfuta.
Halitta na asibiti na cutar HCoV-OC43 suna kama da na kamuwa da cutar HCoV-229E, wanda ba a iya gano shi daga sauran cututtukan numfashi kamar ƙwayoyin cuta na Influenza A da Rhinoviruses.
Dukansu HCoV-229E da HCoV-OC43 suna rarraba a duk faɗin duniya, kuma suna yaduwa yayin hunturu.
A gaba ɗaya, bayyanar cututtukan waɗannan ƙwayoyin cuta biyu ba ta wuce mako guda ba, kuma ciwon yana ci gaba har tsawon makonni biyu.
A cewar wani binciken da aka yi a kan mai ba da gudummawa, mutane masu lafiya da ke fama da cutar HCoV-229E sun kamu da zazzabin cizon sauro mai laushi.
Kadan ne marasa lafiya da ke fama da cutar da ke fama da cutar ta rashin ƙarfi.
SARS, wanda aka fi sani da cutar sankara ta SARS, annobar farko ce da aka samu a tarihin 'yan Adam ta HCoV-Sabia, kuma an gano cutar ta SARS-CoV, wanda shine cutar ta uku.
An gano SARS na farko a ƙarshen 2002 a lardin Guangdong na kasar Sin, a matsayin abin lura na Turai.
Cutar SARS ta bazu a kasashe da nahiyoyi da dama, ta yi sanadiyyar mutuwar mutane 8,096 da kuma raunuka 774.
An kiyasta cewa kowane hali, banda wanda ke yaduwa cikin sauri, yana haifar da karuwar adadin kwayoyin cutar a kusan dukkanin matakan, wanda ke nuna ƙarancin ƙwayar cuta na kwanaki 4 zuwa 7 na haihuwa a rana ta 10 na kamuwa da cutar.
A cikin marasa lafiya da ke da cutar SARS-CoV, alamun farko na rashin lafiya sune malagia, ciwon kai, zazzabi, jin zafi da sanyi, yayin da numfashi ya yi wuya, kuma numfashi ya yi sanyi.
A cikin lab, ana yawan samun cutar lymphocytes (ƙananan ƙwayar lymphocyte a cikin jini), gwaje-gwaje na aikin hanta, da kuma yawan ƙwayar cuta mai suna creatinine kinase (wani enzyme da ke fitowa daga ƙwayar da aka cutar).
An kuma lura da yaduwar cutar alveolar, ƙaruwa a cikin ƙwayoyin mahaifa da kuma ƙaruwa a cikin macrophage a cikin marasa lafiya da cutar SARS.
A matsakaici, kashi 20 zuwa 30% na marasa lafiya suna buƙatar magani na musamman da kuma na'urar numfashi.
Ƙari ga haka, ƙananan numfashi na iya zama da haɗari ga hanta da koda, ciki har da gastrointestinal area, wanda ya fi haɗari tare da cytocin, musamman a cikin marasa lafiya masu rauni.
Da farko dai, cutar ta kamu da dangi ne daga Hong Kong zuwa Hong Kong don a yi masa tiyata ta huhu.
Tun daga wannan lokacin, ya yi amfani da ƙarfinsa sosai wajen bincike na HCov.
A ƙarshen 2004, an sace wani jariri mai watanni bakwai a cikin HCov-NL63 a Netherlands.
Na farko, an gano cewa cutar tana da yawa a cikin yara, manya da marasa lafiya masu fama da cututtukan numfashi.
HCV-NL63 na iya haifar da cututtuka na hanci, kumburi, zazzabi da kuma cutar jan hanci.
Wani binciken da aka yi a Netherlands ya nuna cewa akwai irin wannan kwayar cutar daga numfashin jariri mai watanni 8 da ke fama da cutar samfoti.
Ko da yake an san shi sosai a Netherlands, amma an rarraba shi a dukan duniya.
HCV-NL63 an kiyasta ya shafi kusan kashi 4.7% na cututtukan numfashi na yau da kullun, mafi girma a cikin hunturu, hunturu da farkon Satumba.
HCov-NL63: yana da alaƙa da ƙwanƙwasa ƙuƙwalwa, wanda ake kira croup.
A wannan shekarar, HCov-HKU1 wani mai shekara 71 ne da aka kwantar da shi daga asibiti a Hong Kong saboda ciwon huhu da bronchiolitis.
Baya ga cututtukan huhu da na wuya, an ruwaito HKOVCH-HKU1 yana da alaƙa da ciwon asma mai tsanani.
Kamar HCoV-NL63, HCoV-229E da HCoV-OC43, an gano HCoV-HQ1 a duniya yana haifar da cututtukan numfashi masu sauƙi.
Dukkanin wadannan kwayoyin cutar da aka yi amfani da su a cikin al'umma sun kasance suna aiki sosai a cikin mutane, kuma suna da karancin damar haifar da cututtukan da ke da babban cutar, ko da yake saboda wasu dalilai ba a san su ba, kamar su cutar HIV-NL63, an ruwaito cewa kwanan nan sun haifar da kamuwa da cutar ta hanyar numfashi a cikin kasar Sin.
Gabaɗaya, waɗannan HCoVs suna da ƙarancin kisa ko cutarwa yayin da suke da ikon watsawa da ci gaba da rarrabawa tsakanin mutane.
An fara gano Mers-Cov ne a Saudiyya a shekarar 2012 a cikin wani mutum mai shekaru 60 da haihuwa wanda cutar ta canza zuwa huhu kuma koda ya daina aiki.
Ko da yake yawancin cututtukan da aka tabbatar da su daga dakin gwaje-gwaje sun fito ne daga Gabas ta Tsakiya, an yi rikodin cututtukan biyu na kusanci a ƙasashen Turai da Tunisia.
Wani yaduwar na biyu ya faru ne a kasar Koriya ta Kudu a shekarar 2015 inda aka samu mutane 186 a cikin harin.
Sakamakon bincike ya nuna cewa Mars ya zama kamar SARS, wanda ke zama ciwon huhu.
Ba kamar SARS ba, yawancin marasa lafiya da ke fama da cutar ta MERS sun sami ciwon koda wanda ya fi ƙarfin su, wanda ya sa cutar ta MERS ta bambanta da sauran cututtukan da suka faru a cikin cutar HCV.
Fiye da kashi 30 cikin dari na marasa lafiya suna fama da cututtuka na hanji da hanji, kamar kumburi da kumburi.
Tun daga 14 ga Fabrairu, 2020, an yi rajistar fiye da shari'o'in da aka tabbatar da su a dakin gwaje-gwaje guda 2,500, wanda ya kai adadin mutuwar 34.4%, wanda ya sa cutar ta MERS-CoV ta zama ɗaya daga cikin cututtukan da suka fi cutarwa ga yara.
A tsakiyar watan Disamba na 2019, an gano yawancin marasa lafiya na cutar samba a Wuhan, lardin Hubei, China, waɗanda ke da alaƙa da kamuwa da cutar SARS-CoV-2 daga gaba zuwa ƙarshen.
A cewar Hukumar Lafiya ta Duniya, cutar ta zama sanadiyar gaggawa ga al'ummar duniya saboda ciwon huhu na kasa wanda ya haifar da yaduwar SARS-CoV-2, kuma an sanya sunan COVID-19.
Tun daga 3 ga Maris, 2020, an tabbatar da shari'o'i 90,053 a duniya, tare da ƙimar mutuwa ta 3.4%.
A Hubei China, yawan mutuwar marasa lafiya ya kai kashi 4.2% yayin da a wajen ya kai kashi 1.2%.
SARS-CoV-2 yana haifar da cututtukan numfashi masu haɗari kamar SARS-CoV da MERS-CoV, wanda ke bayyana a cikin harbi, ƙwayoyin cuta da kuma numfashi.
Wasu marasa lafiya ma sun sami ciwon kumburi.
Wani abu mai tsanani da ke nuna rashin lafiyar huhu shi ne rashin lafiyar huhu, kuma yana iya sa mutum ya sami ciwon huhu da sauri.
Ko da yake SARS-CoV da SARS-CoV-2 suna da kusanci sosai saboda daidaitaccen tsarin nucleotide na 82%, an rarraba su a ƙarƙashin rassan bishiyar a cikin alaƙar su ta hanyar tushen tushen.
SARS-CoV-2 ba shi da ƙananan cututtuka idan aka kwatanta da SARS-CoV da MERS-CoV, amma yana da yawa.
An samu rahoton marasa cutar SARS-CoV-2 wanda ba a nuna alamar cutar ba, kuma hakan na iya taimakawa wajen yaduwar cutar a duniya.
Idan aka kwatanta SARS-CoV-2 da sauran HCVs shida, ana iya ganin kamanceceniya da bambance-bambance masu yawa.
A farkon, cutar ta kamu da cutar ta kamuwa da cutar ta zama iri ɗaya.
A wannan yanayin, SARS-CoV-2 ya bi halaye na sauran HCV guda shida.
Matsayin cutar COVID-19 ko kuma yawanta yana tsakanin SARS-CoV da HCoVs huɗu na mutum (watau HCoV-229E, HCoV-OC43, HKU1 da HCoV-NL63).
A gefe guda, kamuwa da SARS-CoV-2 yana da halaye da aka fi gani a lokacin kamuwa da cutar, ciki har da rashin iyakantaccen, ƙananan, ko kuma babu alamun cutar.
A gefe guda kuma, ko da yake adadin ya bambanta, cutar COVID-19 mai tsanani tana kama da cutar SARS-CoV.
Na uku, watsa SARS-CoV-2 ya nuna halin da ake ciki na HCoVs da SARS-CoVs na al'umma.
A gefe guda, yaduwar SARS-CoV-2 tana da girma kamar yadda Aichekov ya yi a cikin al'umma.
A wata ma'anar, har yanzu ba a tabbatar da cewa sars-cov-2 zai iya rage karfin watsawa ba kamar sars-cov da merc-cov bayan kasancewa a cikin mutum.
A ƙarshe, ana iya samun SARS-CoV-2 a cikin samfurin sarkar, wanda ya yi kama da sauran HCovits.
Ko da yake SARS-CoV-2 yana taka muhimmiyar rawa a cikin watsawa ta baka, kamar yadda SARS-CoV case yake, ya kamata a bayyana a cikin wasu lokuta a cikin nazarin gaba.
Akwai babban sha'awa a cikin al'umma don ganin ko SARS-CoV-2 yana da halaye masu canji kamar yadda HCoVs ke da yawa.
Koyaya, yanayin SARS-CoV-2 yana da tasiri sosai kan ƙarshen COVID-19, wanda ke yaduwa, gami da yaduwar cutar, dalilin cutar, da ci gaba da yaduwa bayan kamuwa da ita.
HCoVs huɗu masu haifar da alamun bayyanar cututtuka sun dace da mutane.
A wani bangare kuma, zai iya zama gaskiya cewa mutane sun saba da waɗannan ƙwayoyin cuta huɗu.
A wasu kalmomi, duka biyu na iya zama sanadiyyar cututtukan cutar HCoV na farko.
An cire mutanen da ke fama da cutar HCV da kuma cutar HCV, wanda ke haifar da mummunan ciwo a cikin mutane.
Don haka, a cikin mutane, ƙwayoyin cuta suna ba da damar yin musayar abubuwa masu yawa da ke hana su yin aiki.
A wannan yanayin, akwai damar da za a iya daidaitawa da mutane sosai yayin da cutar SARS-CoV-2 ta daɗe kuma ta shafi mutane da yawa.
Idan an yi amfani da shi sosai, zai yi wuya a iya gano dangantaka tsakanin mutane ko kuma a kawar da wasu matakan da za a iya amfani da su wajen hana kamuwa da cuta.
A cikin shekaru da yawa, an samu cututtukan COVID guda huɗu a cikin al'umma, wanda ke haifar da mura a cikin waɗanda ke da ƙarfin juriya ga cututtukan da aka kamu da su.
Wadannan ƙwayoyin ba sa bukatar babban ajiyar dabbobi.
A akasin haka, SARS-CoV da MERS-CoV, manyan cututtuka ne da ba su da ƙwarewa sosai a cikin mutane, kuma ba za a iya hana su yadawa daga mutane ba.
Suna buƙatar ci gaba da haifuwa a cikin masu ɗaukar cutar da ke dauke da cutar, da kuma yiwuwar yaduwar waɗanda ake zargi da cutar, musamman ta hanyar matsakaici ko wata hanyar da ke dauke da cutar.
SARS-CoV-2 yana da halaye iri ɗaya da SARS-CoV/MERS-CoV da kuma HCV huɗu na al'umma.
Aƙalla a yanzu, HCoVs suna da yawa kamar yadda suke a cikin al'umma.
Koyaya, yana haifar da mafi yawan cututtuka fiye da ciwon HIV da aka samo daga al'umma kuma ƙasa da SARS-CoV ko MERS-CoV.
A nan gaba, za a iya ganin cewa ba zai iya daidaita kansa da mutane ba kuma zai iya yin tafiya a cikin mutane ba tare da wata dabba ko wata dabba ba.
Kafin mu tattauna asalin dabbobi, zai dace mu tattauna ma'anar da kuma halaye na dabbobi masu amfani da dabbobi masu amfani da dabbobi da aka yi amfani da su a cikin halitta da kuma yanayi.
Idan an raba ƙwanƙolin da ke kusa da matakin nucleotide tare da asalinsa, dabba tana aiki a matsayin mai ɗaukar juyin halitta na HCoV.
Kwayar cuta ta hanyar jini ita ce mafi haɗuwa da ɗan adam kuma ba ta yadu sosai.
Hakazalika, mai ɗaukar kaya zai riƙe HCov a kai a kai kuma na dogon lokaci.
A cikin waɗannan yanayi biyu, masu ɗaukar hoto sun kamu da cutar HCV ko kuma na iyaye.
A akasin haka, idan an sake amfani da HCoV a cikin masu ɗaukar hoto da masu watsawa kafin su shiga cikin mutum ko a cikin yanayin da aka haɗa da mutum, ba zai haɗu da sabon mai ɗaukar hoto ba kuma galibi yana haifar da cututtuka.
Wannan mai ɗaukar hoto na iya zama tushen zoonotic don kamuwa da cutar mutum kuma yana iya taka rawa wajen saurin yaduwar kwayar cutar kuma yana watsawa ga mutane don ƙara yawan kamuwa da cutar.
Idan ba a yi amfani da wannan hanyar ba, cutar HCoV na iya ci gaba da zama cuta mai hallaka al'ummar duniya.
A akasin haka, HCoVs na iya daidaitawa da matsakaiciyar hanyarsu kuma suna iya haifar da cututtuka na dogon lokaci.
Idan haka ne, matsakaiciyar mai ɗaukar nauyi za ta zama mai ɗaukar ajiyar halitta.
Bayanai na annoba sun nuna tarihin taɓawa tare da dabbobi masu alaƙa da babban cutar SARS.
A cewar binciken, bambancin da ke tsakanin jinsunan dabbobi da sauran mutane ya nuna cewa jinsunan dabbobi sun fi kama da IgG na anti-SARS-CoV.
An gano ƙwayoyin cuta da suka yi kama da SARS-CoV a kasuwar namun daji na farko a kasuwar kare da kuma kare na raccoon.
Wannan ya sami tallafi a fili, ba a sake yin rajistar SARS ba bayan an cire duk gumakan da ke kasuwa.
Amma, an ruwaito cewa kafin a sami dabbobi masu kama da cats a kasuwa, ba su da SARS-CoV, wanda ya nuna cewa dabbobi kamar cats suna da matsakaiciyar hanyar ɗaukar hoto, ba masu ɗaukar SARS-CoV ba ne.
Musamman, kashi 80% na dabbobi a cikin kasuwar da ke cikin daji suna da maganin rigakafin SARS-CoV, saboda haka ba za a iya raba su da nau'ikan dabbobi masu rarraba da kuma cutar da SARS-CoV ba.
Waɗannan su ne masu ɗaukar sarkar-cove.
Shaidar iri ta nuna cewa tsuntsaye da berayen da ke cikin dare suna amfani da asalin zuriya don yawancin alpha-CoVs da beta-CoVs, yayin da tsuntsaye sune babban adana gamma-CoVs da delta-CoVs.
Wadannan tsuntsayen na dare sun sami maganin anti-SARS-CoV da kuma tsarin kwayoyin SARSr-Rh-BatCoV HKU3.
Wannan da sauran tsuntsayen da ke cikin dare suna da daidaituwa na 88-92% na tsarin nucleotide tare da SARS-CoV.
Waɗannan binciken sun kafa sabon ra'ayi game da cututtukan da ke kamuwa da cututtuka a cikin tsuntsayen dare.
Ko da yake an gano wasu cututtuka masu kama da SARS (SL-CoVs) a tsuntsaye na dare, babu wani nau'in cutar da ke rayuwa sai dai WIV1.
An san angiotensin na mutum a matsayin mai karɓar SARS-CoV-2 na enzyme mai ƙonewa 2 (ACE2).
An bayyana gabatarwar WIV1 don amfani da samfurin tsuntsaye mai karɓa na dare, samfurin tsuntsaye na dare na al'ada da kuma ACE2 na mutum.
Abin mamaki, marasa lafiya da ke fama da cutar SARS ba su da ikon yin amfani da WIV1.
WIV1 shine mafi kusa da SARS-CoV, wanda ke cikin tsuntsayen dare tare da ƙarin homologue na 95% na nucleotide, wanda ke wakiltar WIV1.
Ko da yake akwai bambancin homologous tsakanin ƙwayoyin cuta biyu, ana ganin cewa WIV1 ba ya haifar da cutar SARS-CoV ba kuma tsuntsayen dare ba su kai tsaye ba ne.
Nazarin nau'in kwayar cutar ya kawo MERS-CoV zuwa rukuni guda na bat-CoV-HKU4 da kuma tsuntsu na dare Cove-HKU5.
Tsuntsayen dare Cov-HQ4 da MERS-Cov suna amfani da same receptor receptor DPP4 (DPP4) don shigar da kwayar cutar.
Ana gabatar da jerin MERS-Cov zuwa Beth Kovach a kan layi, wanda ya faru a Turai da Afirka.
Ba a sami wani tsuntsu na dare a cikin daji ba, wanda har yanzu ba shi da rai.
Mers-Cov da dangi na kusa, Bat CoV-HKU25 kawai suna da kashi 87% na hotunan nucleotide.
Saboda haka, tsuntsayen dare ba za su iya zama masu ɗaukar Mers-Cov kai tsaye ba.
A wani bangare kuma, binciken da aka yi a Gabas ta Tsakiya ya nuna cewa, kamar yadda yake a raƙuman Larabawa, ana samun maganin rigakafi mai suna MERS-CoV, wanda ke nufin cewa akwai raƙuman da ke cikin ƙasashen Afirka da yawa kamar yadda ake a Gabas ta Tsakiya.
A cewarsa, cutar ta rayuwa ta MERS-CoV, wadda ta yi kama da wadda aka samu a cikin mutum, ta bambanta da na raƙuma na Larabawa, wanda ya fi nuna cewa raƙuma sune ainihin masu ɗaukar cutar MERS-CoV.
Ya kamata a lura cewa a cikin binciken dakin gwaje-gwaje an lura da ƙananan alamun cutar amma babban adadin ƙwayoyin cuta a kan raƙuma waɗanda aka yi amfani da su don gwaji tare da MERS-CoV.
Ya kamata a lura cewa raƙuma masu tsalle suna fitar da kwayar cutar ba kawai ta hanyar numfashi ba, har ma ta hanyar fitar da fandiya, wanda shine hanyar da tsuntsaye ke fitar da kwayar cutar a daren.
Koyaya, abin da ya kawo tambaya har yanzu shine asalin cutar ta MERS ba a bayyana a kan raƙumi ba kafin cutar ta bayyana, kuma ana tsammanin cewa an sami cutar ta MERS-CoV ta hanyar watsawa daga namiji zuwa namiji ko kuma ba a sani ba.
SARS-CoV-2 yana da kashi 96.2% na nucleotide na racin RATG13 na tsuntsu na dare, wanda aka samo daga tsuntsayen da ke cikin rhinocytes.
Kamar SARS-CoV da MERS-CoV, tsarin SARS-CoV-2 da RaTG13 suna da nisa sosai saboda suna da wuya a yi tunanin dangantakar su.
Wannan yana nufin cewa ba za a iya samun tsuntsayen dare a kusa da sars-cove-2 ba sai an sami irin waɗannan kwatsam a nan gaba.
Wataƙila, an sayar da da dabbobin da ke dauke da SARS-CoV-2 a cikin babban kanti na abincin teku na Hunan kuma an kashe su, kuma yawancin cututtukan COVID-19 suna da alaƙa da wannan, wanda ke nuna cewa an watsa su daga dabba zuwa mutum.
Binciken da aka yi kwanan nan kan tarurruka na metagenomic ya nuna cewa dabbobi masu shayarwa da ake kira pangolin (Manis javanika), wanda ke da ƙananan haɗarin hallaka, na iya ɗaukar tsofaffin beta-covs waɗanda ke hulɗa da SARS-CoV-2.
Waɗannan kwayoyin halitta na Novel Pangolin CoV suna da kwatancen 85-92% na tsarin nucleotide tare da SARS-CoV-2.
Duk da haka, suna da alaƙa da RTG13 a cikin kashi 90% na tsarin nucleotide.
A cikin rukunin masu cutar, ana haɗa su a ƙarƙashin ƙananan kwayoyin SARS-CoV-2, ɗayan wanda ke da kamanceceniya da 97.4% amino acid sequence tare da SARS-CoV-2 binding tip receptor (RBD).
Ko da yake sun fi girma fiye da na farko, amma a kan bayyanar, SARS-CoV-2 da RaTG13 RBDs sun bambanta.
Wani binciken da aka yi a kan penguins da ke da cutar ya gano cewa akwai cutar kwayar cuta a cikin samfurori na huhu, wanda ya kasance da alaƙa da SARS-CoV-2.
Wannan binciken ya ɗauki hanyoyin taro da kuma shirya kayan aiki don yin aiki da tsarin riga-kafi na kwayar cuta wanda ke ɗaukar kusan kashi 86.3% na tsawon kwayoyin.
Ba za mu iya musun cewa pangolin zai iya zama mai watsa SARS-CoV-2 ba.
Amma, saboda rashin daidaituwa tsakanin SARS-CoV-2 da beta-CoVs na Pangolin, babu wani bayani a halin yanzu da ke nuna cewa SARS-CoV-2 ya fito ne daga Pangolin kai tsaye.
Bugu da ƙari, nisan da ke tsakanin SARS-CoV-2 da RaTG13 ya fi nisan da ke tsakanin beta-coves na SARS-CoV-2 da pangolin SARS-CoV-2 .
A cikin tsuntsaye, pangolins da sauran dabbobi masu shayarwa a daren, hanyar juyin halitta ta SARS-CoV-2 ta ci gaba da kasancewa mai dorewa.
Amma an samo babban tsari na homology a cikin RBDs kuma ana raba hotunan babban tsari na genome tsakanin beta-covs, SARS-CoV-2 da RaTG13 waɗanda ke da alaƙa da SARS-CoV-2 da Pangolin SARS-CoV-2.
RBDs (Rebobin Ƙarshen Ƙarƙashin Ƙarƙashin Ƙarƙashin Ƙarƙashin Ƙarƙashin Ƙarƙashin Ƙarƙashin Ƙarƙashin Ƙarƙashin Ƙarƙashin Ƙarƙashin Ƙarƙashin Ƙarƙashin Ƙarƙashin Ƙarƙashin Ƙarƙashin Ƙarƙashin Ƙarƙashin Ƙarƙashin Ƙarƙashin Ƙarƙashin Ƙarƙashin Ƙarƙashin Ƙarƙashin Ƙarƙashin Ƙarƙashin Ƙarƙashin Ƙarƙashin Ƙarƙashin Ƙarƙashin Ƙarƙashin Ƙarƙashin Ƙarƙashin Ƙarƙashin Ƙarƙashin Ƙarƙashin Ƙarƙashin Ƙarƙashin Ƙarƙashin Ƙarƙashin Ƙarƙashin Ƙarƙashin Ƙarƙashin Ƙarƙashin Ƙarƙashin Ƙarƙashin Ƙarƙashin Ƙarƙashin Ƙarƙashin Ƙarƙashin Ƙarƙashin Ƙarƙashin Ƙarƙashin Ƙarƙashin Ƙarƙashin Ƙarƙashin Ƙarƙashin Ƙarƙashin Ƙarƙashin Ƙarƙashin Ƙarƙashin Ƙarƙashin Ƙarƙashin Ƙarƙashin Ƙarƙashin Ƙarƙashin Ƙarƙashin Ƙarƙashin Ƙarƙashin Ƙarƙashin Ƙarƙashin Ƙarƙashin Ƙarƙashin Ƙarƙashin Ƙarƙashin Ƙarƙashin Ƙarƙashin Ƙarƙashin Ƙarƙashin Ƙarƙashin Ƙarƙashin Ƙarƙashin Ƙarƙashin Ƙarƙashin Ƙarƙashin Ƙarƙashin Ƙarƙashin Ƙarƙashin Ƙarƙashin Ƙarƙashin Ƙarƙashin Ƙarƙashin Ƙarƙashin Ƙarƙashin Ƙarƙashin Ƙarƙashin Ƙarƙashin Ƙarƙashin Ƙarƙashin Ƙarƙashin Ƙarƙashin Ƙarƙashin Ƙarƙashin Ƙarƙashin Ƙarƙashin Ƙarƙashin Ƙarƙashin Ƙarƙashin Ƙarƙashin Ƙarƙashin Ƙarƙashin Ƙarƙashin Ƙarƙashin Ƙarƙashin Ƙarƙashin Ƙarƙashin Ƙarƙashin Ƙarƙashin Ƙarƙashin Ƙarƙashin Ƙarƙashin Ƙarƙ
Ka'idar counter-adventure ta lura da sake haɗuwa tsakanin beta-CoV mai alaƙa da SARS-CoV-2 da RaTG13 a cikin ƙwayoyin daji na uku.
Haɗuwa yana da yawa a tsakanin beta-kovacs a matsayin matsin lamba na canji.
Wannan shawarar ta kasance daga asalin sars-cov-2 zoonotic.
Ana nazarin gano HCoV-229E, HCoV-OC43, HCoV-NL63 da HCoV-HKU1 a gefen HCoVs, wanda shine babban abin da ke haifar da cutar.
Shaidar ilimin halittu ta nuna cewa HCoV-NL63 da HCoV-229E sun fito ne daga HCoV-OC43 da HKU1 a cikin nau'in beraye.
ARCoV.2 (Appalachian Ridge Cove), wanda aka samo a cikin tsuntsayen dare masu launi uku a Arewacin Amurka, ya nuna kusancin kama da HCoV-NL63.
A gefe guda kuma, an gano cewa raƙuma suna da alaƙa da wani tsuntsu na dare, HCoV-229E, wanda aka samo a Ghana kuma aka sanya shi Hipposideros/GhanaKwam/19/2008.
Don bayyanawa, an bayyana fahimtarmu game da dabbobi a hoto na 1 da kuma tebur na 2.
Binciken ilimin halittu ya ba da tabbacin cewa a tarihi akwai abubuwan da suka faru na watsawa na kwakwalwa.
A shekara ta 1890 ne aka gano cewa HCov-OC43 ya yi amfani da cutar ta numfashi wajen kai wa mutane hari.
Ba a bayyana yadda ake rarraba HCoV-229E tsakanin jinsuna ba.
An gano alpha-covas na bat da ke kusa da HCoV-229E.
Daga cikinsu akwai Alpha-Cov na Alpaca.
Akwai bayanai da yawa da ke nuna cewa ana iya watsa kwayar cutar kai tsaye daga tsuntsaye zuwa mutane.
Na farko, ba alpacas (dabbobi masu dogon wuyan kafafu a Kudancin Amurka) ba, amma mutane na iya samun alaƙa da tsuntsayen dare a cikin yanayin halittu.
Maimakon haka, mutane ba sa da dangantaka ta kud da kud da alpacas.
Na biyu, alpha-coves na tsuntsaye na dare da aka haɗa da HCoV-229E sun bambanta kuma ba su haifar da cutar a cikin tsuntsaye na dare, yayin da alpha-cov ya haifar da cutar numfashi a cikin dabbobi da ke da cutar.
A ƙarshe, ba a gano Alpaca alfa-COV a cikin namun daji ba.
Saboda haka, bai kamata mu daina tunanin cewa alpacas sun sami alpha-CoVs daga mutane, wanda ya danganta da HCoV-229E ba.
A gaskiya ma, tsuntsayen dare sune ainihin tushen cututtukan da ke cutar da mutane, ciki har da cutar Cutar Cutar Cutar Cutar Cutar Cutar, cutar Ebola, cutar Nipah da cutar Hendra.
Saboda haka, ba abin mamaki ba ne cewa tsuntsayen dare suna iya watsa HCoV-229I kai tsaye zuwa ga mutane.
A matsayin madadin, Alpha-Covits na tsuntsayen dare suna amfani da su azaman HCoV-229E gene pool, kamar yadda Mers-Cov, Alpacas da raƙuman Arabian suke iya ɗaukar ƙwayoyin cuta kuma su watsa su zuwa cikin mutane.
A cikin wannan labarin, an rubuta cewa: "Mers-Cov yana iya zama misali mai kyau na cutar da ke yaduwa daga tsuntsaye zuwa raƙuma, daga raƙumi zuwa mutum, kuma daga raƙumi zuwa mutum.
An fara gano asalin juyin halitta na Mars-Cove daga tsuntsayen dare, kuma an ci gaba da gano su.
A bayyane yake cewa tsuntsayen dare suna samar da tarin kwayoyin cuta don musayar kwayoyin halitta da kuma watsa kwayoyin halitta.
Tsayawa na dogon lokaci, taruwa a wuri ɗaya, haɗuwa da juna da kuma iyawar tashi da ƙarfi na tsuntsayen dare suna da yanayi mai kyau don yada cutar.
A wani ɓangare kuma, Mers-Cov ya mallaki raƙuma na shekaru goma.
An tsara shi sosai don waɗannan raƙuman da suka canza daga matsakaiciyar ɗaukar kaya zuwa mai ɗaukar kaya na dindindin da na halitta.
A cikin waɗannan dabbobi, MERS-CoV yana haifar da ƙananan cututtuka yayin da yake haifar da rashin lafiya.
Cutar da ke faruwa a cikin mutane ba zato ba tsammani ce, kuma mutane za su kasance masu ɗaukar wannan cutar mai haɗari har sai an hana ta.
Matsayin raƙuma a cikin watsawar Mars-Cov ya bambanta da na pangolins.
Mafi mahimmanci, pangolin beta-covoc yana da matukar haɗari ga lafiyar pangolin.
Za su iya zama masu watsawa na ƙarshe ga beta-coves da ke haɗuwa da SARS-CoV-2, kamar yadda yake a cikin SARS-CoV-2 case.
Yawancin damar watsa SARS-CoV-2 daga dabbobi zuwa mutane suna buƙatar a bincika su a cikin nazarin gaba sannan a bincika su ta hanyar binciken waje.
Da farko, tsuntsayen dare na iya zama masu ɗaukar kwayar cutar da ke tattare da SARS-CoV-2 da kuma irin wannan SARS-CoV-2.
'Ya'yan mutane suna iya yin amfani da yanayin halittu kamar tsuntsayen dare ta wajen ciyar da dabbobi ko kuma yin hakar ma'adinai.
Na biyu, ana samun cutar ta hanyar masu daukar hoto da sauri da kuma kwayar cutar SARS-CoV-2 da ke dauke da cutar ta hanyar kamuwa da cutar ta hanyar kamuwa da cutar ta hanyar kamuwa da cutar ta hanyar kamuwa da cutar ta hanyar kamuwa da cutar ta hanyar kamuwa da cutar ta hanyar kamuwa da cutar ta hanyar kamuwa da cutar ta hanyar kamuwa da cutar ta hanyar kamuwa da cutar ta hanyar kamuwa da cutar ta hanyar kamuwa da cutar ta hanyar kamuwa da cutar ta hanyar kamuwa da cutar ta hanyar kamuwa da cutar ta hanyar kamuwa da cutar ta hanyar kamuwa da cutar ta hanyar kamuwa da cutar ta hanyar kamuwa da cutar ta hanyar kamuwa da cutar ta hanyar kamuwa da cutar ta cutar ta hanyar kamuwa da cutar ta cutar ta cutar ta cutar ta cutar.
Mutane suna kamuwa da cutar ne ta wurin kula da dabbobi da kuma cin abinci.
Yawancin dabbobi masu shayarwa, ciki har da dabbobi masu gida, na iya zama masu haɗari ga SARS-CoV-2.
An yarda da binciken dabbobi na gida da na daji don amfani da kwayoyin rigakafi.
Na uku: Kamar yadda aka bayyana a sama, ana iya ganin cewa SARS-CoV-2 ya sake yin aiki da kuma daidaitawa a cikin wani nau'in na uku na tsuntsaye da penguins.
Ana ci gaba da binciken asalin dabba na SARS-CoV-2.
Ba kamar sauran nau'ikan dabbobi masu ɗaukar hoto ba, manyan abubuwan da ke haifar da cutar guda uku suna da mahimmanci don daidaita COVID a cikin iyakokin haɗuwa.
Da farko, ana auna babban bambanci a cikin samfurin RNA.
Idan aka kwatanta da sauran ƙwayoyin RNA guda ɗaya, ana iya rarraba adadin adadin cocoves daga matsakaici zuwa matsakaici zuwa matsakaici zuwa matsakaici zuwa matsakaici zuwa matsakaici zuwa matsakaici 2 a kowace shekara, a matsayin matsakaici zuwa matsakaici ~10-4 a kowace shekara, bisa ga matakin daidaitawar cocoves ga masu ɗaukar ƙwayoyin cuta.
Covochs suna da ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta, wanda ya haifar da babban canji a halayyar mutum da rashin iyawar yin tunani ko ci gaba.
Abin mamaki, ana iya ganin cewa irin wannan ƙwayar cuta ta Remdesvir tana murkushe ƙwayar cuta ta hanyar riƙe wannan exoribonucleus da RNA mai dogara da RNA polymers.
Remdesivir yana ɗaya daga cikin wakilai masu fa'ida na anti-SARS-CoV-2 da aka bincika a cikin gwaji na asibiti.
Amma, ƙwayoyin cuta na Cove sun fi masu ɗaukar su sau miliyan.
Bugu da ƙari, yawanci, masu karɓar karuwa suna da ƙarancin canji, idan ba su dace da mai ɗaukar su ba.
Idan aka kwatanta da SARS-CoV-2 wanda ke da ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙ
wataƙila: wataƙila an riga an yi masa amfani da wani mai ɗaukar hoto da ke kusa da mutane.
Baya ga SARS-CoV-2, ya kuma shafi Mars-CoV, wanda aka saba da shi a kan raƙuma masu taya ɗaya.
A takaice dai, allurar rigakafin jini da maganin rigakafin cutar ba za su yi nasara da sauri ba tare da SARS-CoV-2.
Na biyu, babban DNA a cikin Covots yana fitar da ƙarin filastik a cikin canje-canje da sake haɗuwa a cikin haɓakar kwayoyin halitta, yana ƙara yiwuwar juyin halitta tare da abubuwan da ke cikin jiki, yana haifar da sauƙin haɓakar coronavirus a lokacin da yanayi ya dace.
Wannan yana tallafawa ta hanyar tsarin karatu na musamman da kuma ayyukan furotin da aka sanya a ƙarshen 3′ na jini.
"Na uku, yayin da Kovach RNA ke ninkawa, zai iya ninka kansa da kuma canzawa a kai a kai da kuma sau da yawa ta hanyar "sawu-zabar" na musamman".
A cikin mai ɗaukar hoto, sauye-sauye na tsalle-tsalle suna faruwa sau da yawa yayin ɓoyewar RNA na Cove.
Hakanan, yawancin cikakkun tsawon da ƙananan RNAs na genomic zasu iya sake haɗuwa tare don ƙirƙirar sabon covch.
An gano wani nau'in halitta na phylogenetic a cikin HCoV-HKU1 da HCoV-OC43 da kuma cikin tsuntsaye na dare SL-CoV da batCoV-HKU9.
A cikin wannan labarin, an rubuta cewa: "A cikin Littafi Mai Tsarki, ana iya ganin cewa mutum yana da ƙwayoyin cuta da ke saurin kamuwa da cutar.
Tare da waɗannan dalilai guda uku na ƙwayoyin cuta, haɗuwa da ƙwayoyin cuta shine wani muhimmin dalili da ke haifar da tasiri ga yaduwar ƙwayoyin cuta.
An dauki sake haɗuwa da Saras-Cov a matsayin misali, wanda ya nuna tabbacin zaɓin da aka yi a lokacin abubuwan da ke faruwa a cikin zuriya.
A kan bincike na kwatanci, guda ɗaya tsakanin mutane da ƙwayar SARS-CoV, SARS-CoV, yana da saurin daidaitawa a cikin masu ɗaukar kaya daban-daban, musamman ma a cikin musayar S-protein RBD.
RBD, wanda ke cikin furotin Cove S, yana haɗuwa da mai karɓar selula kuma ya zama mai karɓar amsawar antigen.
A cikin SARS-CoV, RBD yana cikin sashin S1 na amino acid 318 zuwa 510 wanda ke ɗaure da ACE2 na mutum don ƙirar ƙwayar cuta.
SARS-CoV RBD (Reserver of the Adhesive Dimension) na da ikon gano masu karɓar ACE2 na dabbobi daban-daban, gami da tsuntsayen dare, albasa, beraye da karnuka na raccoon, wanda ke ba da damar watsa siginar cutar.
Hakanan, an gano amino acid 6 na amino acid a cikin bambance-bambance daban-daban daga kwayar cutar mutum da ƙwayoyin cuta, kuma 4 daga cikin waɗannan masu musayar masu karɓar ACE2 suna cikin taken mai karɓa-ƙulla.
Civeat SARS-CoV-RBD (mai karɓar ƙofar haɗuwa) yana da ma'amala na K479 da S487T kuma ya haɓaka haɗin haɗin haɗin haɗin kai a cikin mai karɓar ACC2 na mutum.
A wasu kalmomi, waɗannan amino acid guda biyu suna iya zama masu mahimmanci don kwayar cutar ta iya zama mutum.
Abu mai ban sha'awa shine cewa SARS-CoV-2 yana tafiya tare da kwayoyin halitta iri ɗaya da SARS-CoV.
Bambanci na 30% tsakanin SARS-CoV-2 da SARS-CoV-2 wanda ke nuna s protein a cikin S1 unit na iya dakatar da haɗuwa da s protein tare da ACE2 na mutum.
A gaskiya ma, binciken na CRI-EM ya nuna cewa wannan adherence yana da hulɗa mai ƙarfi sau 10 zuwa 20 fiye da tsakanin ACE2 da SARS-CoV S sunadarai na mutum.
Ana buƙatar sanin ko akwai sauran masu karɓar mai karɓar SARS-CoV-2 da ake buƙata ko a'a.
Abin mamaki, Hkovich-NL63 yana manne da ACE2 amma yana tare da wani S.
Akwai wasu masu karɓar HCoVs, kamar aminopeptide N don HCoV-229E, da 9-O-acetylated sialic acid don HCoV-OC43.
Bayan an yi amfani da su a cikin zuriya daga dabbobi masu ɗaukar kaya, ba su da babban tasiri wajen daidaita waɗannan kwari zuwa mutum.
Baya ga masu karɓar kwayoyin halitta, sakamakon rarraba a cikin jinsin HCoVs yana rinjayar wasu ƙwayoyin cuta masu ɗaukar hoto da sauran dalilai.
Rarraba waɗannan furotin masu ɗaukar nauyi tsakanin mutane da manyan masu ɗaukar su na halitta, kamar tsuntsayen dare, raƙuma masu hawa ɗaya da beraye masu dogon fuska, na iya ƙuntata watsawar abubuwa.
Don HCovits su sami nasarar rarraba jinsunan, dole ne su maye gurbin batutuwan mafaka da kuma kwafin masu haɓaka masu watsa shiri.
A wannan yanayin, ƙwayoyin halitta suna ƙayyadewa, suna bambanta kuma suna rarraba su ta hanyar hali game da hulɗar mai ɗaukar hoto.
Yin amfani da fasahar fasaha ta CRISPR don gano abubuwan da ke haifar da mafaka da iyakancewar masu ɗaukar hoto na SARS-CoV-2 wanda ba shi da wata hujja.
"Abin da ya faru da shi shi ne, an yi amfani da shi wajen yin amfani da kayan aiki da kuma yin amfani da shi wajen yin amfani da kayan aiki.
Bambancin tsuntsayen dare yana ba da babbar dama ga ƙwayoyin cuta na Novel.
A wannan yanayin, tsuntsayen da ke cikin dare suna aiki ne a matsayin wurin da za a tattara zuriyar tsuntsaye.
Bugu da ƙari, sauyawa da sake tsarawa na jinsi suna aiki a matsayin matakai biyu a cikin wannan tsari don ƙayyade tsarin HCoV.
Alal misali, ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayo.
Daga cikin sunadarai masu amfani da SARS-CoV, ORF8 ya zama dole don daidaitawa da mutane, wanda aka gano don shigar da sunadarai daban-daban na ORF8 yayin da aka bambanta shi da tsuntsayen dare masu alaƙa da SARS-CoV.
An gano cewa an rasa yanayin SARS-CoV-29 nucleotide a cikin ƙoƙarin da aka yi a farkon annobar a kan mutum.
Wannan kawarwa ta haifar da haɓaka haɓaka ta al'ada ta hanyar raba ORF8 zuwa ORF8a da ORF8b.
Bugu da ƙari, SARS-CoV yana da alaƙa ta tarihi da covid-CoVs da gamma-CoVs saboda ƙananan abubuwa suna cikin RNA-responsive RNA-polymeres.
An kuma nuna wuraren sake haɗuwa a cikin nsp9, mafi yawan nsp10, da kuma sassan nsp14.
Hakazalika, cutar MERS-CoV ta nuna cewa an sake haifar da abubuwan da suka faru a cikin kwayoyin halitta daban-daban a cikin wani shinge a Saudi Arabia.
A cikin wasu HCoVs, an lura da abubuwan sake haɗuwa, tare da SARS-CoV da MERS-CoV, wanda shine yanayin da HCoVs ke sake haɗuwa da kwayoyin halitta marasa tsari tare da sauran covenan dabba.
Dole ne a yi taka tsantsan sosai saboda haɗarin cutar, musamman a cikin tsarin rigakafi mai ƙarfi, na iya haifar da ƙwayoyin cuta waɗanda ba a iya kiyaye su ba, wanda zai iya haifar da ƙwayoyin cuta a cikin matsin lamba na zaɓi.
Misali na wannan mummunan sakamako shine rage tsawon ORF4 a cikin nauyin kwayar HCoV-229E, wanda ke nufin cewa nucleotides biyu sun ɓace.
ORF4 ya nuna ƙwayoyin cuta na tsuntsaye da raƙumi da ke da alaƙa da HCoV-229E, wanda ya nuna shigarwar nucleotide guda ɗaya na alpha-CoV na alpaca saboda canjin kwayar.
A ƙarshe, juyin halitta na Novell HCVs ya kasance ne kuma ya haifar da matsin lamba a cikin masu ɗaukar kaya.
Lokacin da tsuntsayen dare suka yi tawaye da koguna, ba su da wata alama ko kuma suna nuna alamun ƙarami; suna nuna cewa akwai dangantaka tsakanin tsuntsaye da koguna a cikin dare.
An nuna cewa tsuntsayen dare sun saba da COVID a zahiri da kuma jiki.
Alal misali, idan tsuntsaye suka yi barci da dare, ba za su iya nuna alamun cutar ba, saboda haka za su rage yawan cutar da ke haifar da cutar.
A gefe guda, a cikin tsuntsaye na dare, ana iya matsawa zuwa aikin halitta mai kisa na ƙwayoyin halitta don hana ƙwayoyin halitta masu kisa NKG2/CD94 girma, kuma mafi girman alamar rashin tausayi na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta.
Bugu da ƙari, yawan ƙwayar oxygen mai ƙonewa (ROS) da ke fitowa daga ƙwayoyin cuta na tsuntsaye na dare mai ƙarfi na iya haifar da ƙarancin matsin lamba akan ƙwayar cuta ko kuma ya shafi sake karantawa ta exoribonucleus, don haka yana haifar da mummunan cutar yayin da matsin lamba na zaɓi ya shiga cikin mai ɗaukar cutar.
Ƙari ga haka, ƙwayoyin cuta na Cove za su iya girma ta hanyar haɗuwa, wanda zai haifar da sababbin furotin ko kuma abubuwan da ke nuna furotin don daidaita mai ɗaukar.
Saboda haka, ba zato ba tsammani ba ne cewa Novell Hkovets uku sun faru a cikin shekaru ashirin da suka gabata.
CoVs ba su haifar da cututtuka ba ko kuma suna haifar da alamun bayyanar cututtuka a manyan masu ɗaukar su, kamar tsuntsaye da raƙuma.
Ba su da wata hanyar da za su iya magance cutar.
Bayan haka, an sake bayyana abin da ya sa masu ɗaukar cutar ba su da alamun cutar suka bayyana kuma me yasa suke haifar da mummunan cutar a cikin kamuwa da cutar.
A cikin yanayin da ake fama da cutar, ana iya samun alamun cututtuka masu tsanani a lokacin da ake samun karuwar sinadarin cytokine a cikin yanayin da ake fama da cutar sosai, kuma idan aka yi hakan, cutar huhu za ta ƙara muni.
A akasin haka, an rage yawan amsar da ake samu daga masu ɗaukar siginar a cikin masu ɗaukar siginar.
Hanyar da ta dace da maganin hana rigakafi na iya haifar da sakamako mai amfani ga maganin SARS-CoV-2.
Amsar interferon tana da ƙarfi sosai a tsuntsaye na dare.
Saboda haka, gudanar da Interferon Type I ya kamata ya zama da amfani a farkon kamuwa da cutar SARS-CoV-2 a cikin mutum.
Bugu da ƙari, ba a sami farkon ƙwayar ƙwayar cuta ta NLRP3 a cikin tsuntsaye na dare.
A cikin wannan ma'anar, ana iya amfani da adana NLRP3 inflammasome daga MCC950 gaira don magance COVID-19.
A cikin yanayin da aka samo SARS-CoV da MERS-CoV gabaɗaya, asalin SARS-CoV-2 ya biyo baya.
An gano cewa tsuntsayen dare na beta-Covs suna da SARS-CoV da ke da kashi 95% na nucleotide, kuma akwai SARS-CoV-2 da ke da kashi 96% na nucleotide.
Amma an gano ƙwayoyin cuta da ke kama da SARS-CoV a cikin farashi da sauran dabbobi, waɗanda ba su da alaƙa da waɗanda ke watsa SARS-CoV-2 a kusa.
An gano pangolin beta-CoV a matsayin homologous ga SARS-CoV-2, wanda ke nuna cewa pangolin zai iya haɗuwa da nau'ikan SARS-CoV-2 na ƙarshe na masu ɗaukar jini, ko kuma pangolin beta-CoV.
Ko da yake akwai tambayoyi, babu wata hujja da ta nuna cewa an yi shirin kashe SARS-CoV-2 ko kuma an yi ta ne kawai.
Kwanan nan, an sake mayar da hankali ga Kovč saboda barkewar cutar SARS-CoV-2.
Binciken Covech a cikin tsuntsaye da sauran dabbobi na dare ya canza fahimtarmu game da asalin cutar Covech da mahimmancin masu ɗaukar dabbobi don watsawa zuwa mutane.
An samu shaidu masu tabbaci cewa SARS-CoV, Mars-CoV da SARS-CoV-2 sun samo asali ne daga tsuntsayen dare kuma ana watsa su zuwa ga mutane ta hanyar jiragen ruwa.
Idan an rufe kasuwanni kuma an kashe masu amfani da cutar ta SARS-CoV saboda cutar ta samo asali ne daga mutane da ƙwayoyin cuta a kasuwa, cutar ta SARS-CoV za ta tsaya.
Hakazalika, saboda akwai nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ukan nau'ikan nau'ukan nau'ikan nau'ukan nau'ukan nau'ukan nau'ukan nau'ukan nau'ukan nau'ukan nau'ukan
Amma, ana iya yin bincike a nan gaba a kan yadda za a iya watsa SARS-CoV-2 zuwa mutane ta hanyar pangolins da sauran dabbobi.
A wani ɓangare kuma, an daɗe ana samun raƙumi mai ɗauke da wata ƙugiya mai ɗauke da ƙugiya.
Ana amfani da raƙuma a matsayin kayan sufuri, nama, madara, farar fata da fata don al'ummar yankin.
An yada su sosai daga Gabas ta Tsakiya zuwa Afirka.
Saboda haka, ba za a iya yin hadaya da dukan raƙuma don kare Mersun ba, kamar yadda aka yi a kasuwar dabbobin daji don hana yaduwar SARS-CoV-2 a kasar Sin.
Don dakatar da cutar ta cutar ta MERS, yana da mahimmanci a bi hanya mai mahimmanci kuma yana da amfani a haɗa da wasu matakan hana kamuwa da cuta don samun allurar rigakafi mai tasiri daga cutar MERS-CoV, wanda ke kamuwa da raƙumi.
Ba za mu iya kawar da waɗannan ƙwayoyin ba, saboda haka za a iya samun sabon ƙwayoyin cuta masu cutar.
Akwai wasu 'yan bindiga masu yawa da ke tafiya a cikin daji.
A musamman, tsuntsayen da ke cikin dare suna da bambanci sosai da suke da ikon kamuwa da cuta.
Akwai damar da yawa cewa waɗannan kwatsun zoonotic za su iya zama masu yaduwa da / ko masu kisa ga 'yan adam a nan gaba idan aka canza su kuma an sake haɗa su.
Don rage yawan shan nama da na dabbobi, dole ne a hana cin nama a wasu yankunan kasar Sin.
Saboda cutar SARS, MERS da COVID-19, ana buƙatar cikakken shiri da kuma jiran magani da wuri.
A gaskiya, ƙwayoyin cuta da yawa sun daɗe suna rayuwa a duniya.
Za su kasance a cikin yanayin su har sai an sami yanayi mai kyau don yada su.
Ko da yake tsuntsayen dare suna da damar da za su iya watsa ƙwayoyin cuta, idan mutane suka san cewa za su guje musu, za su rage hulɗarsu da tsuntsaye da sauran dabbobin daji.
Kulawa da dabbobi masu shayarwa a kai a kai yana da mahimmanci don fahimtar yanayin yanayin yanayin Cove da masu ɗaukar su na halitta, wanda ke tabbatar da mahimmancinsa don hana yaduwar cutar daga dabba zuwa mutum da cututtukan nan gaba.
A takaice dai, hanya mafi inganci ga mutane na hana kamuwa da cutar ita ce ta kauce wa asalin muhalli wanda yake dauke da cutar.
A cikin ka'idar asalin SARS-CoV-2, abubuwa da yawa masu ƙarancin gaske suna da mahimmanci.
Idan tsuntsayen dare suna watsa SARS-CoV-2 zuwa penguin, to, ya kamata a yi nazarin abin da tsuntsayen dare da penguin suka yi kama da shi.
Na biyu, idan tsuntsaye na dare suna taka rawa a cikin watsa kwayar cutar zuwa mutum, dole ne a san yadda mutane ke iya yin hulɗa da tsuntsayen dare.
Na uku, idan dabba mai shayarwa ta uku ita ce ainihin mai watsawa, dole ne a bayyana yadda take hulɗa da sauran jinsuna, ciki har da mutane, tsuntsaye na dare da pangolins.
A ƙarshe, dole ne a lura da bincike na kamuwa da cuta, saboda dabbobi masu shayarwa da yawa, ciki har da dabbobin gida, suna iya zama masu haɗari ga SARS-CoV-2.
Ko da tsuntsayen dare ne, ko pangolin, ko wasu dabbobi, ana sa ran SARS-CoV-2 ko wasu ƙwayoyin cuta masu kama da su za su iya zama masu ɗaukar hoto na halitta.
Ci gaba da bincike a wannan fannin zai bayyana juyin halitta na SARS-CoV-2 a cikin dabbobi tare da shawarwari don hanawa da sarrafa COVID-19 a cikin mutane.
Dole ne a sabunta ƙa'idodin binciken da ake tsammani na COVID-19 da kuma wanda ba a tabbatar da shi ba
A ranar 6 ga Fabrairu, 2020, ƙungiyarmu ta buga jagorar gaggawa don ganowa da magance kamuwa da cutar Coronavirus (2019-nCoV) ta 2019 kuma wannan jagorar tana ba da ƙwarewarmu kuma tana ba da kyakkyawan bayani game da yaƙar cutar a duniya.
Koyaya, cutar coronavirus 2019 (COVID-19) sabuwar cuta ce, tare da ci gaba da bincike da kuma ayyukan asibiti, iliminmu da faɗakarwarmu suna ƙaruwa a hankali, don haka, hanyoyin bincike da magani suna ci gaba da kasancewa kusa.
A cikin wannan wasikar, mun amsa ra'ayoyinmu game da jagorarmu kuma mun gabatar da sabon ka'idar gwaji bisa ga sabon binciken bincike da kuma jagororin likita na COVID-19 (nau'i na bakwai) a cikin sabon binciken da aka bayar ta kwamitin kiwon lafiyar jama'a na Jamhuriyar Jama'ar Sin.
A watan Disamba na 2019, cutar ta haifar da annobar cutar Coronavirus (2019-nCoV), wanda yanzu ake kira cutar coronavirus 2019 (COVID-19) da cutar ta sami sunan cutar ta Coronavirus 2 (SARS-CoV-2).
A ranar 11 ga Maris, 2020, WHO ta ayyana COVID-19 a matsayin annoba ta duniya.
Don magance cutar SARS-CoV-2, ƙungiyarmu ta tsara jagorar shawara mai sauri kuma ta buga ta kan layi ta hanyar Nazarin Likitanci na Soja a ranar 06 ga Fabrairu 2020.
Tun lokacin da aka buga shi, an mai da hankali sosai.
Ka lura, duk da haka, COVID-19 sabon cuta ne, kuma bisa ga binciken bincike da ayyukan asibiti na yanzu, fahimtarmu da iliminmu suna ƙaruwa a hankali, don haka hanyoyin bincike da magani suna ci gaba da haɓaka.
Misali, jagororin bincike da magani na COVID-19 da Kwamitin Lafiya na Kasa na Jamhuriyar Jama'ar Sin (http://www.nhc.gov.cn/) ya bayar, A.E. ya fitar da bugu bakwai a cikin lokaci daga 16 ga Janairu, 2020 zuwa 3 ga Maris, 2020, tare da wasu mahallin da aka canza sosai.
Yanzu da jagorarmu ta karɓi ra'ayoyi daga ƙananan, sun ba da shawarar samar da sakamako mai sauƙi dangane da kwarewar asibiti.
Ayyukan su sun ba mu sabon tabbaci game da abin da ya faru kuma sun ba da muhimmiyar daraja ga annobar a duniya.
Muna tallafa wa wannan muhimmin aikin kuma muna nuna godiyarmu.
Koyaya, bisa ga COVID-19 (sarrafa ta bakwai) da kuma sabbin binciken bincike da ke cikin binciken, aikin su ma yana buƙatar sabuntawa.
A cewar fitowar ta bakwai (Maris 32020), mai yiwuwa mai yiwuwa ya cika bayanan cututtuka uku na asibiti, sai dai idan ba a bayyana ba ko kuma ya tabbatar da cewa bayanan asibiti biyu suna buƙatar haɗawa da abubuwa biyu don gudanar da cikakken bincike:
Tarihin annoba: (1) tarihin tafiya ko kasancewa a cikin garin Wuhan da ke da alamun COVID-19 da aka ruwaito a cikin kwanaki 14 kafin bayyanar cutar, ko kuma a cikin wasu lokuta na COVID-19, (2) tarihin tuntuɓar cututtukan SARS-CoV-2 (tare da gwajin acid), (3) tarihin haɗuwa da zazzabi ko cututtukan numfashi a cikin garin Wuhan da ke da alamun cutar, ko wasu al'ummomin da suka shafi COVID-19, a cikin makonni 2 kafin bayyanar cutar, ko kuma a cikin ƙananan yankuna kamar tarin abubuwan da suka faru (watau gida, ofis, makaranta, da sauransu) (≥ 2 KZ)
Bayanan asibiti: (1) zazzabi da/ko alamun numfashi; (2) tare da manyan alamun bayyanar cututtukan kamuwa da COVID-19; (3) yawan adadin ƙwayoyin jini na fari na yau da kullun, ragewa, ko rage yawan lymphocytes a farkon matakin.
Dole ne a dogara da binciken da aka tabbatar da cewa ya faru idan an yi la'akari da (1) gwajin PCR na ainihi na SARS-CoV-2 mai kyau; (2) tsarin gabaɗaya na kwayar cuta wanda ke nuna babban amsa ga ƙwayoyin cuta na coronavirus na yau da kullun; (3) gwajin jini don ƙwayoyin cuta na IgM da IgG na SARS-CoV-2 masu kyau a cikin gwajin sauti, ko kuma sau 4 na ƙwayoyin cuta na IgG na SARS-CoV-2 daga mai cutar mara kyau zuwa mai kyau, ko kuma a cikin matakin dawowa mai tsanani.
Ana iya ganin nucleic acid a cikin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin num
An kara da gwajin jini a cikin fitowar na huɗu (Janairu 27-2020) da na biyar (Fabrairu 8-2020). Sa'an nan kuma an kara da shaidar sarologic a fitowar ta bakwai.
Wadannan gyare-gyare sun dogara ne akan ci gaba da aikin masu bincike don ingantaccen kayan aikin gano nucleic acid don ganewa cikin sauri da kuma ƙara samfurori daban-daban daga numfashin jiki, gami da samfurin jini, don samar da sakamako mai kyau na musamman na rigakafin mutum a cikin ƙimar da aka tabbatar.
Bugu da ƙari, akwai ƙarin bayanai da ke sa mu yi hankali da marasa lafiya da ke nuna alamun bayyanar cututtuka da waɗanda ba su nuna alamun ba.
Saboda haka, saboda an ƙayyade cewa marasa alamun asibiti ba su da wata barazana, ya kamata a sake nazarin jadawalin tsarin Zhou et al.
Hakanan dole ne a tabbatar da tsarin sakamako a cikin gwaji da nazarin asibiti.
A ƙarshe, muna kiran masu karatu su ba da ra'ayinsu domin akwai hujja ta kai tsaye.
Muna ba da shawarar yin bincike kan lamura da kuma zargin da ba a tabbatar da su ba, bin sabbin ka'idoji da kuma bin dokokin ƙasarsu.
A koyaushe, ƙungiyarmu tana sabunta jagorarmu don taimaka wa mutane.
Bangladesh ta ba da rahoton sabbin mutane biyar da suka mutu a rana saboda COVID-19
Jiya, Bangladesh ta tabbatar da sabbin mutane biyar da suka mutu a wannan ranar saboda COVID-19.
Wannan shi ne adadin mutuwar da aka fi samu a rana ɗaya.
Har zuwa jiya, Cibiyar Kula da Cututtuka ta Bangladesh, Cibiyar Kula da Cututtuka da Bincike (IEDCR) ta ba da rahoton kamuwa da cutar, ciki har da mutane 114 da ke cikin asibiti da kuma 33 da ke cikin gida.
An kashe mutane 17 a total.
A cikin wani rahoto na kan layi, Daraktan IEDCR, Dokta Mirjadadi Sabrina Flora, ya ce, daga cikin wadanda suka mutu maza hudu da mace daya.
A cewar Dr. Mercadie, marasa lafiya biyu sun fi shekara 60, biyu sun kai shekaru 51 zuwa 60, ɗaya kuma yana da shekaru 41 zuwa 50.
Ya ce biyu daga cikin masu sauraron sun fito ne daga Dhaka.
A ranar 11 ga watan Maris, Hukumar Lafiya ta Duniya ta ayyana cutar ta CIDID-19 a matsayin annoba.
Ofishin kula da asibitin ya sanar da kamfanin dillancin labaran Anadolu na yankin cewa Jalal Saifur Rahman, darektan hukumar yaki da cin hanci da rashawa ta Bengali, yana cikin wadanda suka mutu, wanda ake kula da su a asibitin Kuwait Maitree.
A ranar Asabar, a cikin wani sanarwa ta bidiyo, Ministan Sufuri da Bridges na Bangladesh Obaidul Quader ya ce zirga-zirgar jama'a za ta rufe har zuwa ranar Asabar mai zuwa fiye da yadda aka tsara a baya.
Wannan rufewar ta hanyar sufuri ta jama'a ta fara ne a ranar 26 ga Maris kuma ana shirin dakatar da ita a ranar Asabar, 4 ga Afrilu.
Har yanzu ana ba da izinin jigilar kayayyaki masu muhimmanci - magani, mai da abinci.
An fara samun kamuwa da cutar COVID-19 a Bangladesh a ranar 8 ga Maris, tare da mutane biyu da matar wani daga Italiya.
A ranar 19 ga Maris, waɗannan ukun sun riga sun warke.
Yawan wadanda suka kamu da SARS-CoV-2 a duniya ya wuce miliyan daya
A ranar Alhamis, adadin mutanen da suka kamu da cutar SARS-CoV-2 ta coronavirus ya wuce miliyan a duk duniya, a cewar bayanan Jami'ar Johns Hopkins.
Akalla mutane 52 ne suka mutu sakamakon cutar coronavirus.
A Zambia, inda Malawi ta tabbatar da cewa akwai wadanda suka fara kamuwa da cutar coronavirus, an samu mutuwar farko da ta shafi cutar coronavirus.
Koriya ta Arewa ta ce tana daya daga cikin kasashe kalilan da suka rage daga cutar coronavirus tun ranar Alhamis.
Hukumar lafiya ta duniya ta sanar a jiya cewa an samu mutum 1,051,635 da suka kamu da cutar, ciki har da mutum 79,332 a cikin sa'o'i 24 bayan 10 na yammacin Turai (0800 UTC) na ranar 4 ga Afrilu, a duniya.
An yi rajistar kamuwa da cutar coronavirus sama da 244,000 a Amurka, tare da mutuwar mutane 5,900 aƙalla.
CBS News ta ruwaito cewa, a ranar Laraba, mutane sama da 1,000 ne suka mutu a Amurka sakamakon kamuwa da cutar korona, bisa ga bayanan jami'ar Johns Hopkins.
A duniya, kasashe sun sanar da daukar matakan dakile yaduwar cutar.
A ranar Alhamis, magajin garin Moscow, Sergei Sobyanin, ya kara tsawon lokacin da zai zauna a gidan gari har zuwa ranar 1 ga Mayu.
A matakin kasa da kasa, Shugaba Vladimir Putin ya sanar da cewa 'yan Rasha za su ci gaba da karbar albashin da ba su shiga aiki ba har zuwa 30 ga watan Afrilu.
Majalisar dokokin Portugal ta yanke shawarar tsawaita dokar ta baci ta kasa na kwanaki 15 da kuri'u 215 da suka amince da ita, 10 da suka amince da ita, da kuma kuri'u 1 da suka yi adawa da ita.
Saudiyya ta tsawaita dokar hana fita a cikin biranen da aka tsarkake a Mecca da Madina, inda a baya an dakatar da shi daga karfe 3 na yamma zuwa 6 na safe.
Thailand na shirin aiwatar da dokar hana fita na dare 10 da dare 4.
Gwamnan jihar Ohio Mike DeWine ya sanar da cewa jihar ta kara dokar hana fita zuwa ranar 1 ga Mayu.
Shaguna a Ostiraliya sun rage yawan takardar bayan gida a cikin sayayya guda
A daren Lahadi da Asabar, shagunan sayar da kayayyaki na Australiya, Welworth & Coles, sun rage iyakar tallace-tallace zuwa biyu da ɗaya a kan takardar bayan gida guda ɗaya a duk shagunan da ke cikin ƙasa.
ALDI kuma ta sanar da iyakancewar ranar Litinin.
An sanya waɗannan takunkumi a cikin kundin adireshin kuɗi da kuma hanyoyin haɗin yanar gizo na Facebook.
An bayar da rahoton cewa masu amfani sun ajiye kayayyaki saboda tsoron COVID-19 da kuma yiwuwar warewa.
A ranar Laraba, kamfanin Woolworths ya sauke takardun wanka da kayan aikin wanka don zuwa gida a cikin wani tsari.
Waɗannan canje-canjen sun bi ƙa'idodin da aka gabatar da Woolworths da Coles a cikin tsari na hudu a cikin juzu'in Maris 4 da 5.
A wani jawabin da aka yi a shafinsa na Facebook a ranar Talata, ALDI ya ce, "Sau daya da yawa na shagunan da aka tura suna ci gaba da sayarwa kuma bukatar ba a taɓa gani ba", yayin da yake aiwatar da shirin dakatar da abubuwa hudu a ranar 8 ga Maris.
A makon da ya gabata, kakakin kamfanin Woolworths ya ce, tallace-tallace sun karu sosai.
Wani kantin sayar da kayayyaki na Costco a Canberra ya rage adadin da aka ba da izini zuwa kashi biyu a makon da ya gabata.
Don rage ƙarancin, Coles ya ba da umarni daga manyan masu samarwa da haɓaka yawan isarwa; Walworth ya ba da ƙarin kayan da aka shirya don siyarwa, kuma ALDI ta shirya tallace-tallace na musamman a ranar Laraba.
Russell Zimmerman, babban darektan kungiyar masu sayar da kayayyaki, ya yi korafin cewa masu sayar da kayayyaki suna son kara yawan tallace-tallace, amma takunkumin da majalisar ta kafa game da lokacin kawo manyan motoci sun sanya hakan ya zama da wuya.
Yana tsammanin farashin samfurin zai ragu yayin da masu samarwa da sauran masu ba da izini ke jiran isar da flagons.
ALDI ta sanar a ranar Litinin cewa wasu shagunan ajiya ba za su yi bikin ranar Laraba ba, bayan an saki Stocks a baya.
A cikin rahoton News.com.au, Dr. Gary Mortimer, masanin sayar da kayayyaki daga Jami'ar Fasaha ta Queensland, ya ce shagunan suna cike da kayan sayarwa kowace dare.
Takardar gidan wanka / software babban abu ne, wanda ke sa ya zama ƙarami a cikin shaguna kuma yayin sayarwa, yana haifar da sararin sararin ɗakunan ajiya, wanda ke haifar da ƙarancin ra'ayi.
"A cewar ABC, "Russell Singer, ra'ayin Coles da Woolworths shi ne cewa idan an samu abubuwa da yawa a kan shiryayye, za a iya rage yawan damuwa ta sayen kayan tsabtace jiki da tawul don tsabtace jiki".
A ranar Laraba, wani mai samar da takardar bayan gida mai cike da ruwa ya ce za a yi watsi da kayayyakin da ake samu a cikin gidan wanka.
Kimberly-Clark, Knex Toilet Software, da Solaris Paper sun nuna cewa suna aiki 24/7 don tallafawa wadata, a cewar rahoton News.com.au.
Shafin yanar gizon Real State Domain.com ya ba da rahoton wasu masu siyar da kadarori da ke ba da takardar shaidar gidan wanka kyauta ga mai neman farko a cikin gwanjon a Melbourne, saboda masu siye ba su da hutu a cikin dogon makon ranar ma'aikata na 'yan gwanjo.
Labarin NT News na Alhamis, wanda Darwin ke buga a kowace rana, ya ƙunshi shafi takwas don yin rubutu da amfani da shi azaman takardar gidan wanka.
Da farko, shagunan sun ƙi yin takunkumi, kuma sun ce ba su da wani shiri don gabatar da ƙuntatawa kan sayayya, a cewar rahoton ABC Australia a ranar 3 ga Maris.
Russell Zimmerman ya kara da cewa akwai bukatar kayayyaki da yawa, har da masks, sanitizers, kayan bushewa, wanke hannu da foda.
Hakazalika, babban kanti na Ocado na Burtaniya a waje da Ostiraliya ya sanar a ranar Lahadi cewa za a sayar da fursunoni 12 kawai a cikin gidan wanka na Andres.
Hukumar Lafiya ta Duniya ta bayyana COVID-19 a matsayin annoba ta duniya
A ranar Laraba, Hukumar Lafiya ta Duniya (WHO) ta sanar da yaduwar COVID-19 a matsayin annoba ta duniya ta coronavirus SARS-CoV-2.
Kalmar nan panemc ba kawai ta nuna irin wahalar da wani abu yake da ita ba, amma ta nuna irin yadda cutar ta yadu.
"Dukkanin kasashe na iya canza yanayin annobar".
"Darakta Janar na Hukumar Lafiya ta Duniya, Tedros Adhanom Gebreyesus, ya ce "" idan ƙasashe sun bincika, sun warke, sun bambanta, sun bincika, kuma sun sami amsa daga jama'a. ""
Domin wannan cuta tana da tsanani kuma tana da ban tsoro, muna mai da hankali sosai ga yin amfani da maganin da ya dace.
"Daga tsohon darektan kula da cututtuka da rigakafin cutar Amurka, Dokta Tom Frieden, an bayyana annobar a matsayin "ba a taɓa gani ba".
"A cikin wani bayani da CNN ta wallafa a watan Fabrairu, ya ce, ""ba a samu wani kwayar cutar numfashi ba sai mura tun lokacin da ta faru har zuwa lokacin da ta ci gaba da yaduwa a duniya".
"Gretesu ya bayyana ra'ayi iri ɗaya da na cewa, "Ba mu taɓa ganin annobar kamar ta coronavirus ba".
"Sai ya ce, "Kuma ba mu taɓa ganin annobar da za a iya sarrafawa a lokaci guda ba a baya".
Sabon yanayin ya biyo bayan shawarar Hukumar Lafiya ta Duniya ta bayyana cewa, annobar ta zama gaggawa ga lafiyar jama'a.
Darakta Anthony Fusi, darektan Cibiyar Kula da Cututtuka da Cututtuka ta Kasa ta Amurka, ya ce, yaduwar cutar ta zama da wuya sosai saboda ta shiga cikin al'umma.
A ranar Alhamis, Associated Press ta ba da rahoton cewa akwai shari'o'i 126,000 na COVID-19 a duniya, kuma fiye da mutuwar 4,600 ne sakamakon haka.
Cutar coronavirus ta 2019-20 ta kasance annobar cutar coronavirus ta 2019 (COVID-19) wacce ke yaduwa kuma ta haifar da cutar coronavirus ta numfashi mai tsanani 2 (SARS-CoV-2).
An bayyana cutar a cikin lardin Wuhan, China, Disamba 2019, Janairu 30-2020 a matsayin gaggawa na gaggawa ga lafiyar jama'a, wanda aka bayyana a matsayin annoba a ranar 11 ga Maris 2020.
A ranar 10 ga Afrilu 2020 an samu kimanin mutane miliyan 1.61 da suka kamu da cutar COVID-19 a kasashe 210 da suka yi sanadiyar mutuwar kusan mutane 97,000.
An warkar da mutane 364,000.
An kiyasta cewa adadin mutuwar cutar ta CAZ a kasar Sin ya kai kashi 4 cikin 100 da sauran kasashen duniya suka kai kashi 13.04 cikin 100 a Aljeriya zuwa 0.08 cikin 100 a New Zealand.
Babban alamun cututtukan su ne zazzabi, tari da kuma rashin numfashi.
Abubuwan da ke damun mutane sun haɗa da pneumonia da kuma ciwon rashin ƙarfi.
A yawancin lokaci, lokacin da aka fara bayyanar cututtuka ya kai kwanaki biyar, amma zai iya zuwa kwanaki biyu zuwa goma sha huɗu.
Babu allurar rigakafi da aka sani ko maganin rigakafin cutar da aka tsara don wannan.
Babban magani shine magani na alama da tallafi. Matakan kariya da aka ba da shawarar sun haɗa da wanke hannu, rufe bakinka lokacin da kake yin lalata, kiyaye nesa da wani, da kuma kula da kanka da keɓe kanka ga waɗanda suke tunanin cewa sun kamu.
Hukumomi a duk faɗin duniya sun amsa ta hanyar yin amfani da takunkumin tafiye-tafiye, killacewa, iyakance lokacin aiki, sarrafa haɗarin wurin aiki, da rufe wuraren aiki.
Cutar ta haifar da mummunan tashin hankali na tattalin arzikin duniya, jinkirta da soke wasanni, ayyukan addini, siyasa da al'adu, da kuma karancin wadata a cikin cinikin da ya faru.
A kasashe 193 an rufe makarantu da jami'o'i na gida ko na duniya, wanda ya shafi kashi 99.4 cikin dari na yawan dalibai.
Ana samun ƙiyayya da warewar 'yan ƙasa daga China, kudu da gabashin Asiya da sauran ƙasashen da suka kamu da cutar saboda rarraba cikakken bayani game da cutar ta yanar gizo.
Saboda rage yawan tafiye-tafiye da kuma rufe manyan masana'antu, gurɓataccen iska da kuma fitar da carbon sun ragu.
Jami'an lafiya a Wuhan, China (babbar birnin lardin Yubei), sun sanar da cewa akwai cutar pneumonia da ba a san asalinta ba a ranar 31 ga Disamba 2019 kuma sun fara binciken a watan Janairu 2020.
Yawancin abubuwan da suka faru suna da alaƙa da kasuwar sayar da abincin teku ta Huanana, kuma ana tsammanin cutar ta samo asali ne daga zoonotic.
An gano sabon kwayar cutar da ta haifar da yaduwar da ake kira SARS-CoV-2, wanda ke da alaƙa da ƙwayoyin cuta na tsuntsaye na dare, ƙwayoyin cuta na penguin da SARS-CoV. An gano cewa mutumin da ya fara nuna alamun cutar ya kamu da cutar a ranar 1 ga Disamba 2019 kuma ba shi da alaƙa da rukunin kasuwa mai zafi.
Kashi biyu bisa uku na shari'o'in da aka samu a farkon watan Disamba na 2019 suna da alaƙa da kasuwa.
A ranar 13 ga watan Maris, 2020, jaridar Morning Post ta Kudu ta kasar Sin ta ruwaito cewa, a ranar 17 ga watan Nuwamba, 2019, an samu kamuwa da cutar ta farko a wani mutum mai shekaru 55 mai suna Sao da ke lardin Hube. A ranar 26 ga watan Fabrairu, 2020, WHO ta ruwaito cewa, sabon kamuwa da cutar a kasar Sin ya ragu, kuma a akasin haka, ya fara ƙaruwa a Italiya, Iran da Koriya ta Kudu.
Akwai ƙananan cututtuka da yawa, musamman a cikin ƙananan alamun cututtuka.
A ranar 26 ga Afrilu, an samu karamin adadin cututtuka a tsakanin matasa 'yan ƙasa da shekaru 19, wanda ya kai kashi 2.4% na cututtuka a duniya. Patrick Valance, babban mai ba da shawara kan kimiyyar Burtaniya, ya kiyasta cewa ya kamata a yi wa 60% na yawan mutanen Burtaniya maganin kafin su ji cewa sun sami nasarar magance cutar.
Abubuwan da aka yi magana a kansu sun shafi mutanen da aka gwada su da COVID-19 da kuma waɗanda aka tabbatar sun tabbata a cikin gwajin bisa ga ƙa'idodin jama'a.
A ranar 23 ga Maris, babu wata ƙasa da ta bincika fiye da kashi 3 cikin 100 na yawan jama'arta, kuma ƙasashe da yawa kamar Italiya, Netherlands, Spain, da Switzerland suna da ƙa'idodin hukuma don bincika waɗanda kawai ke da alamun rashin ƙarfi.
A cewar wani bincike da aka wallafa a ranar 16 ga watan Maris, kimanin kashi 86 cikin 100 na yaduwar COVID-19 a kasar Sin ba a san su ba har zuwa 23 ga watan Janairu. Waɗannan yaduwar da ba a yi rajista ba su kasance tushen yaduwar cutar ga kashi 79 cikin 100 da aka yi rajista.
Binciken kididdiga da aka buga a ranar 30 ga Maris ya nuna cewa adadin wadanda aka kashe a Italiya ya fi yawan wadanda aka kashe.
Hasashen farko shine yawan sake haifar da COVID-19 (R0) daga 1.4 zuwa 2.4.
Wani bincike da Cibiyar Kula da Cututtuka da Tsare-tsare ta Amurka ta wallafa ya kammala da cewa, zai iya zama 5.7.
Yawancin mutanen da ke da COVID-19 suna murmurewa.
Ga wadanda ba su sani ba, lokacin da mutum zai mutu yana tsakanin kwanaki 6 zuwa 41, kuma mafi yawan kwanaki 14 ne.
Daga 10 ga Afrilu 2020 zuwa yau, an yi rahoton kusan mutuwar 97,000 da suka shafi COVID-19.
A ranar 5 ga Fabrairu, kashi 80% na mutuwar da aka yi a kasar Sin sun wuce shekaru 60, kuma kashi 75% na masu cutar jini da ciwon sukari. Yawan mutuwar da aka yi a hukumance saboda COVID-19 ya shafi mutanen da suka mutu a matsayin masu cutar COVID-19 bisa ga ka'idojin hukuma.
Yawan mutuwar COVID-19 na iya ƙaruwa ba tare da haɗa waɗanda suka mutu ba, kamar waɗanda suka mutu a gida, likitocin gida, da sauransu.
Bayanai na ɓangare a Italiya sun nuna cewa adadin mutuwar marasa lafiya a lokacin annobar ta duniya ya ninka sau 4-5 na mutuwar COVID a hukumance.
"Maganar mai magana da yawun Cibiyoyin Kula da Cututtuka na Amurka (CDC) ta ce ""Mun san cewa an kiyasta cewa [ƙididdigar mutuwar] ta ragu"," inda rahoton da aka yi a Amurka ya nuna cewa irin wannan ƙididdigar ta raguwa ta faru a wasu lokatai a lokacin annobar, kamar yadda ta faru a cikin yaduwar cutar H1N1 ta mura a shekarar 2009.
Mutuwar farko ta faru ne a ƙasar Sin a ranar 1 ga Fabrairu a ƙasar Filifin, kuma a Faransa a ranar 14 ga Fabrairu a wajen Asiya.
A ranar 28 ga watan Janairu, an samu karin mutuwar a kasar Iran, Koriya ta Kudu da Italiya, banda kasar Sin.
A ranar 13 ga Maris, ya ce, fiye da kasashe da jihohi arba'in sun sami mutuwar a kowace nahiya, ban da Antarctica.
Wadannan lambobi sun bambanta daga wuri zuwa wuri, amma a lokaci ana matsa lamba ta hanyar yawan gwajin da aka shirya, ingancin sabis na kiwon lafiya, likitoci da shugabanni, lokacin da annobar ta fara da kuma al'ummomin da suka shafi shekaru, jinsi da lafiyar jama'a gaba ɗaya.
A cewar kididdigar Jami'ar Johns Hopkins, yawan mutuwar masu cutar a duniya a Amurka ya kai kashi 6.0% (97,039/1,617,204) a ranar 10 ga Afrilu, 2020.
Yawan adadin ya bambanta daga yanki zuwa yanki.
A China, yawan mutuwar marasa lafiya ya ragu daga 17.3% (wanda ke da alamun cutar daga 1-10 ga Janairu, 2020 zuwa 0.7% (wanda ke da alamun cutar bayan 1 ga Fabrairu, 2020). Sauran matakan sun haɗa da CFR, wanda ke nuna yawan mutanen da suka mutu daga cutar da aka bincika, kuma yawan mutuwar kamuwa da cutar (IFR) wanda ke nuna yawan mutanen da suka mutu daga cutar (wanda aka gudanar da bincike da waɗanda ba a bincika ba).
Wannan ƙididdigar ba ta da iyaka a kan lokaci, kuma ta hanyar wani tsari na shari'a, za a bi idan an kamu da wani al'umma.
Masana da yawa sun yi ƙoƙarin lissafa waɗannan lambobin don wasu alƙaluma.
Cibiyar Lafiya ta Jami'ar Oxford ta kiyasta cewa mutuwar da cutar ta haifar zai iya zama tsakanin kashi 0.1% zuwa 0.39%.
Tunanin farko na wannan zangon ya fara ne da binciken kididdiga na gwajin COVID-19 na Jamus da kuma na CFR.
WHO ta ce ana iya sarrafa cutar.
Ba wai kawai yana da wuya a faɗi ainihin lokacin da annoba za ta kai ga mafi girma ba, amma kuma zai iya bambanta daga wuri zuwa wuri.
Jami'ar Penn State ta shirya wani sabon abu, wanda cutar ta kasance daidai. Daga nan, cutar ta ragu yayin da ta ɓace daga cikin waɗanda suka kamu da cutar.
Amma ba za a iya tunanin lokacin da hakan zai faru ba.
"Zhong Nanchang, babban mai ba da shawara kan harkokin kiwon lafiya na gwamnatin kasar Sin, ya yi murna da cewa idan dukkan kasashe suka bi shawarar Hukumar Lafiya ta Duniya game da matakan da za a dauka don hana yaduwar cutar, za ta "dakatar da shi a watan Yuni".
A ranar 17 ga Maris, Adam Kucharsky na likitancin tsaftacewa da kuma maganin zafi na London ya ce SARS-CoV-2 "yana faruwa sau da yawa a shekara ko shekaru biyu".
"A cewar wani bincike na kolejin Imperial wanda Neil Ferguson ya gudanar, "ana bukatar a yi nesa da jiki da sauran matakai har sai an samu rigakafi (watakila watanni 18 ko fiye) ".
"William Schaffner na Jami'ar Vanderbilt ya ce: "Wannan cutar coronavirus tana da sauƙin kamuwa da ita, saboda haka yana da wuya a ce za a kawar da ita gaba ɗaya kuma ina tsammanin za ta iya dawowa kowace shekara kuma ta zama cuta ta yau da kullun".
Ana ƙaddara lalacewar dawowa ta hanyar haɗin kai da kuma canjin DNA.
A wani ɓangare, alamun COVID-19 ba su da bambanci kuma waɗanda suka kamu da cutar ba za su iya nuna alamun cutar ba.
Alamomin biyu na kowa sune zazzabi (88%) da tari (68%).
Alamu da ba su da yawa sun haɗa da gajiya, rashin numfashi, rashin numfashi, rashin numfashi, ciwon tsoka da na'ura, ciwon wuya, ciwon kai, jijiyoyi, zubar da jini, tari mai saurin shiga jini, ciwon kumburi ko kuma ciwon fata.
Cibiyoyin Kula da Cututtuka da Cututtuka na Amirka (CDC) sun lissafa alamun gaggawa kamar rashin numfashi, ciwon kirji ko matsa lamba, tashin hankali, rashin iya tafiya, da kuma kumburi a fuska ko a lebe, kuma idan aka lura da waɗannan alamun, ana ba da shawarar samun taimakon likita nan da nan.
Wasu daga cikin wadanda suka kamu da cutar suna iya zama ba su da wata alama, ba su da alamun asibiti amma sakamakon gwajin ya nuna kamuwa da cutar, masu bincike sun ba da shawarar cewa a lura da su sosai kuma a bincika su don kawar da kamuwa da cutar.
Kasashen China sun kiyasta rashin alamar daga kashi 44 zuwa kashi 44 cikin dari.
Lokacin haifuwa na yau da kullun (lokacin da ke tsakanin kamuwa da cuta da bayyanar cututtuka) yana tsakanin kwana ɗaya zuwa 14, yawanci kwanaki biyar. Misali, rashin tabbas, kashi na mutanen da ke da COVID-19 sun kiyasta cewa sun rasa ƙanshi da farko 30% kuma daga baya sun ragu zuwa 15%.
Za a bayyana wasu bayanai game da yadda cutar za ta kamu da cutar a nan gaba.
Ana iya samun cutar ta hanyar kusanci da kuma saukad da ƙananan saukad da ke faruwa yayin da ake yin zane, numfashi, ko magana, wanda ke da tsayi daga mita 1-2 (daga 3 zuwa 6 ƙafa).
Bincike ya nuna cewa tari da ba a rufe shi ba zai iya haifar da danshi mai tsawon mita 4.5 zuwa mita 8.2.
Wasu sun ce za a iya watsa kwayar cutar ta hanyar saukad da magana kuma za su iya kasancewa a cikin iska na dogon lokaci. Za a iya samun saukad da numfashi a lokacin numfashi, har da magana, amma ba a yawanci ana samun kwayar cutar ta iska ba.
Za su iya yin kwanciya a kan hanci ko hanci ko kuma a cikin huhu na mutane da ke kusa da su.
Aikin da ake yi na karkatarwa na huhu (CPR) zai iya sa mutum ya kamu da cututtuka masu yaduwa daga huhu.
wani mutum zai iya samun gurɓataccen wuri da ya taɓa idanunsa, hanci ko bakinsa bayan ya taɓa fata.
Ko da yake akwai barazanar cewa za a iya watsa ta hanyar kwayoyin halitta, amma wannan barazanar ba ta da yawa.
Gwamnatin kasar Sin ta musanta cewa SARS-CoV-2 ta hanyar baki ne. An gano cewa cutar tana yaduwa sosai a cikin kwanaki uku na farko, duk da cewa ba a nuna alamun cutar ba kuma idan an gano mai cutar za ta iya yaduwa.
Mutane sun sami alamun cutar kwanaki uku kafin bayyanar bayyanar cututtuka, kuma hakan ya nuna cewa za a iya watsa cutar kafin bayyanar cututtuka.
Akwai rahotanni kaɗan na masu cutar da aka tabbatar da su a cikin dakin gwaje-gwaje, amma an gano irin wannan yaduwar yayin da aka bincika su a wasu ƙasashe kuma ba su da Nicky.
Cibiyar Tsaro da Kula da Cututtuka ta Turai (ECDC) ta ce ba a san yadda cutar ta yadu da sauƙi ba, ko mutum ɗaya zai iya kamuwa da cutar daga mutum biyu zuwa uku.
A kan filastik (polypropylene) da kuma bakin karfe 304, cutar za ta iya wucewa har zuwa kwanaki uku, a kan tagulla kuma har zuwa sa'o'i huɗu.
Amma wannan ya bambanta dangane da zafi da zafin jiki. An gano cewa dabbobi da sauran dabbobi sun kasance masu COVID-19.
Babu wata hujja da ta nuna cewa dabbobi za su iya watsa kwayar cutar ga mutane, amma jami'an Burtaniya sun ba da shawarar cewa a yi wanka a bayan dabbobi kamar yadda ake yi bayan mutum ya taɓa bene.
Coronavirus 2 (SARS-CoV-2) cuta ce mai tsanani ta numfashi, cutar Novel, wadda ta bambanta da farko a cikin mutane uku da ke fama da cutar huhu da ke da alaƙa da cututtukan cututtukan numfashi masu tsanani a Wuhan.
Sabo na SARS-CoV-2 yana da dukkan siffofinsa a cikin yanayi tare da coronavirus. A waje da jikin mutum, cutar tana kashe sabulu a gida, saboda sabulu yana kawar da rigakafin cutar. SARS-CoV-2 yana da alaƙa da SARS-CoV na asali.
An yi imani da cewa sun fito ne daga zoontaks.
Binciken kwayoyin halitta ya nuna cewa kwayar cutar korona ta samo asali ne daga kwayoyin halitta guda biyu, daga jinsin betacoronavirus, da kuma daga ƙananan kwayoyin cutar serbecovirus (lineage B) daga sauran kwayoyin halitta.
A duk matakan genomic, samfurin coronavirus na wani tsuntsu na dare (BatCov RaTG13) ya yi kama da kashi 96%.
A watan Fabrairun shekarar 2020, masu binciken kasar Sin sun gano cewa bambancin amino acid guda daya ne kawai a wasu sassan tsarin kwayoyin halitta tsakanin kwayar cutar Pangolin da kwayar cutar mutum.
Kwatantaccen dukkanin kwayoyin halittar mutum ya zuwa yanzu ya nuna cewa akwai kashi 92% na kayan iri tsakanin cutar sankarar cutar ta pangolin da SARS-CoV-2, wanda ya isa ya tabbatar da cewa pangolins sune masu ɗaukar matsakaici.
Ana iya magance kamuwa da cutar bisa ga alamun cutar, amma ana iya tabbatar da shi ta hanyar jujjuyawar kwayar cutar ta hanyar jujjuyawar ƙwayar cuta ta hanyar jujjuyawar ƙwayar cuta (rRT-PCR) ko kuma hotunan CT.
Wani bincike a Wuhan wanda ya kwatanta PCR da CT ya nuna cewa CT ya fi PCR rauni, amma ya nuna rashin bayyanar idan aka kwatanta da sauran cututtukan huhu da kuma cututtukan cututtuka.
Zuwa watan Maris na 2020, Cibiyar Nazarin Radiology ta Amurka ta bayar da shawarar cewa kada a yi amfani da shi don tantance COVID-19 ko a yi amfani da shi azaman gwajin layi na farko.
Hukumar Lafiya ta Duniya ta fitar da jagorar farko na gwajin RNA don binciken SARS-CoV-2 a ranar 17 ga Janairu.
Gwajin yana amfani da amsa sarkar polymerase mai jujjuyawar lokaci na ainihi (rRT-PCR).
Ana iya yin gwajin a cikin numfashi ko kuma a cikin jini.
Ana samun sakamako a cikin 'yan sa'o'i kaɗan zuwa rana ɗaya.
Ana yin gwajin ne ta hanyar cire hanci daga cikin hanci, kuma ana iya yin samfurin ƙwanƙwasa ƙuƙwalwa. Yawancin dakunan gwaje-gwaje da kungiyoyi suna shirya gwajin maganin maganin maganin maganin maganin.
Tun daga ranar 6 ga Afrilu, 2020, babu wani daga cikin waɗannan da aka amince da su don amfani da su a ko'ina.
Gwajin sirologic da Selks ta gina a Amurka, an amince da shi ne kawai daga dakunan gwaje-gwaje da aka tabbatar da gaggawa.
Radiographs da computed tomography (CT) da kuma halayyar mutane masu alamun sun kasance a tsakanin gilashin da ba a yi amfani da shi ba da kuma gilashin da ba a yi amfani da shi ba.
Ƙungiyar Radiology ta Italiya tana aiki da bayanan hoto na duniya na kan layi wanda ke nuna abubuwan da suka faru.
Saboda yawan sauran cututtukan kamar adenovirus, an iyakance iyakancewar gano COVID-19 ta hanyar hotunan da ba a tabbatar da PCR ba.
Wani babban bincike a kasar Sin ya kwatanta sakamakon CT na kirji da PCR kuma, ko da yake hoton ya nuna bambanci kaɗan ga cutar, ya yi la'akari da shi azaman kayan aikin bincike na sauri da kuma kulawa da hankali don cutar.
An yi amfani da ilimin kere kere wajen gano abubuwan da ke cikin kwayar cutar ta hanyar daukar hoto da CT.
Gabaɗaya, hanyoyin da za a iya amfani da su wajen isar da cutar, gami da tsabtace jiki, wanke hannu, hana shan idanu da hannaye marasa wanka, hanci ko hanci da kuma shafawa da kuma zubar da su a kan kayan shafa da kuma jefa su kai tsaye a cikin shara.
An shawarci wadanda suka riga sun kamu da cutar su sanya abin rufe fuska kafin su je wurin jama'a.
Ana kuma ba da shawarar yin nesa da jiki don hana yaduwar cutar. Gwamnatoci da yawa sun ba da shawarar hana ko hana duk tafiye-tafiye marasa mahimmanci zuwa da kuma zuwa ƙasashen da cutar ta bazu.
Koyaya, cutar ta kai ga yaduwar al'umma a sassa da yawa na duniya.
Wannan yana nufin cewa cutar tana yaduwa a cikin al'umma, kuma wasu 'yan al'umma ba su san inda aka kamu da cutar ba ko kuma yadda aka kamu da ita. Ana ba da shawarar cewa masu kula da lafiya da ke kula da al'umma mai yuwuwar kamuwa da cutar su yi shiri, su yi la'akari da taɓawa da kuma kula da idanunsu. Binciken rashin taɓa jiki tare da mutumin da ke da cutar, tabbatarwa hanya ce mai mahimmanci ga hukumomin lafiya don gano asalin cutar da hana yaduwar cutar.
Amfani da bayanan muhalli ta wayoyin salula na gwamnati don wannan dalili ya haifar da damuwa ga mutane, Amnesty International da fiye da kungiyoyi 100 sun yi kira da su su takaita irin wannan sa ido kan leken asiri.
Yawancin aikace-aikacen hannu suna kusan amfani da su a cikin amfani da flagship, yayin da masana da yawa ke jiran ranar 7 ga Afrilu, 2020, don samun ƙarin waya ta hanyar amfani da Bluetooth a hankali.
Idan masu amfani sun kasance kusa da mutumin da aka gwada tabbatacce ga COVID-19, za a sami saƙo. Ra'ayoyi marasa kyau game da yadda za a hana kamuwa da cuta suna yaduwa, misali, wanke hanci da wanke bakuna ba su da tasiri.
Ko da yake ƙungiyoyi da yawa suna aiki don ƙirƙirar, babu allurar rigakafin COVID-19.
Ana ba da shawarar yin wanka a hannu don rage yaduwar cutar.
Hukumar kula da lafiyar jiki ta ce mutane su wanke hannuwansu da sabulu da ruwa na akalla na biyu, musamman bayan sun je gidan wanka ko sun wanke hannuwansu a fili, kafin su ci abinci, kuma bayan sun taɓa hanci, sun ji rauni, ko kuma sun yi wa kansu rauni.
Wannan shi ne saboda ƙwayoyin cuta suna mutuwa a waje da jikin mutum ta wurin wanke su da sabulu.
CDC ta ba da shawarar yin amfani da maganin hana hannu mai dauke da barasa 60% inda babu sabulu da ruwa.
WHO ta ce kada mutane su taɓa idanunsu, hancinsu ko bakinsu da hannu ba tare da an wanke su ba.
Abubuwan da ke ciki za a iya tsabtace su ta hanyar magunguna da yawa (mai tsabtace ƙarfe mai ƙarfe a cikin minti ɗaya), daga 6271% ethanol, 50100% propellol, 0.1% sodium hypochloride, 0.5% hydrogen peroxide, da 0.27.5% poividon-iodine.
Sauran hanyoyin, kamar benzallkonium chloride da chromexideine gluconate, sun rage ingancin su.
CDC ta ba da shawarar cewa ana iya gano ko tabbatar da kamuwa da COVID a wurare kamar wuraren aiki, ofis ko gidan wanka na yara, inda ake buƙatar tsabtace wuraren wanka, wuraren amfani da wutar lantarki da kuma wuraren amfani da wutar lantarki, tebur, kwamfuta, ATM, da sauran wurare da ke da maganin kashe cutar.
Kungiyoyin kiwon lafiya sun ba da shawarar cewa a rufe bakinsu da hanci da hannu ko kuma a cire duk wani abu da aka yi da sauri idan ana yin zane ko kuma a cire shi.
Ana ba da shawarar yin aikin tiyata ne kawai ga mutanen da cutar ta shafa. Domin cutar ba ta yadu sosai ba kuma tana hana yaduwar cutar yayin magana, fure da kuma shan magani.
Hukumar Lafiya ta Duniya ta ba da umarni kan lokacin da kuma yadda za a yi amfani da abin rufe fuska.
"A cewar masanin cututtuka na jami'ar Legas, Stephen Griffin, ""masks na iya rage yawan taɓa fuska, wanda ke hana kamuwa da cuta da hannaye da ba a wanke su da kyau ba". Masks na iya kuma hana mutane da ke da cutar kamuwa da cutar".
Mutane masu lafiya sun ba da shawarar cewa kada su sanya abin rufe fuska da hanci tare da waɗanda ke tallafawa waɗanda ke da COVID-19 idan suna da nicky da kuma baƙi, da sauransu, duk da cewa sun fahimci cewa yana da kyau a rufe fuska da hanci.
Kasashe da dama sun fara ƙarfafa amfani da abin rufe fuska ga 'yan ƙasarsu.
A Amirka, CDC ta ba da shawarar yin abin rufe fuska da aka yi da masana'anta don yin magani. A kasar Sin, ana ba da shawarar yin amfani da abin rufe fuska na likita na lokaci ɗaya don yin amfani da shi a cikin al'umma mai lafiya, musamman ma a lokacin da suke da kusanci da wasu mutane (1 mita (3 feet) ko ƙasa da haka).
Yana ba da shawarar yin abin rufe fuska na aikin tiyata yayin amfani da sufuri na jama'a ko lokacin da kake zama a wuraren da mutane suke da yawa.
Hukumomin lafiya a Thailand suna ƙarfafa mutane su saka abin rufe fuska da kuma wanke su kowace rana.
Jamhuriyar Czech da Slovakia sun haramta fita a cikin filin ba tare da yin abin rufe fuska ko rufe hanci da hanci ba.
A ranar 16 ga watan Maris, Vietnam ta ba da umarnin cewa kowane ɗan ƙasa ya saka abin rufe fuska don kare kansa da wasu yayin da yake fita daga gida zuwa wuraren jama'a.
Gwamnatin Austria ta tilasta duk wanda ya shiga kantin sayar da kayan masarufi ya saka abin rufe fuska.
Isra'ila ta bukaci dukkan 'yan kasar ta su sanya abin rufe baki da fuska a lokacin da suke fita.
Taiwan, wadda ta samar da abin rufe fuska miliyan goma a rana tun tsakiyar watan Maris, ta ba da umarnin cewa fasinjojin jirgin ƙasa da bas na birni su sanya abin rufe fuska daga ranar 1 ga Afrilu.
Panama ta tilasta wa duk wanda ya fita waje ya saka abin rufe fuska, kuma ta ƙarfafa waɗanda ba su iya saya su yi aikin gida.
An kuma yi amfani da abin rufe fuska a Japan, Koriya ta Arewa, Malaysia, da kuma Singapore.
Tsayawa a waje ko kuma (wanda aka fi sani da tsayar da jiki) ya ƙunshi kiyaye yanayin yaduwar cutar, rage hulɗa tsakanin mutane, rage yaduwar cutar.
Hanyoyin sun hada da warewa, hana tafiya, rufe makarantu, wuraren aiki, filayen wasa, gidajen wasan kwaikwayo da wuraren kasuwanci.
Mutane za su iya yin amfani da hanyoyin nesa ta zamantakewa ta hanyar zama a gida, ta hanyar hana tafiya, ta hanyar guje wa mutane da yawa, ta hanyar yin sallama ba tare da taɓa su ba, ta hanyar nisantar kansu da wasu.
Yawancin gwamnatoci a halin yanzu suna ba da shawarar kuma suna sanya ƙaura ta al'umma a cikin jihohin da cutar ta shafa.
An rage yawan taron daga 250 (idan babu alamun COVID-19 da aka sani) zuwa 50 sannan kuma mutane 10 a matsayin tarurruka da aka ba da shawarar ta hukumar gwamnati da Hukumar Lafiya ta Amurka.
A ranar 22 ga Maris, 2020, Jamus ta haramta kowa ya fita waje da mutane fiye da biyu. A ƙarshen Maris, WHO da sauran kungiyoyin kiwon lafiya sun fara maye gurbin kalmar "tsayawa ta zamantakewa" da "tsayawa ta jiki", saboda manufar rage hanyoyin sadarwar zamantakewa ta hanyar amfani da Intanet ko nesa.
A cikin wannan labarin, an yi amfani da kalmar warewa ta hanyar zamantakewa don nuna mutanen da suka shiga cikin cikakken zaman kansu, maimakon su ba da shawarar ci gaba da hulɗa da wasu ta hanyar wasu hanyoyi. Wasu hukumomi sun ba da ƙa'idodin kiwon lafiya na jima'i a lokacin annobar duniya.
Waɗannan sun haɗa da ba da shawara cewa a yi jima'i da mutumin da ke zaune tare da shi kawai kuma ba shi da cutar ko alamun cutar.
Ga waɗanda ake zaton suna da cutar kuma suna da COVID-19, ana ba da shawarar a keɓe su a gida.
Hukumomin lafiya sun ba da cikakken umarnin keɓewa. Gwamnatoci da yawa sun ba da shawarar cewa mutane a wuraren da cutar ta fara zama a keɓewa.
An ba da ƙa'idodin keɓe kai ga waɗanda ke cikin rukunin haɗari mai tsanani.
Ana ba da shawarar cewa waɗanda za su iya kasancewa cikin haɗari da wani wanda ke da COVID-19 da waɗanda suka yi tafiya zuwa ƙasar ko yankin da cutar ta bazu kwanan nan su keɓe kansu na kwanaki 14 daga ranar ƙarshe da aka gano su.
Hanyoyin da za a iya amfani da su don sarrafa watsawa su ne hana ko hanawa da ragewa.
Ana yin hanawa a farkon fasalin annobar, tare da manufar ganowa da gano waɗanda suka kamu da cutar da kuma gabatar da wasu sabbin hanyoyin sarrafa kamuwa da cuta don rage yaduwar zuwa sauran al'umma.
Idan ba za a iya hana yaduwar cutar ba, ana gudanar da gwaje-gwaje zuwa matakin jurewa, ana daukar matakan rage yaduwar da kuma magance tasirin da ke kan tsarin kiwon lafiya da al'umma.
Za a iya ɗaukar matakan riƙewa da juriya tare.
Ana buƙatar ƙarin matakai don rage yawan yaduwar cutar ta ƙasa da 1. Wani ɓangare na sarrafa cutar mai yaduwa shine ƙoƙarin rage yaduwar cutar ta amfani da hanyar da ake kira hanyar yaduwar cutar.
Wannan zai ba da ƙarin lokaci don samar da alluran rigakafi da magani don hana ayyukan kiwon lafiya yin aiki da yawa.
Abubuwan da za su iya hana cutar daga maganin sun hada da tsaftace hannu, rufe baki da hanci da ware kanka; rufe makarantu, soke shirye-shiryen taron jama'a; shigar da al'umma don tabbatar da amincewa da irin wannan haramcin; da kuma tsaftace matakan da suka dace.
Sauran ƙasashe sun ɗauki matakai daban-daban a duniya don hana yaduwar cutar.
Koriya ta Kudu ta gabatar da gwaji da keɓewa, wanda ya ƙunshi yawancin mutane, kuma tana ba da sanarwar lokacin da waɗanda suka kamu da cutar ke motsawa.
Singapore ta sake ba da tallafi ga waɗanda suka yi watsi da kansu na ɗan lokaci kuma ta sake hukunta waɗanda suka yi hakan.
Taiwan na kara samar da kayan rufe fuska da hada kayan kiwon lafiya. Binciken da aka yi na Burtaniya da Amurka ya nuna cewa rage (amma ba a daina yaduwar cutar) da kuma sarrafawa (dakatar da ci gaban annobar) suna fuskantar kalubale masu tsanani.
Yin amfani da manufofi masu kyau zai rage yawan mutuwar kashi biyu bisa uku na matsalar lafiya ta farko. Amma dubban mutuwar da kuma tsarin kiwon lafiya sun nuna cewa akwai matsaloli da yawa.
Zai fi kyau a yi amfani da rigakafi muddin cutar tana yaduwa a cikin mutane amma dole ne a jira (ko har sai an sami allurar rigakafi, idan hakan ya fara faruwa), don yaduwar ta amsa da sauri idan yanayi ya yi.
Yin tsayayya da cutar na dogon lokaci yana haifar da rikicin zamantakewa da tattalin arziki.
Babu takamaiman magungunan rigakafin cutar COVID-19 da aka amince da su, amma an yi ƙoƙari na ci gaba, gami da gwajin magungunan da ke akwai.
Yin amfani da magunguna da ba a rubuta su ba, shan ruwa, da kuma hutu na iya rage alamun rashin lafiya.
Za a iya bukatar maganin oxygen, jini da kuma taimakon numfashi, dangane da nauyinsa.
Yin amfani da magungunan steroids na iya haifar da sakamako mafi muni.
Ana bincika wurare da yawa da aka ba da izinin yin magani don cututtukan da ke haifar da cutar don amfani da COVID-19.
Hukumar Lafiya ta Duniya ta ce wasu "magunguna na gargajiya da na gida" na iya taimakawa wajen magance alamun cutar SARS-CoV-19".
WHO ta ce, karfafa bukatun marasa lafiya na COVID-19 da inganta kula da lafiya mataki ne na farko don ƙaddamar da yaduwar cutar.
ECDC da Hukumar Lafiya ta Duniya sun ba da umarni ga asibitoci da kuma ayyukan kiwon lafiya na farko, gami da tura kayan aiki na Turai a cikin manyan girma, wanda ya haɗa da mai da hankali kan ayyukan dakin gwaje-gwaje game da gwajin COVID-19, soke hanyoyin a duk lokacin da zai yiwu, ganowa da keɓe marasa lafiya masu cutar COVID-19 da kuma horar da ma'aikata don haɓaka ƙarfin kula da marasa lafiya na tsanani da haɓaka yawan injunan numfashi da gado.
Akwai ra'ayoyi da yawa game da asalin cutar ta farko (Carrier Zero).
An fara gano wasu cututtukan cutar korona a Wuhan, Hubei, China, a ranar 1 ga Disamba, 2019.
A cikin wata daya, adadin wadanda suka kamu da cutar coronavirus a Hubei ya ragu.
Yawancin waɗannan suna da alaƙa da kasuwar sayar da abincin teku na Hawai'i, ban da masu sayar da dabbobi masu rai, kuma ra'ayi ɗaya shine cewa kwayar ta fito ne daga ɗayan waɗannan nau'ikan dabbobi; ko kuma asalin zoonotic. An gano asibitin huhu wanda ba a san dalilinsa ba a ranar 26 ga Disamba kuma likita Zhang Jixian ya kula da shi a asibitin lardin Hebei wanda ya sanar da Wuhan Jiangsan CDC a ranar 27 ga Disamba.
"A ranar 30 ga watan Disamba, 2020, wani rukuni na likitoci a babban asibitin Wuhan ya sanar da abokan aikinsa cewa akwai "tafiyar cutar coronavirus kamar SARS".
Likitoci takwas daga cikin wannan ma'aikatar, ciki har da Li Wenliang, an yi gargadin su da yin jita-jita, kuma an yi wa wani mai kula da su da laifin yin hakan da sunan Ai Fen.
Hukumar Lafiya ta Municipal Wuhan ta ba da sanarwar a ranar 31 ga Disamba kuma ta sanar da WHO.
An ba da rahoton cewa an gwada isasshen cututtukan huhu da ba a sani ba a farkon watan Janairu. A lokacin farkon fasalin yaduwar, adadin cututtukan ya ninka sau biyu a kowace kwana bakwai da biyar.
A farkon da tsakiyar Janairu 2020, kasancewa cibiyar ƙaura da sufuri na Sabuwar Shekara ta Sin da kuma manyan musayar jirgin ƙasa, ya taimaka wa cutar ta bazu zuwa sauran lardunan China.
A ranar 20 ga watan Janairu, kasar Sin ta ba da rahoton kusan sabbin mutane 140 da suka mutu a rana guda, ciki har da mutane biyu a Beijing da kuma mutum daya a Shenzhen.
Bayan haka, bayanan hukuma sun nuna cewa mutane 6,174 sun nuna alamar cutar a ranar 20 ga Janairu, 2020. A ranar 26 ga Maris, Amurka ta fi yawan mutanen da suka kamu da cutar fiye da na China da Italiya. A ranar 9 ga Afrilu, 2020, an yi rajistar fiye da miliyan 1.61 na kamuwa da cutar a duniya, fiye da mutane 97,000 suka mutu kuma fiye da mutane 364,000 sun warke.
Kasashe da yankuna kusan 200 suna da akalla shari'ar guda.
Kasashe da dama a yankin Schengen sun dakatar da motsi saboda annobar a Turai, kuma sun fara kula da iyakoki.
Ya zuwa ranar 2 ga Afrilu, kusan mutane miliyan 300 ko kashi 90% na 'yan kasar Amurka suna cikin dokar hana fita, kusan miliyan 50 a Philippines, miliyan 59 a Afirka ta Kudu, da kuma biliyan 1.3 a Indiya.
A ranar 26 ga watan Maris, mutane biliyan 1.7 ne ke cikin gidajen wuta ko wasu wuraren da ake tsare, daga biliyan biyu zuwa biliyan 2.6 a duniya. Wannan ya rufe kashi ɗaya bisa uku na yawan mutanen duniya.
An gano farkon kamuwa da COVID-19 a cikin ruwa a ranar 1 ga Disamba, 2019, yayin da rahoto mara tabbata ya nuna cewa an gano farkon a ranar 17 ga Nuwamba.
Dokta Zhang Jixian ya gano asalin cutar huhu da ba a san asalinsa ba a ranar 26 ga Disamba, 2016, sannan ya sanar da asibitinsa ga Wuhan Jianghan CDC (Central Centers for Disease Control and Prevention) a ranar 27 ga Disamba, 2020.
A ranar 27 ga watan Disamba 2019 an yi gwajin kwayoyin halitta a cikin samfurin marasa lafiya wanda ya nuna cewa akwai kwayar cutar korona kamar SARS.
An fitar da sanarwar a ranar 31 ga watan Disamba a Hukumar Lafiya ta Birnin Wuhan.
An sanar da Hukumar Lafiya ta Duniya a wannan ranar.
A lokacin da aka yi wannan sanarwar, likitocin ruwa sun sami gargadi daga 'yan sanda don yin amfani da 'yan ta'adda don yada' yan ta'adda.
Hukumar Lafiya ta kasar Sin ta ce babu wata hujja a kan yadda za a iya daukar kwayar cutar daga mutum zuwa mutum.
A karshen watan Janairu, babban sakataren jam'iyyar kwaminis ta kasar Sin, Xi Jinping, ya ce gwamnatin kasar Sin ta gudanar da yakin neman yaki da yaduwar cutar, wato yakin mutane.
A ranar 23 ga Janairu, a cikin abin da ake kira mafi girman keɓewa a tarihin ɗan adam, an hana yin tafiya cikin ko daga Wuhan, wanda aka ba da umarnin a biranen 15 na Hubei, wanda ya shafi kusan mutane miliyan 57.
An haramta amfani da motocin sirri a cikin garin.
An soke bikin Sabuwar Shekara ta kasar Sin (25 ga Janairu) a wurare da dama.
Jami'an sun kuma sanar da cewa za a gina asibiti na wucin gadi daga asibitin Huxengsan a cikin kwanaki 10.
Daga baya aka gina wani asibiti kuma mai suna Leshenshun Hospital don kula da ƙarin marasa lafiya.
Baya ga sabbin asibitoci da aka gina, kasar Sin ta mayar da cibiyoyi na musamman 14 kamar wuraren shakatawa na jama'a da filayen wasa a Wuhan zuwa asibiti na kayan ado. Gwamnati ta dauki wasu matakai a ranar 26 ga Janairu don hana barkewar COVID-19, ciki har da sabon sanarwar da sanarwar game da fasinjoji da kuma tsawaita ranar bukukuwan musamman.
Jami'o'i da makarantu a fadin jihar sun rufe.
An dauki matakai da yawa a yankunan Hong Kong da Macau, musamman game da makarantu da jami'o'i.
An dauki matakan aiki a nesa a yankuna da yawa na kasar Sin.
An hana yin tafiya a cikin birnin Hubei da kuma wajensa.
An rufe gidajen tarihi na dan lokaci a duk kasar Sin saboda sauyin zirga-zirgar jama'a.
"An sanya matakan hana jama'a zuwa birane da yawa, kuma an hana kusan mutane miliyan 760 (kimanin rabin yawan kasar Sin) fita daga gidajensu. Bayan yaduwar cutar ta shiga matakin duniya a watan Maris, hukumomin kasar Sin sun dauki tsauraran matakai don hana cutar "shiga" China daga wasu ƙasashe".
Alal misali, birnin Beijing ya ba da izinin yin kwana 14 a wuraren da aka ba su izinin shiga. A ranar 23 ga Maris, a kasar Sin, an yi amfani da shi ne kawai kwanaki biyar da suka gabata don yin amfani da shi.
A ranar 24 ga watan Maris na shekarar 2020, Firayim Ministan kasar Sin Li Keqiang ya ba da rahoton cewa an hana kamuwa da cutar ta cikin gida kuma ana iya sarrafa yaduwar cutar a kasar Sin.
A wannan ranar ne aka sauƙaƙa ƙuntatawa a Hubei, wanda ya kasance cikin watanni biyu na ƙuntatawa a waje da Wuhan. Kamar yadda Ma'aikatar Harkokin Wajen China ta sanar a ranar 26 ga Maris, 2020, duk da cewa ba a bayyana lokacin da wannan manufar za ta ƙare ba, kodayake masu izinin shiga ko izinin zama ba za su iya shiga ba daga ranar 28 ga Maris.
Masu neman shiga kasar Sin dole ne su nemi takardar visa a ofisoshin jakadancin kasar Sin ko kuma a ofisoshin jakadancin kasar.
Gwamnatin kasar Sin ta yi kokarin dawo da kamfanoni da masana'antu daban-daban da aka rufe saboda COVID-19 daga ranar 21 ga Maris, 2012, ta ba da tallafi don ƙarfafawa da kuma ƙarfafa waɗannan ƙungiyoyin. Duk da cewa ta yi magana da bikin Qingming na shekara-shekara, ta kuma sanar da hukumomin kasar cewa ranar 26 ga Maris, 2012, da karfe 4:00 na yamma, ranar makoki ta ƙasa, kuma an yi addu'ar minti uku. Gwamnatin ta tsakiya ta ba da gayyatar jama'a su ba da hankali da kuma yin gudunmawa ga jama'a don hana COVID-19 sake fashewa.
A ranar 20 ga Janairu, 2020 an ba da rahoton yaduwar COVID-19 daga China zuwa Koriya ta Kudu.
Hukumar lafiya ta kasa ta ruwaito cewa a ranar 20 ga Fabrairu, an samu karuwar yawan wadanda suka kamu da cutar, kuma ana yin taron ne a sabon addinin da ake kira Shincheonji Church of Jesus a Daegu.
Shincheonji ya yi shakkar cewa ziyarar Wuhan na iya zama tushen watsa labarai.
A ranar 22 ga Fabrairu, a cikin mabiya 9,336 na cocin, kusan kashi 13 cikin ɗari na mutane 1,261 sun kamu da cutar. Koriya ta Kudu ta ba da sanarwar faɗakarwa a ranar 23 ga Fabrairu, 2020.
A ranar 28 ga Fabrairu, an samu karin mutane 2,000 da suka kamu da cutar, amma a ranar 29 ga Janairu, adadin ya karu zuwa 3,150.
An yi garambawul da cewa a killace sansanonin sojin Koriya ta Kudu dukansu bayan an samu sojojin uku da cutar.
An kuma shafi tsarin jirgin sama, saboda haka an canza shi. Koriya ta Kudu ta ƙaddamar da babbar kuma mafi tsari a duniya don bincika jama'a game da cutar da gano duk wanda ke da cutar da ganowa da kuma gano waɗanda suka same ta.
Hanyoyin tacewa sun haɗa da tabbatar da alamun cutar a cikin sabon kudin shiga na duniya ta hanyar aikace-aikacen hannu, da sanarwar kai tsaye ta tilas, gwajin ƙwayoyin cuta a cikin mota a rana mai zuwa, da kuma ƙara ƙarfin bincike ga kusan mutane 20,000 kowace rana.
Ko da yake ba a rufe birane gaba ɗaya ba, shirin Koriya ta Kudu ya kasance mai tasiri wajen sarrafa annobar.
Yawancin 'yan Koriya suna tattara sa hannu don neman Shugaba Moon ya yi laifi ko kuma ya yaba da amsarsa saboda rashin fahimtar cutar.
A ranar 23 ga Maris, Koriya ta Arewa ta samu karamin kamuwa da cutar a rana ɗaya cikin makonni huɗu.
A ranar 29 ga Maris, 1 ga Afrilu, a shekara ta 2015 duk sabbin kudaden shiga na kasashen waje za a ware su na tsawon makonni biyu.
Rahotanni sun nuna cewa a ranar 1 ga Afrilu, Koriya ta Kudu ta nemi taimakon bincike na cutar daga kasashe 121 daban-daban.
Iran ta ba da rahoton kamuwa da cutar SARS-CoV-2 ta farko a ranar 19 ga Fabrairu a Kwouw, inda mutane biyu suka mutu a wannan ranar, a cewar Ma'aikatar Lafiya da Ilimi.
Matakan farko da gwamnati ta dauka sun hada da rufe kide kide da sauran tarurrukan al'adu, wasanni, Ibadar Juma'a, jami'o'i, cibiyoyin ilimi na farko da makarantun sakandare.
Iran ta ba da dala tiriliyan biyar don yaki da cutar.
A ranar 26 ga Fabrairu, 2020, Shugaba Hassan Rouhani ya ce babu wani shiri na rufe wuraren da cutar ta shafa, sai dai a ware mutane.
Ko da yake har yanzu akwai zirga-zirga mai yawa a cikin biranen da ke gaban Nuwar Shekara ta Farisa, an sanar da shirin dakatar da zirga-zirgar birane a watan Maris.
An bude wuraren ibada na Shi'a a wuraren da aka kafa har zuwa 16 ga Maris 2020 don masu yawon bude ido na ruhaniya. Iran ta zama cibiyar yaduwar cutar bayan China a watan Fabrairu.
Da yake magana game da zarge-zargen rufe cutar a Iran, fiye da kasashe goma za su haɗa da Iran a ranar 28 ga Fabrairu, yana nuna cewa akwai yiwuwar samun mummunan yaduwar fiye da shari'o'in 388 da gwamnatin Iran ta ruwaito a wannan ranar.
An rufe majalisar dokokin Iran a ranar 3 ga Maris bayan an gano cewa an gano cewa akwai cutar a cikin mambobi 23 daga cikin 290 da aka yi wa gwaji.
A ranar 12 ga watan Maris, masu kare hakkin bil adama sun bukaci hukumomin kurkuku na Iran da su saki wadanda aka tsare da su a dalilin zanga-zangar kare hakkin bil adama ba tare da wata doka ba, kuma su gaggauta sakin duk wadanda aka tsare da su.
An ce wurare da aka rufe kamar kurkuku suna da mafi yawan yiwuwar yaduwar cutar, kuma ba a samun isasshen taimako na likita a waɗannan wuraren.
A ranar 15 ga watan Maris, gwamnatin Iran ta ba da rahoton mutuwar mutane 100 a rana ɗaya, wanda shine mafi girma a cikin ƙasar tun lokacin da annobar ta fara.
Akalla 'yan siyasa da jami'an gwamnati 12 na yanzu ko na baya na Iran sun mutu daga cutar a ranar 17 ga Maris na wannan shekarar.
A ranar 23 ga watan Maris, Iran ta samu sabbin mutane 50 a cikin awa daya, kuma mutum daya ya mutu a kowane minti goma saboda cutar korona.
A cewar rahoton Hukumar Lafiya ta Duniya, adadin wadanda ke kamuwa da cutar a Iran ya ninka sau biyar.
Ya ce takunkumin da Amurka ta dauka kan Iran na iya cutar da karfin tattalin arzikin kasar wajen mayar da martani ga annobar cutar.
Babban Kwamishinan 'Yancin Bil Adama na Majalisar Dinkin Duniya ya bukaci a yi wa kasashen da cutar ta fi shafa, ciki har da Iran, takunkumin tattalin arziki.
An tabbatar da cewa cutar ta bazu a Italiya a ranar 31 ga Janairu, lokacin da 'yan yawon bude ido biyu na kasar Sin suka tabbatar da gwajin SARS-CoV-2 a Rome.
Da zarar an samu karuwar annobar, gwamnatin Italiya ta sanar da dokar ta baci ta dakatar da zirga-zirgar jiragen sama daga China zuwa Italiya da kuma Italiya zuwa China.
Tun daga ranar 21 ga Fabrairu, an gano mutane 16 da suka kamu da cutar COVID-19 a Lombardy kuma an sake samun wadanda ba su da alaƙa da COVID-19. A ranar 22 ga Fabrairu, Majalisar Ministoci ta ba da sanarwar sabon umarni don sarrafa yaduwar, gami da ware mutane sama da 50,000 daga garuruwa 11 daban-daban a arewacin Italiya.
Firayim Minista Giuseppe Conte ya ce babu shiga da fita a wuraren da cutar ta shafa.
An riga an ba da umarnin dakatar da ayyukan aiki da wasanni a waɗannan yankuna. A ranar 4 ga Maris, lokacin da mutuwar 100 ta kai Italiya, gwamnatin Italiya ta ba da umarnin rufe dukkan makarantu da jami'o'i a duk faɗin ƙasar.
Duk manyan abubuwan wasanni, gami da wasannin ƙwallon ƙafa na Serie A, dole ne a rufe su har zuwa Afrilu, amma a ranar 9 ga Maris, an dakatar da duk wasanni gaba ɗaya na akalla wata ɗaya.
A ranar 11 ga Maris, 2020, Firayim Minista Conte ya ba da umarnin dakatar da duk ayyukan kasuwanci a kusa da wurin, sai dai manyan kantuna da kantunan magani. A ranar 6 ga Maris, 2021, Kwalejin Italiyanci ta Anaesthesia, Analgesia, Resuscitation da Kulawa mai tsanani (SIAARTI) ta buga shawarwari game da halayyar likita game da matakan sa ido na gaggawa da za a iya amfani da su.
A ranar 19 ga watan Maris, Italiya ta mamaye kasar Sin kuma ta kashe mutane 3,405 sakamakon annobar coronavirus.
A ranar 22 ga watan Maris na shekarar 2020, an ruwaito cewa Rasha ta tura jiragen saman soja tara zuwa Italiya da ke dauke da kayan aikin likita.
A ranar 5 ga Afrilu, an samu kamuwa da cutar 128,948 a Italiya, mutane 15,887 sun mutu kuma mutane 21,815 sun warke, yawancinsu a yankin Lombardy.
Rahoton CNN ya nuna cewa, yawan tsofaffin mutanen Italiya da rashin iyawar gano duk wadanda cutar ta iya kamuwa da su, sun haifar da yawan mutuwar.
Amsar Ingila ga cutar ta kasance mafi sauki a cikin ƙasashe da aka fi shafa, kuma har zuwa 18 ga Maris 2020 , gwamnatin Burtaniya ba ta ɗauki wani matakin warewar jama'a ko keɓewa ga 'yan ƙasa ba.
A ranar 16 ga Maris, Firayim Minista Boris Johnson ya ba da sanarwar da ke ba da shawarar jama'a su guji duk wani tafiya da tuntuɓar zamantakewa mara mahimmanci, mutane su yi aiki daga gida kamar yadda za su iya, da kuma guje wa wuraren kamar mashaya, gidajen abinci da gidajen wasan kwaikwayo.
A ranar 20 ga Maris, ya sanar da rufe dukkan wuraren shakatawa kamar wuraren shakatawa da wuraren motsa jiki da sauri, yana ba da sanarwar cewa zai rufe 80% na albashi har zuwa £2,500 a wata. A ranar 23 ga Maris, Firayim Minista ya sanar da tsauraran matakan nisantar zamantakewa, ya hana mutane sama da biyu kasancewa tare da iyakance tafiya, ya sanya ƙuntatawa kan ayyukan waje, kuma ya ba da izini ga ayyukan da suka wajaba kawai.
Ba kamar matakan da aka ɗauka ba, 'yan sanda ne za su yi amfani da waɗannan ƙuntatawa ta hanyar caji da kuma rarraba taro.
"An umarci mafi yawan kasuwancin da aka rufe, ban da manyan kantuna, kantuna, kantuna, shagunan kayan aiki, wuraren shakatawa da garages, sai dai waɗanda aka amince da su a matsayin ""masu amfani".
An gano mutum na farko da aka tabbatar da COVID-19 a ranar 20 ga Janairu a Pacific Pacific a arewa maso yammacin Washington, a kan wani mutum da ya dawo daga Wuhan a ranar 15 ga Janairu.
An kafa aikin White House na mayar da martani kan cutar coronavirus a ranar 29 ga Janairu.
A ranar 31 ga Janairu, gwamnatin kasar ta sanar da dokar ta baci ta kiwon lafiya ta kasar Sin, ta kuma hana masu tafiya daga kasar Sin zuwa kasar.
A ranar 28 ga Janairu, 2020, Cibiyar Kula da Lafiya ta Gwamnatin Amurka ta sanar da cewa ta samar da kayan aikin gwajin kanta.
Duk da haka, Amurka ta yi jinkirin fara bincike, wanda ya zama abin ƙyama a lokacin don fahimtar ainihin girman yaduwar.
A watan Janairu, an katse binciken saboda gwamnatin tarayya ba ta samar da kayan aikin bincike na inganci ba. Ƙuntataccen matakin gwamnatin tarayya na amincewa da kayan aikin bincike na ƙungiyoyi marasa gwamnati (ma'aikata, kamfanoni da asibitoci) har zuwa ƙarshen Janairu, da kuma yanayin da zai hana mutane yin bincike har zuwa farkon Maris (wanda daga baya ake buƙatar umarnin likita).
A ranar 27 ga Fabrairu, jaridar Washington Post ta ruwaito cewa, a Amurka, an gudanar da bincike kasa da 4,000.
A ranar 13 ga Maris, an yi gwajin cutar ba a kai 14,000 ba, in ji Atlantic.
"A ranar 22 ga Maris, Associated Press ta ruwaito:" Mutane da yawa da ke da alamun cutar da umarnin likita sun jira awanni ko kwanaki don yin gwaji. "Bayan an yi rajistar mutuwar farko a Amurka a jihar Washington a ranar 29 ga Fabrairu, Gwamna Jay Inslee ya ba da sanarwar gaggawa, kuma sauran jihohi sun bi ta nan da nan".
A watan Maris na shekarar 2020 ne aka rufe makarantu a yankin Seattle, kuma a tsakiyar watan Maris ne aka rufe makarantu a kasar. A ranar 6 ga Maris, 2020 ne jami'ar Imperial College London ta Amurka ta ba da shawarar kungiyoyin masu ilimin cututtuka game da hasashen rikicin da sabon kwayar cutar korona ke haifar a kasar.
A wannan ranar ne Shugaba Trump ya sanya hannu kan sanarwar shirya shirye-shiryen da kuma kara mayar da martani ga cutar coronavirus don samar da kudade na gaggawa na dala biliyan 8.3 ga hukumomin tarayya.
Kamfanoni sun bukaci ma'aikatansu su hana tafiya, su soke taron, kuma su karfafa ma'aikatansu su yi aiki daga gida.
An soke taron wasanni da shirye-shirye. A ranar 11 ga Maris, Trump ya sanar da dakatar da zirga-zirgar jiragen sama daga Turai, banda Ingila, wanda zai fara aiki na kwanaki 30 daga ranar 13 ga Maris.
A rana mai zuwa, an dakatar da Isra'ila da Birtaniya.
A ranar 13 ga Maris, shekarar, an sanar da dokar ta baci ta kasa, wanda ya sa aka saki kudade na tarayya don magance matsalar.
Tun farkon 15 ga Maris, 2020, an rufe shaguna da yawa a duk faɗin Amurka ko kuma an rage lokacin aiki don rage yaduwar cutar.
A ranar 17 ga watan Maris, cutar ta yadu a duk jihohi 50 da kuma jihohin Columbia. A ranar 23 ga watan Maris, an samu kamuwa da cutar ta coronavirus 10,700 a birnin Newark, wanda ya fi yawan wadanda aka samu a Koriya ta Kudu.
A ranar 25 ga Maris, Gwamnan ya ce ana ganin an yi nesa da zamantakewar jama'a, inda ya ce adadin ci gaban ya ragu daga kwanaki 2.0 zuwa kwanaki 4.7.
A ranar 28 ga Maris, a birnin New York kadai, mutane 32,308 ne suka kamu da cutar, kuma mutane 672 ne suka mutu sakamakon kamuwa da cutar. A ranar 26 ga Maris ne kawai, Amurka, China da Italiya suka kai wasu a duk faɗin duniya.
Rahotanni na kafofin watsa labarai sun bayyana a ranar 30 ga Maris cewa, Shugaba Trump na Amurka ya yanke shawarar tsawaita ka'idojin nisantar jama'a har zuwa ranar 30 ga Afrilu.
A wannan ranar, jirgin asibiti na USNS Comfort ya isa New York, wanda ke dauke da gado 1000.
A ranar 3 ga Afrilu, Amurka ta yi rikodin mutuwar mutane 884 a cikin awanni 24 na cutar coronavirus.
A ranar 3 ga Afrilu, mutane sama da 100,000 suka kamu da cutar a jihar New York. Fadar White House ta soki shi da cewa ya sauƙaƙa hadarin kuma ya jagoranci hukumomin lafiya da kuma sarrafa saƙonnin ta hanyar tura masana kimiyya don yin magana da jama'a da kuma buga littattafai masu alaƙa da cutar a ƙarƙashin ofishin mataimakin shugaban Amurka Mike Pence.
A matsayinta na mai mulki, amincewar gwamnatin Trump ta magance matsalar ta haifar da rabuwa tsakanin magoya bayan jam'iyyar.
Wasu jami'an Amurka da masu ba da shawara sun soki Amurka da dogaro da shigo da kayayyaki masu mahimmanci daga kasar Sin, gami da kayayyakin kiwon lafiya masu mahimmanci.
An yi amfani da nazarin hanyoyin jirgin sama a taswira kuma an lissafa hanyoyin rarrabawa kuma A.A. ya buga shi a cikin Travel & Medicine Journal a tsakiyar Janairu 2020.
A cewar rahoton 2018 na Hukumar Kula da Sufurin Jiragen Sama ta Duniya, Bangkok, Hong Kong, Tokyo, da Taipei sun dauki bakuncin mafi yawan fasinjoji daga kasar Hunan.
Dubai, Sydney da Melbourne manyan wurare ne ga masu zuwa daga Wuhan.
Bali ita ce mafi ƙanƙanta a cikin biranen da aka fi so 20 a cikin shirye-shirye, kuma an yi tunanin cewa za ta zama biranen Ostiraliya. Ostiraliya ta ƙaddamar da shirin gaggawa na gaggawa don sabon coronavirus (COVID-19) a ranar 7 ga Fabrairu.
Za a iya samun ƙarin bayanai game da COVID-19 a nan gaba, kuma an ce Ostiraliya za ta mai da hankali kan kula da iyakoki da sadarwa don amsa cutar.
A ranar 21 ga watan Maris, an sanar da cewa an yi gaggawa a samar da lafiyar kwayoyin halitta a Australia.
Don ingantaccen keɓancewar jigilar jama'a a Han Han da Hubei, ƙasashe da yawa suna shirin fitar da 'yan ƙasa da ma'aikatan diflomasiyya zuwa ƙasashensu ta hanyar ba da izinin hukumomin China ta hanyar jiragen da aka keɓance musamman don wannan dalili.
Kanada, Amurka, Japan, Indiya, Sri Lanka, Australia, Faransa, Argentina, Jamus, da Thailand sune manyan kasashen da ke shirin yin tafiya ne kawai don 'yan ƙasarsu.
Ya ce Pakistan ba za ta fitar da 'yan kasar ta daga kasar Sin ba.
A ranar 7 ga Fabrairu, Brazil ta kori 'yan Brazil 34 ko kuma danginsu tare da 'yan Poland hudu, da Sinawa daya da kuma Indiyawan.
'Yan kasar Poland, China da Indiya sun sauka a Poland kafin jirgin Brazil ya tashi zuwa Brazil.
Ya ware 'yan Brazil da ke zuwa birnin Juan daga sansanin soja da ke kusa da birnin Braça-Lia.
A wannan ranar, an bar 'yan Kanada 215 (176 daga jirgin saman, da 39 daga jirgin sama na biyu da gwamnatin Amurka ta ba da izini) daga ruwa zuwa CFB Trenton kuma an keɓe su na makonni biyu.
Wani jirgin sama da ke dauke da 'yan Kanada 185 ya tashi a CFB Trenton a ranar 11 ga Fabrairu.
Jami'an Ostiraliya sun kai 'yan kasa 277 zuwa Cibiyar Kula da Tsibirin Kirsimeti a ranar 3 da 4 ga Fabrairu, inda suka zauna a cikin wani wuri na keɓewa na kwanaki 14.
Jirgin da ke tashi daga New Zealand ya sauka a Auckland a ranar 5 ga Fabrairu, kuma an ware fasinjojin (gami da wasu Australiyawa da Pacific) a sansanin Sojojin Ruwa na Wuhan Gapparoa, arewacin Auckland.
A ranar 15 ga watan Janairu, Amurka ta sanar da cewa za ta fitar da 'yan kasar da ke cikin jirgin ruwan Diamond Pyrenees na Yashershur.
Jirgin da ya sauka daga Diamond Princess a ranar 21 ga Fabrairu, yana dauke da fasinjoji 129 na Kanada, ya sauka a Trenton, Ontario.
A farkon watan Maris, gwamnatin Indiya ta fara fitar da 'yan kasar daga Iran. A ranar 14 ga Maris, kamfanin jirgin saman Afirka ta Kudu ya dawo da 'yan Afirka ta Kudu 112 zuwa ƙasarsu.
An sake duba lafiyar 'yan Afirka ta Kudu da suka nuna alamun cutar coronavirus kafin a fitar da su.
Sai dai 'yan Afirka ta Kudu da suka samu sakamako mara kyau ne suka koma gida.
Sakamakon binciken ya tabbatar da cewa duk 'yan Afirka ta Kudu, ciki har da ma'aikatan jirgin sama, ma'aikatan otal, 'yan sanda da sojoji, sun kasance cikin koshin lafiya, gami da duk' yan Afirka ta Kudu, waɗanda suka shiga aikin ɗan adam kuma suka yi kwanaki 14 a cikin kulawa da keɓewa a cikin Ranch Resort don yin rigakafi.
A ranar 20 ga Maris, shekara ta 200 A.Z., Amurka ta fara janye dakarunta daga Iraki a wani ɓangare saboda annobar.
A ranar 5 ga watan Fabrairu, ma'aikatar harkokin wajen kasar Sin ta sanar da cewa kasashe 21 (ciki har da Belarus, Pakistan, Trinidad da Tobago, Masar, da Iran) sun aika da taimako ga kasar Sin.
A ranar 30 ga Janairu, wasu daliban kasar Sin da ke karatun jami'o'i a Amurka sun ba da rahoton cewa an tura masks na fuska da hanci 50,000 N95 zuwa asibitoci a jihar Hubei don taimakawa yankunan da cutar ta shafa a kasar Sin.
A ranar 5 ga Fabrairu, Bill da Melinda Gates sun sanar da cewa za su ba da gudummawar dala miliyan 100 ga WHO don tallafawa bincike da magani na allurar rigakafi a Afirka da Kudancin Asiya.
A cewar Interaction, Richard Gordon ya tura murfin baki da hanci na 3.16 zuwa kasar Sin daga Wuhan zuwa Philippines a ranar 6 ga Fabrairu.
A ranar 19 ga watan Fabrairu, kungiyar agaji ta Red Cross ta Singapore ta sanar da cewa za ta tura tallafin dala miliyan 2.26 zuwa kasar Sin.
Japan ta ba Wuhan takunkumi miliyan shida na rufe fuska da goshi, Turkiyya ta ba da kayan magani da kayan aiki, Rasha ta ba Wuhan tan 13 na kayan magani da kayan aiki, kuma ta sanar da cewa ta mayar da takalma miliyan 18 ga Wuhan zuwa China, Jamus ta ba da kayan ado na gaba da kayan magani na gaba da 10,000, kuma Amurka ta ba da kayan aikin likita na ton 17.8 ga China, ta kuma yi alkawarin ba da dala miliyan 100 ga ƙasar da cutar ta shafa.
A watan Maris, kasar Sin da Cuba da kuma Rasha sun tura kayan kiwon lafiya da kwararrun masana don taimakawa Italiya da cutar ta coronavirus ta shafa.
Jack Ma, wani dan kasuwa, ya aika da kayan bincike miliyan 1.1 da abin rufe fuska miliyan 6 da kuma tufafi 60,000 zuwa kungiyar tarayyar Afirka a Addis Ababa, Habasha don rarrabawa.
Daga baya, ya aika da kayan gwaji 5,000, abin rufe fuska 100,000 da kuma iska mai sanyaya iska 5 zuwa Panama.
Ma ta ba da kayayyakin kiwon lafiya ga Kanada. Netherlands, Spain, Turkiyya, Georgia da Jamhuriyar Czech sun nuna damuwa game da masks da kayan gwaji da aka yi a China.
Misali, kasar Spain ta fitar da kayan aikin bincike na coronavirus 58,000 da kasar Sin ta kera domin suna da inganci na 30%. Hakanan, Netherlands ta sanya kayan rufe bakunansu 600,000 da kasar Sin ta kera don amfani da su.
Belgium ta dawo da abin rufe fuska 100,000 da ba za a iya amfani da su ba, wanda aka fara tunanin cewa an sayo daga China, amma ainihin abin da aka samo daga Colombia.
A wata sassa kuma, an samu tallafin kasar Sin a Latin Amurka da kuma wasu sassan Afirka. A ranar 2 ga Afrilu, Bankin Duniya ya kaddamar da taimakon gaggawa ga kasashe masu tasowa.
Hukumar WHO ta yaba da matakin da hukumomin kasar Sin suka dauka na sarrafa cutar da kuma hana ta.
"WHO ta lura da kwatancen da ke tsakanin annobar SARS ta 2004-2004, da hukumomin kasar Sin suka yi a ɓoye, wanda ya hana kokarin rigakafi da kulawa, kuma gwamnatin tsakiya ce ta rikicin yanzu, "ta ba da cikakken bayani game da lokacin don kawar da firgita kafin Sabuwar Shekara ta wata".
A ranar 23 ga Janairu, wakilin Majalisar Dinkin Duniya, Godeen Gale, wanda ya amsa shawarar da hukumomin tsakiya suka yanke na yin takunkumin hana zirga-zirga a Wuhan, ya bayyana cewa, duk da cewa ba shawarar Hukumar Lafiya ta Duniya ba ce, an sake bayyana cewa, an yi gaggawa a duniya (PHEIC) a matsayin babban abin da ya fi muhimmanci da kuma ba a taɓa gani ba a tarihin lafiyar jama'a. A ranar 30 ga Janairu, bayan an tabbatar da cewa ana canja wurin mutane daga China zuwa wasu ƙasashe da kuma yawan mutane a wasu ƙasashe, an sanar da barkewar cutar ta gaggawa ta duniya (PHEIC), wanda shine matakin na shida na PHEIC tun lokacin da cutar sankarar sankara ta barke a shekara ta 2009.
"Darakta Janar na Hukumar Lafiya ta Duniya, Tedros Adhanom PHEIC, ya ce, "mun yi magana game da barazanar yaduwar duniya a kasashe masu karamin da matsakaicin kudin shiga, musamman ma wadanda ba su da ingantaccen tsarin kiwon lafiya".
Game da yadda ake aiwatar da takunkumin tafiye-tafiye, Tedros ya ce, "babu wani dalili da zai sa a takaita ba tare da bukatar ba a tafiye-tafiye da kasuwanci na duniya" kuma "Kungiyar Lafiya ta Duniya ba ta ba da shawarar hana kasuwanci da motsi ba".
A ranar 5 ga watan Fabrairu, WHO ta nemi taimakon dala miliyan 675 ga al'ummar duniya don tallafawa shirin ƙasashe masu karamin kudin shiga.
Mr. Tedros ya kuma ce: "Mu masu rauni ne kamarmu, muna da ƙarfi sosai", kuma ya yi kira ga al'ummar duniya su zuba jari a yau ko kuma su biya ƙarin daga baya. A ranar 11 ga Fabrairu, Hukumar Lafiya ta Duniya ta kira cutar COVID-19 a cikin wata sanarwa ta manema labarai.
A wannan ranar, Tedros, babban sakataren Majalisar Dinkin Duniya, Antonio Guterres, ya ce sun amince da amsawa da dukan sojojin Majalisar Dinkin Duniya.
Hukumar Majalisar Dinkin Duniya da aka kafa ta hanyar ƙungiyar gudanar da rikicin bala'i ta Majalisar Dinkin Duniya za ta ba da damar daidaita ayyukan da za a yi don mayar da hankali kan lafiyar jama'a, yayin da sauran hukumomi za su iya amfani da ilimin su don bayyana tasirin cutar da ci gabanta a kan yanayin zamantakewa da tattalin arziki.
A ranar 14 ga Fabrairu, ƙungiyar ta hadin gwiwa tare da China da Hukumar Lafiya ta Duniya ta gudanar da wani aiki don taimakawa kwararru na cikin gida da na duniya a cikin China wajen gudanar da gudanar da gudanar da bita da taro da bita. Ya ce a ranar 25 ga Fabrairu, dole ne duniya ta yi aiki sosai don shirya don kimanta tasirin ayyukan amsawa a yankuna da larduna, gami da manyan cibiyoyin ƙasa da ƙauyuka, ya ce, yayin da ake kira cutar coronavirus, dole ne ƙasashe su kasance a matakin shiri.
"Domin amsawa ga annobar da ta barke a Iran, WHO ta aika da wata ƙungiya ta hadin gwiwa don tantance matsalar. A ranar 28 ga Fabrairu, jami'an WHO sun ce kimantawar barazanar cutar coronavirus za ta ƙaru daga "babba" zuwa "babba".
A wani jawabi da shugaban kasa na shirin gaggawa na Hukumar Lafiya ta Duniya, Mike Ryan ya yi, ya ce: "Wannan gwaji ne na gaskiya ga kowace gwamnati a duniya.
Wannan kwayar cutar tana iya zuwa kuma kana bukatar ka kasance a shirye, saboda yin amfani da matakan kariya masu kyau zai sa duniya ta iya shawo kan mafi munin.
"Ryan ya kara da cewa, bayanan da ake samu yanzu sun nuna cewa, irin wannan sanarwar ba ta ba da tabbacin cewa jami'an kiwon lafiya na al'umma za su yi ikirarin barkewar cutar ta duniya ba, suna cewa, ""Mun amince cewa dukkan 'yan Adam a duniya za su iya kamuwa da cutar".
WHO ta bayyana cutar korona a matsayin annobar duniya a ranar 11 ga Maris.
"Darakta-janar na Hukumar Lafiya ta Duniya ya ce, "yana da matukar damuwa saboda matakan da ake damuwa game da yaduwar cutar da kuma mummunanta da kuma rashin daukar mataki". An soki shi sosai saboda jinkirin sanar da dokar ta baci ta kiwon lafiya ta duniya da jinkirin kiran cutar annobar duniya".
An tattara sa hannun shugaban hukumar lafiya ta duniya, Theodore Adhanom, don ya yi murabus, kuma mutane 733,000 ne suka sanya hannu a ranar 6 ga Afrilu.
A ranar 26 ga Maris, 2020, masana kare hakkin bil adama da dama na Majalisar Dinkin Duniya sun mai da hankali kan hana cin zarafin kowa a cikin annobar COVID-19.
Masana sun ce, kowa yana da alhakin yin aiki tare don ceton rayukan mutane, kuma gwamnati tana da alhakin gudanar da wannan.
Kamar yadda kungiyar ta nuna, ba za a yi amfani da rashin dukiya ko inshorar lafiya don kai hari ga ƙungiyar da ta fi dacewa ba.
Masana sun jaddada cewa kowa yana da haƙƙin kiwon lafiya, gami da nakasassu, ƙananan ƙungiyoyi, tsofaffi, 'yan gudun hijira, marasa gida, waɗanda ke cikin matsanancin talauci, waɗanda ke kurkuku, da kuma 'yan gudun hijira da sauran ƙungiyoyin da ba a bayyana ba waɗanda ke buƙatar tallafin gwamnati.
Ayyukan gwamnatoci masu zaman kansu suna aiki tare don magance matsalolin tattalin arziki da zamantakewar da COVID-19 ya haifar.
Kungiyar hadin gwiwa da ci gaban tattalin arziki ta kafa wani wuri wanda ke ba da amsa mai dacewa da cikakkiyar manufa da kuma ba da ra'ayoyi da shawarwari ga ƙasashe a duk faɗin duniya.
Karfafa tsarin kiwon lafiya da tattalin arzikin duniya ta hanyar manufofi don taimakawa juna don koyo da juna don magance sakamakon rufewa da ƙuntatawa na tafiya, magance cibiyar dijital, gami da bin diddigin manufofin ƙasa da kuma ba da gudummawa ga ayyukan coronavirus.
Michel Gove, dan majalisar dinkin duniya na Amurka, da Edouard Boursano, dan shugaban kasar Brazil, ya zargi gwamnatin kasar Sin da cewa cutar ta fito ne daga lardin Hubei na kasar Sin kuma kasar Sin ce ta kamu da cutar.
An kori wasu jami'an hukumar kula da yankin (CPC) a tsakiyar kasar Sin saboda kokarin da suka yi na keɓewa a kasar, a sakamakon yadda ta mayar da martani ga annobar a yankunan.
Wasu masu sharhi sun yi imanin cewa an dauki wannan matakin ne don hana fushin jama'a a kan babban sakataren jam'iyyar kwaminis ta kasar Sin, Xi Jinping, game da yaduwar cutar coronavirus.
Wasu jami'an kasar Sin, kamar Zhao Lijian, sun yi watsi da cewa COVID-19 ya fara ne daga ruwa, suna tallafawa wani shiri na ɓoye wanda ba zai yiwu ba ya fito daga Amurka ko Italiya.
"Shugaban gwamnatin Donald Trump na Amurka ya ce kasar Sin ta "ƙaddamar da cutar da ba a bincika ba ta zama annoba ta duniya", inda ta bayyana coronavirus a matsayin "ta'addancin kasar Sin" ko "ta'addancin Wuhan", inda wasu masu sukar suka soki shi da nuna wariyar launin fata da "rashin ikon gudanarwarsa na sarrafa cutar".
A cikin majalisar tsaro ta kasa, ana kiran Daily Beast a matsayin hanyar sadarwa ta hanyar samar da hanyoyin sadarwa, saboda China kadai ce tushen rashin rai a cikin sadarwa ta zamani a Amurka.
An gaya mana mu yi amfani da wannan sakon ta kowace hanya da za mu iya, gami da sanarwar manema labarai da shirye-shiryen talabijin. Kasashen waje kamar siyasa, manufofin waje da Bloomberg sun ce ƙoƙarin da China ke yi na aikawa da taimako ga ƙasashen da cutar ta shafa na daga cikin tasirin yada labarai na duniya.
Shugaban harkokin wajen kungiyar Tarayyar Turai Joseph Borelli ya yi gargadin cewa akwai wani abu da zai iya haifar da tasirin siyasa ta kasa da kasa da ake kira siyasa ta al'umma da kuma sadaukarwa.
"Borrell ya ce, "China tana yada sakon cewa ita ce abokiyar da ta fi dacewa da kuma amintacciyar abokiyar da Amurka ta yi".
Kasar Sin ta yi kira da yawa ga Venezuela da Iran da kuma Amurka ta yi kira da ta sassauta takunkumin da ta dauka a kan Syria da Venezuela da kuma Iran.
An dakatar da takunkumin Amurka a ranar 3 ga Afrilu, na maskolin 100,000 da Jack Ma ya bayar wa Cuba.
An zargi jami'an Amurka da amfani da kudaden tallafi don su ba da kansu ga wasu ƙasashe.
A cikin batun rufe fuska da gaba, an ji rashin jituwa tsakanin Jamus, Austria, Switzerland, Jamhuriyar Czech da Italiya.
Turkiyya ta kuma kama daruruwan kayan numfashi da ake turawa zuwa Spain.
A farkon watan Maris, Tarayyar Turai ta soki gwamnatin Italiya da rashin haɗin kai da Italiya da ke fama da cutar coronavirus.
"Shugaban Italiya a Tarayyar Turai, Maurizio Massari, ya ce, "China ce kawai ta ba da amsa biyu".
Wannan ba misali ne mai kyau ba ga 'yan Turai.
A ranar 22 ga watan Maris, bayan tattaunawa ta tarho da shugaban Rasha Vladimir Putin da Firayim Ministan Italiya Giuseppe Conte, sun shirya cewa likitocin tsaro, da wasu kayayyakin kiwon lafiya da kuma motocin da ke yin allurar rigakafi za su isa Italiya.
Jaridar La Stampa ta Italiya ta ruwaito cewa kashi 80 cikin 100 na taimakon Italiya ba su da amfani ko kuma ba su da amfani sosai, kamar yadda wani babban dan siyasa ya ce.
"An soki Rasha a matsayin mai "tsokoki a fannin siyasa da diflomasiyya".
Shugaban Lombardy, Attilio Fontana, da Ministan Harkokin Wajen Italiya Luigi Di Maio sun gode da kawo rahotannin kafofin watsa labarai.
Rasha ta tura wani abu mai dauke da maganin Auroplane zuwa Amurka.
"Maganar Kremlin Dmitry Peskov ya ce, "a lokacin da [Putin] ya ba da goyon baya ga abokan aikin Amurka, ya yi tunanin cewa idan masana'antun na'urorin likita da kayan aikin Amurka suka samu gaggawa, za su iya sake dawowa idan ya cancanta".
Babban aikin NATO na yaki tun bayan karshen yakin sanyi, NATO Defender 2020, wanda aka shirya a Jamus, Poland da Baltic States, za a gudanar a cikin ƙananan matakan.
"Sakatare Janar Kate Hudson, Babban Sakatare na Kamfanin Kare Makaman Nukiliya, ta soki ayyukan Defender 2020".A cikin rikicin kiwon lafiyar jama'a na yanzu, ba kawai rayuwar sojoji daga Amurka da na kasashen Turai da yawa ba, har ma da rayuwar mazaunan kasashen da suke aiki a cikin hadarin. "Gwamnatin Iran ta kamu da cutar sosai, kusan 'yan majalisa goma sha biyu sun kamu da cutar, kuma siyasa goma sha biyar na yanzu ko na baya sun kamu da cutar".
A ranar 14 ga Maris, 2020, shugaban Iran, Hassan Rouhani, ya rubuta wasiƙa zuwa ga gwamnatocin duniya, yana mai cewa takunkumin tattalin arzikin Amurka a kan kasarsa babban cikas ne ga nasarar ƙoƙarin hana cutar.
Masu sharhi kan siyasa sun yi hasashen cewa wannan zai iya shafar yiwuwar sake zaben Donald Trump a zaben shugaban kasa na 2020. Dangantakar diflomasiyya daga Japan da Koriya ta Kudu ta lalace sakamakon annobar.
"Bayan Japan ta sanar da cewa, "duk wani dan kasar Koriya ta Kudu zai zauna a wani wuri da gwamnati ta shirya na makonni biyu", Koriya ta Kudu ta zargi Japan da "zabar da ba ta da gaskiya da kuma yanke shawara mara kyau".
A farkon matakin da Shugaba Moon Jae-in ya dauka na mayar da martani ga rikicin, an hana al'ummomin Koriya ta Kudu yin aiki sosai.
Yawancin 'yan Koriya sun yi kuskure da gwamnati ta sa hannu kan bukatar da ta bukaci a hukunta wata a sama, ko kuma suna yaba da amsa.
Wasu masu sharhi sun nuna damuwa cewa zai iya taimaka wa gwamnatoci su karfafa ikonsu.
A Hungary, majalisar dokokin kasar ta ba da izinin firaministan kasar Viktor Orbán ya yi mulki bisa ga dokar, ya dakatar da majalisar dokoki na wucin gadi, ya hana zaben, kuma ya yi amfani da wadanda ke yada labaran karya game da cutar da kuma abin da gwamnati ke yi don sarrafa rikicin.
Cutar coronavirus ta kasance mai wahala saboda rashin wadataccen kaya, amfani da cutar a duniya don yaƙar cutar, sayayya mai ban tsoro, da kuma dakatar da masana'antu da ayyukan kaya.
Hukumar Abinci da Magunguna ta Amurka ta yi gargadin cewa ƙarancin magunguna da na'urorin likita na iya faruwa saboda karuwar buƙatun masu amfani da kuma rikicewar masu samarwa.
Yawancin mutanen yankin sun lura cewa rashin wadata ya faru saboda rashin abinci, takarda na gidajen wanka, da ɗakunan ajiya na ruwa da suka cika da damuwa.
Masana'antun fasaha sun yi gargadin cewa za a iya jinkirta jigilar kayayyakin lantarki.
A cewar babban darektan WHO, Tedros Adhanom, bukatar kayan tsaro na mutum ya karu da sau 100.
Wannan bukatar ta haifar da karin farashin sau ashirin fiye da yadda ake tsammani kuma ta haifar da jinkirin watanni hudu zuwa shida na kayan aikin likita.
Hukumar lafiya ta duniya ta ce, rashin kayan tsaro na mutum a duniya ya haifar da rashin tsaro, wanda ke sa ma'aikatan kiwon lafiya cikin hadari.
A Ostiraliya, annobar duniya ta ba da sabuwar dama ga masu amfani da Dagu don sayar da kayayyakin Ostiraliya ga China.
An samu karancin kayan abinci ga yara a wata babbar kasuwa, kuma gwamnatin Ostiraliya ta soke aikin. Duk da cewa yawan cututtukan COVID-19 a arewacin Italiya da yankin Wuhan sun yi yawa, duk da haka, dukansu sun tsira daga rashin abinci saboda rashin abinci na farko.
Matakan da aka dauka a China da Italiya don hana adana kayayyaki masu mahimmanci da kuma haramtacciyar kasuwanci sun kasance masu tasiri, kuma sun kawar da ƙarancin abinci a Turai da Arewacin Amurka.
Arewacin Italiya ba ta nuna raguwa mai yawa ba saboda yawan aikin gona, amma zan iya ƙara farashin, kamar yadda masana'antun suka ce.
Za a iya samun ɗakunan ajiya na ɗan lokaci, wanda a cikin birnin Wuhan kanta, jami'an gwamnatin China sun buɗe ɗakunan ajiyar alade don tabbatar da cewa akwai wadatattun abinci ga jama'a.
A Italiya, akwai irin wannan dokar da ta bukaci masu samar da abinci su ajiye lokaci don irin wannan hatsarin.
An kuma ga lalacewar tattalin arzikin duniya a China: A cewar wani rahoto na 16 ga Maris, kafofin watsa labarai sun ce, tattalin arzikin China ya yi mummunan rauni, kuma tallace-tallace na kiri ya ragu da kashi 20.5 cikin dari, bisa ga matakan da gwamnati ta dauka don rage yaduwar cutar a farkon watanni biyu na 2020.
Kasar Sin ta zama cibiyar tattalin arziki da masana'antu kuma cutar ta barke a duniya.
Agathe Demarais na Cibiyar Ilimin Tattalin Arziki ta Economist Intelligence Unit ya ce, kasuwanni za su ci gaba da kasancewa masu sassauci har sai an fitar da ƙarin sakamako.
A watan Janairun 2020, wasu manazarta sun kiyasta cewa matsalar tattalin arziki da annobar ke haifar a duniya na iya zama mafi girma fiye da annobar SARS a 2002-2004.
A cewar masana a Jami'ar Washington ta St. Louis, za a iya kawar da nauyin da ke kan sarkar samar da kayayyaki a duniya fiye da dala biliyan 300 a cikin shekaru biyu.
Rahotanni sun ce, da yake bukatar mai da farashin mai na kasar Sin sun ragu, kungiyar kasashen da ke fitar da mai (OPEC) ta yi watsi da neman kasuwar.
Kasashen duniya sun fadi a ranar 24 ga Fabrairu saboda karuwar shari'o'in COVID-19 a wajen yankin China.
A ranar 27 ga watan Fabrairu, saboda barazanar yaduwar cutar coronavirus, yawancin alamun kayayyaki na Amurka, ciki har da NASDAQ-100, S&amp;P 500 Index, da Dow Jones Industrial Average, sun sanya mafi ƙasƙanci tun shekara ta 2008, kuma sun ragu da maki, wanda shine mafi girman raguwa na kwana ɗaya daga rikicin kuɗi tun daga 2007-08.
Dukkanin alamun sun kammala makon da suka ragu da sama da kashi 10 cikin dari.
A ranar 28 ga Fabrairu, kamfanin Scope Ratings GmbH ya tabbatar da cewa kasar Sin ta zama ƙasa mai 'yanci game da bashi.
Kasuwancin ya sake faɗuwa saboda barazanar cutar coronavirus, kuma an sami babban faɗuwa a ranar 16 ga Maris.
Mutane da yawa suna ganin cewa tattalin arziki zai iya lalacewa.
Masanin tattalin arziki Mohamed El-Erian ya yaba wa gwamnatocin Backu da jihohi na tsakiya don matakan gaggawa na wucin gadi.
Babban Bankuna na Amurka sun amsa da sauri fiye da yadda suka yi don fita daga rikicin kudi na 2008.
Yawon shakatawa na daga cikin bangarorin da aka fi shafa da takunkumin tafiye-tafiye, rufe wuraren jama'a, gami da wuraren jan hankali, da kuma shawarwarin gwamnatoci da su dakatar da duk wani tafiya a duniya.
A sakamakon haka, kamfanonin jiragen sama da dama, ciki har da British Airways, China Eastern Airlines da Canton sun soke zirga-zirgar jiragen sama saboda rashin bukatar, kuma kamfanin jirgin saman yankin na Burtaniya ya fadi.
A cikin shekaru da yawa, masana'antun jirgin ruwa sun yi amfani da jiragen ruwa masu yawa don yin amfani da jiragen ruwa.
An kuma rufe tashoshin jirgin kasa da dama da tashoshin jiragen ruwa.
A cikin birnin Ch'un'un, babban abin da ke jan hankalin tafiye-tafiye a lokacin bikin Sabuwar Shekara ta kasar Sin, cutar ta bazu.
Gwamnatoci na ƙasa da na yanki sun soke wasu abubuwan da suka shafi taro mai yawa, gami da bikin Sabuwar Shekara, kuma kamfanoni masu zaman kansu suna rufe shagunan su da wuraren yawon buɗe ido kamar Hong Kong Disneyland da Shanghai Disneyland.
An kara da cewa an gina gidan ibada na gargajiya na Carnival na Anna a birnin Forbidden a cikin Beijing, kuma an rufe wuraren shakatawa da yawa don bikin Sabuwar Shekara ta Lunar don hana taron jama'a.
Hukumomi daga jihohi 31, birane da yankuna a cikin China sun ba da umarni cewa a cikin 24 na sabuwar shekara, bikin ya kara zuwa 10 ga Fabrairu kuma a dakatar da buɗe wuraren aiki da yawa har zuwa ranar.
Waɗannan yankuna suna wakiltar kashi 80% na ƙirar ƙasa da 90% na fitarwa.
Hong Kong ta kara yawan yadda take amsa cutar, ta kuma ayyana dokar ta baci, ta rufe makarantu har zuwa watan Maris kuma ta soke bikin Sabuwar Shekara a Alouchen.
Ziyarar masu siyarwa a Turai da Latin Amurka ta ragu da kashi 40%.
Kasuwancin Arewacin Afirka da Gabas ta Tsakiya sun sami ragi na 50  60%.
Wannan ya haifar da raguwar zirga-zirgar ƙafa zuwa wuraren cin kasuwa na 3343% a watan Maris idan aka kwatanta da Fabrairu.
Masu gudanar da kantin sayar da kayayyaki a duk faɗin duniya sun ɗauki ƙarin matakai kamar ƙarin tsabtace jiki, ƙwanƙwasawar zafin jiki don bincika yanayin zafi na masu amfani, da soke shirye-shirye. Kamar yadda Hukumar Tattalin Arziki ta Latin Amurka ta Majalisar Dinkin Duniya ta kiyasta, rufewar annobar na iya haifar da talauci mai tsanani tsakanin mutane miliyan 14 da 22 a Latin Amurka fiye da waɗanda suka shiga cikin matsalar annobar ba tare da cutar ba.
A cikin watan Janairu da Fabrairu na shekarar 2020, a lokacin annobar Wuhan, kimanin mutane miliyan 5 na kasar Sin sun rasa ayyukansu.
Kimanin ma'aikata 'yan gudun hijira miliyan 300 na kasar Sin sun bar gidajensu ko kuma su zauna a tsakiyar kasar a lardin Hubei. A watan Maris na shekarar 2020, sama da Amurkawa miliyan 10 sun rasa ayyukansu kuma sun nemi taimakon gwamnati.
Yaduwar cutar coronavirus ta lalata ayyuka miliyan 47 a Amurka kuma yawan rashin aikin yi ya kai kashi 32 cikin dari, kamar yadda bankin tarayya na St. Louis ya kiyasta. Rufe-rufe na Indiya ya yi wa miliyoyin ma'aikatan Indiya da ke yin aiki (ma'aikata masu biyan albashi na yau da kullun) rashin aikin yi. Binciken Cibiyar Angus Reid ya gano cewa kashi 44% na iyalai na Kanada sun sami rashin aikin yi. A Spain, duk abin da aka rufe tun tsakiyar watan Maris na 2020, kusan ma'aikata 900,000 sun rasa aikin su.
A rabin rabin watan Maris, ma'aikata miliyan 4 na Faransa sun nemi tallafin rashin aikin yi na wucin gadi kuma ma'aikata miliyan 1 na Burtaniya sun nemi tsarin bashi na duniya, kusan rabin miliyan na kamfanonin Jamus sun tura ma'aikatansu zuwa tsarin rage aikin wucin gadi na gwamnati da ake kira Kurzarbeit.
An fara aiwatar da shirin biyan kuɗin aiki na ɗan gajeren lokaci a Faransa da Ingila a Jamus.
Abubuwan tarihi na fasaha da al'adu sun sami mummunan rauni daga annobar, wanda ya shafi ayyukan ƙungiyoyi da ma'aikata da kuma masu zaman kansu a duniya.
Kungiyoyin fasaha da al'adu sun yi ƙoƙari don tabbatar da manufofin su (galibi tallafi daga gwamnati) na samar da al'adun gargajiya ga al'umma, kare lafiyar ma'aikata da jama'a, da tallafawa 'yan wasan da yawa.
A watan Maris na shekarar 2020, an soke ko kuma a dage ayyukan gidajen karatu, gidajen tarihi, wuraren wasan kwaikwayo da sauran cibiyoyin al'adu na duniya saboda girman su ya bambanta.
Wani sabon abu kuma da ke saurin bunkasa a wannan cutar shi ne soke ayyukan addini, manyan abubuwan da suka faru a wasanni, da sauran abubuwan zamantakewa, kamar bukukuwa da kide kide, tarurrukan fasaha da kuma nuna kayan ado.
A cikin watan Maris na shekarar 2016, an yi amfani da wannan hanyar don yin amfani da kayan ado na musamman don yin amfani da kayan ado na musamman.
Yawancin majami'u sun bukaci dattawa su zo tare da taron jama'a a ranar Lahadi su bar gidajensu, wasu majami'u suna ba da damar yin amfani da rediyo, watsa shirye-shiryen kai tsaye ko talabijin don gudanar da ayyukan coci, wasu kuma suna ba da damar yin amfani da mota don gudanar da ibada.
Tun lokacin da Romawa suka hana cocin Katolika tattara masu bauta da kuma bayan da aka saki filin wasa na St. Peter daga masu bautar Kirista, sauran kungiyoyin addinai sun hana jama'a yin taro da kuma taro a coci.
Ma'aikatar Lafiya ta Iran ta sanar da soke sallar Juma'a a wuraren da cutar ta shafa kuma an rufe wuraren ibada daga baya, yayin da Saudiyya ta hana masu yawon bude ido na kasashen waje shiga da kuma shiga wuraren ibada na Mecca da Medina.
Wannan annoba ta sa an matsa lamba sosai a kan wasanni da kuma shirye-shiryen wasanni a duniya bayan Yaƙin Duniya na Biyu.
An soke wasu wasanni da dama, ciki har da gasar zakarun Turai ta 2019-20, gasar Premier ta 2019-20, gasar zakarun Turai ta 2020, gasar zakarun Turai ta 2020, gasar NBA ta 2019-20 da gasar NHL ta 2019-20.
"Cutar ta rushe shirye-shiryen gasar Olympics ta bazara ta 2020, wanda aka shirya a ƙarshen Yuli, amma a ranar 24 ga Maris, kwamitin wasannin Olympics na duniya ya ba da sanarwar cewa taron zai "ci gaba da faruwa bayan 2020 amma ba kafin lokacin bazara na 2021 ba".
Wannan ya sa yawancin masu caca suka shiga yanar gizo, kuma shafukan caca na kan layi da yawa sun ba da rahoton cewa sun ga ƙaruwar yawan sababbin masu biyan kuɗi. Masana'antar nishaɗi ta sha wahala kuma ƙungiyoyi da yawa sun dakatar da zagaye na wasan kwaikwayo.
Yawancin manyan gidajen wasan kwaikwayo kamar Broadway sun dakatar da duk shirye-shiryen su.
"Wasu masu fasaha sun bincika yanayi don samarwa da raba damar watsa shirye-shiryen kai tsaye na gargajiya kamar kide kide kide na kai tsaye ko "ƙungiyoyi" na yanar gizo don masu fasaha suyi aiki, watsawa da buga ayyukansu".
Yawancin nishaɗin kan layi na coronavirus sun bazu a kan layi, yawancin su sun zama abin dariya da nishaɗi ba zato ba tsammani.
Tun lokacin da annobar COVID-19 ta fara, an lura da keɓewa mai yawa, nuna bambanci da wariyar launin fata a tsakanin Sinawa da Asiya, mutanen da ke da asalin Asiya ta Gabas da kuma waɗanda suka zo daga Turai, Amurka da sauran ƙasashe masu yawan cutar.
Tsoro, shakku, abubuwan da suka faru na abokan gaba sun bazu a ƙasashe da yawa kuma an lura da su a Turai, Gabashin Asiya, Arewacin Amurka da Asiya ta Pacific.
Rahotanni na Fabrairu (wanda ya zuwa yanzu ya fi yawa daga cikin wadanda aka samu a kasar Sin) sun nuna cewa, kamar kungiyoyi daban-daban a duniya, jama'ar kasar Sin suna da cutar ko kuma ana daukar daukar wannan a matsayin matakin ramawa.
A wasu biranen Afirka, an nuna rashin son kasar Sin.
Ya ce Wuhan da Hubei suna fuskantar nuna wariya ne kawai saboda sun kasance tushen cutar.
Alert. Akwai tallafi ga Sinanci a kan layi da kuma waje da kuma yankunan da cutar ta shafa.
A cikin sabuwar kasada a Turai, kamar Italiya, inda cutar COVID-19 ta fara yaduwa, akwai yiwuwar tashin hankali da tashin hankali a sakamakon lamarin. 'Yan ƙasa daga Malaysia, New Zealand, Singapore da Koriya ta Kudu suna aiwatar da ayyukan sa hannu don hana mutane shiga daga China don rage yaduwar cutar.
A Japan, hashtag #ChineseDontComeToJapan ya zama mafi yawan abu a Twitter.
An ruwaito karuwar tashin hankali a cikin jama'ar kasar Sin da kuma sauran 'yan Asiya a Burtaniya da Amurka.
Shugaba Donald Trump na Amurka ya fuskanci sukar da yawa saboda ya ce coronavirus shine cutar ta China, kuma ya sanya shi mai nuna wariyar launin fata da adawa da kasar Sin.
'Yan adawa a Ukraine sun kai hari kan motar da ke kaiwa 'yan Ukraine da sauran 'yan kasashen waje daga Wuhan zuwa Novi Sanzari.
An ruwaito cewa an yi wa daliban da ke kan iyaka da kasar Sin, da kuma daliban da ke arewa maso gabashin Indiya, da kuma daliban da ke karatu a manyan biranen Indiya, fyade a cikin wani abu da ya shafi annobar cutar coronavirus.
"A jihar Bengal ta yamma, a cikin yankin Dilip Gosh, shugaban jam'iyyar Bharatiya Janata Party ya ce kasar Sin ta lalata yanayi kuma ""Allah yana saka musu da azaba saboda wannan dalili".
"A baya, ofishin jakadancin kasar Sin a Kolkata ya bayyana cewa, ra'ayoyin "ba daidai ba ne". A kasar Sin, ana nuna rashin jin daɗin jama'a da kuma nuna wariyar launin fata a kan mutanen da ba 'yan kasar Sin ba saboda annobar, kuma ana bayyana 'yan kasashen waje a matsayin "ƙazanta na waje" da kuma "karɓa".
Yawancin jaridu da ke da ɗakunan biyan kuɗi ne kawai sun bar waɗannan ɗakunan saboda wasu ko duk wani labarin da suka yi game da cutar coronavirus.
Yawancin masu wallafa kimiyya sun buɗe takardun kimiyya game da annobar da ta bullo.
Wasu masana kimiyya sun raba sakamakon da suka samu a kan sabobin kamar bioRxiv don saurin bugawa.
Cutar da ke jawo kamuwa da cuta a yanzu  Cutar da ke jawo kamuwa da cuta a yau ita ce sabuwar cuta kuma tana da ciwo ko kuma ta yadu
Rashin daidaituwa da cututtuka: Gajeren bayani game da yanayin duniya da kuma yanayin cutar.
Jerin cututtuka da annoba a duniya  Yawan mutuwar da ake samu daga cutar Sitta
Damuwa da ke tattare da safarar dabbobin daji da cututtuka da ake watsawa daga dabbobi zuwa mutane ko kuma cinikin dabbobi masu saurin zama na daji
Gwaje-gwajen gwaji suna amfani da hanyoyin da za su sanar da cutar coronavirus ta numfashi 2019 (COVID-19) da kuma yiwuwar cutar SARS-CoV-2 da ke da alaƙa da maganin rigakafi don amsa wannan kamuwa da cuta.
Ana tabbatar da kwayar cutar a cikin samfurin ta hanyar RT-PCR kuma tana iya gano RNA na coronavirus.
Wannan gwajin yana da iyaka kuma yana da amfani wajen gano SARS-CoV-2.
Yana taimaka wajen gano abubuwan da suka fi ƙazantawa kwanan nan ko kuma waɗanda suke da tasiri.
Gano kwayoyin cuta (serology) yana taimakawa wajen bincike da kuma lura da jama'a.
Ana gwada rigakafin jikin mutum don gano yawan mutanen da ke da cutar, har da waɗanda suke da alamun cutar amma ba su da alamun cutar ko kuma ba su da alamun cutar.
Ana iya gano ainihin adadin kashewa da kuma rigakafin mutane daga wannan binciken.
Saboda iyakantaccen aikin bincike, babu tabbataccen bayani game da yadda yawancin mutane ke rarraba a kowace ƙasa a watan Maris na 2020.
Babu wata ƙasa da ta yi gwajin fiye da kashi 3 cikin 100 na yawanta har zuwa 23 ga Maris, kuma akwai bambancin da ke tsakanin gwaje-gwajen da aka yi a kowace ƙasa.
Wannan bambancin yana da tasiri sosai a kan yawan mutuwar, kuma a wasu ƙasashe, ana iya ganin hakan fiye da yadda ake tsammani.
Yin amfani da maganin polymerase chain reaction (rRT-PCR) na lokaci guda na juyawa zai ba da damar bincika samfurin da aka samu ta hanyar yin amfani da narkewa ko kuma cirewa.
Sakamakon zai kasance tsakanin sa'o'i kaɗan zuwa kwanaki 2.
Gwajin RT-PCR da aka yi ta hanyar ɗaukar samfurin ruwa a cikin makogwaro zai kasance mai aminci ne kawai a makon farko na kamuwa da cutar.
Daga baya, cutar za ta iya tashi daga wuyansa ta kuma yadu a cikin ƙwayar cuta.
A mako na biyu, za a iya amfani da wani samfurin samfurin don gano waɗanda suka kamu da cutar ta hanyar amfani da kateter mai shan ruwa ko kuma maganin sal (mai tsabta).
Daya daga cikin na farko, an yi gwajin PCR a Berlin a watan Janairun 2020 kuma mai yinsa Charité ne. A wannan lokacin, tare da mayar da martani na polymer-chain (rRT-PCR), an gudanar da gwajin 250,000 a cikin rarraba ta Hukumar Lafiya ta Duniya (WHO).
Ƙasar Ingila ta shirya gwajin a ranar 23 ga Janairu, 2020. Kamfanin Kogenebiotech na Koriya ta Kudu ya samar da kayan aikin bincike na SARS-CoV-2 (PowerChek Coronavirus), wanda ya dogara da PCR don gwajin asibiti a ranar 28 ga Janairu, 2020.
"Yana neman asalin ""E"" wanda yake cikin dukkan cututtukan corona, wanda ke buƙatar maye gurbin RdRp don SARS-CoV-2. Kungiyar BGI a China ta kasance daga cikin ƙungiyoyi na farko da suka sami fa'ida ta gaggawa daga Hukumar Kula da Kayayyakin Kiwon Lafiya ta China, kuma kayan aikin gano SARS-CoV-2 na PCR. Cibiyar Kula da Cututtuka da Rigakafi (CDC) a Amurka ta ba da rahoton 2019 Novel Coronavirus (2019-nCoV) na RT-PCR panel don gwajin lafiyar al'umma a lokacin ta hanyar wakili na duniya".
An sami sakamako mara kyau daga cikin gwaje-gwaje uku na jinsi saboda gano wani mummunan mai amfani a cikin kayan aikin bincike na baya, kuma an haifar da wani mummunan sakamako a gwajin da aka yi a CDC a Atlanta, wanda aka yi nasarar yin samfurin 100 a kowace rana a cikin watan Fabrairu 2020.
Har zuwa 28/Fabrairu 2020, ba a tantance amincin gwajin da ake amfani da sassan biyu ba, kuma har zuwa yanzu, dakunan gwaje-gwaje na ƙasa da na gida ba su sami izini don yin gwaji ba.
Hukumar Abinci da Magunguna ta ba da izinin yin gwajin a ƙarƙashin izinin amfani da gaggawa.
A ranar 5 ga Maris, 2020, LabCorp ta sanar da cewa akwai gwajin COVID-19 na ƙasa bisa RT-PCR.
Quest Diagnostics ta shirya gwajin COVID-19 na ƙasa a ranar 9 ga Maris, 2020.
Babu iyakancewar sashi, kuma ana buƙatar tattara samfur da ciyarwa bisa ga ƙa'idodin CDC.
A Rasha, gwajin COVID-19 ya kasance a cikin cibiyar bincike ta VECTOR, cibiyar bincike ta Virology da Biotechnology ta gwamnati.
A ranar 12 ga Maris, 2020, an ruwaito cewa asibitin Mayo ya shirya gwajin da zai iya gano kamuwa da COVID-19. A ranar 13 ga Maris, 2020, Roche Diagnostics ta sami izini daga FDA don yin gwaji mai yawa wanda zai sanar da sakamako a cikin awanni 3.5 - wanda zai ba da damar yin gwaje-gwaje 4,128 a cikin awanni 24.
A ranar 19 ga Maris, 2020, FDA ta ba da izinin amfani da gaggawa (EUA) ga Abbott Laboratories, wanda ke gwada tsarin Abbott m2000; FDA ta ba da izini iri ɗaya ga Hologic, LabCorp da Thermo Fisher Scientific.
A ranar 21 ga Maris, 2020, Cepheid ta sami EUA iri ɗaya daga FDA, wanda ke ɗaukar minti 45.
FDA ta ba da shawarar cewa a ba da izinin amfani da fasahar isotherman nucleic acid don maye gurbin PCR.
Wannan yanayin zafin jiki ba ya buƙatar juyawa, saboda sakamakon mai kyau a cikin ɗan gajeren lokaci na minti biyar zai haifar da sakamako mara kyau har zuwa minti 13.
A halin yanzu akwai na'urori 18,000 a Amurka, kuma Abbott tana hanzarta samarwa don yin gwaje-gwaje 50,000 a rana. Gwaje-gwaje da ke amfani da maganin rigakafin monoclonal suna da alaƙa kai tsaye da furotin nucleocapsid (N protein) na kwayar cutar coronavirus, kuma ana sa ran nuna sakamakon cikin minti 15 zuwa 20 kamar gwajin sauri na mura.
A cikin bita na Literature na Maris 2020, an kammala cewa a farkon matakan, farashin radiographs na fata ba shi da yawa, amma sakamakon CT \\[computed tomography] na iya kasancewa tun kafin a sami alama a wurin.
Abubuwan da suka fi dacewa a cikin City sun haɗa da binary multilayer floor-glass opassiphites tare da daidaitaccen, rashin damuwa da kuma rarraba baya.
Matsin lamba na rashin bambancin ra'ayi, rashin adalci da kuma haɗakarwa suna ƙaruwa yayin da cutar ta canza.
A farkon binciken da ya kwatanta PCR da CT a cikin ruwa, CT ya fi karɓar PCR, amma mafi yawan siffofin hoto da ƙananan ƙuntatawa suna kama da na tsokoki da cututtuka.
A watan Maris na 2020, Kwalejin Radiology ta Amurka ta ce kada a yi amfani da CT a matsayin gwajin farko na COVID-19. A watan Maris na 2020, CDC ta ba da shawarar yin amfani da PCR a matsayin gwajin farko.
Maganin rigakafi na jiki yana samar da rigakafi na jiki, wanda ya hada da IgM da IgG.
Ana iya yin gwaje-gwaje a cikin manyan dakunan gwaje-gwaje (CLT) ko kuma a wuraren kula (PoCT) a cikin mutane da suka kai kwanaki 7 ko fiye da fara nuna alamun cutar.
A yawancin dakunan gwaje-gwaje, ana iya yin waɗannan gwaje-gwaje ta hanyar tsarin sarrafa kansa da ake kira High-Sruput, kuma yawan abubuwan da aka gano zai dogara da yawan samfurin da ke cikin kowane tsarin.
Ana amfani da samfurin jini ɗaya don CLT, amma ana iya amfani da samfurin jini don ganin yadda rigakafin ke amsawa.
Ana samun samfurin jini na PoCT ta hanyar allura.
Ya kamata a fara aiki kafin a fara amfani da hanyoyin PCR. A ranar 26 ga Maris, 2020, sun sanya sanarwa ga Hukumar, sun sanya sunayen cibiyoyin 29 da suka ba da sanarwar da ake buƙata, kuma yanzu sun sami damar rarraba gwajin rigakafin mutum.
A ranar 7 ga Afrilu, 2020, FDA ta ba da izini guda ɗaya kawai don amfanin gaggawa. A ƙarshen Maris, 2020, Euroimmun Medical Laboratory Diagnostics da Epitope Diagnostics sun sami izinin Turai don gano magungunan rigakafi a cikin samfurin jini IgG da IgA.
Ana iya yin gwajin da sauri ta hanyar PCR don gano RNA na kwayar cutar daga na kowa.
A farkon watan Afrilu, babu wani kayan aikin bincike na rigakafi da aka saya a Burtaniya da ya taimaka.
Hukumar kula da lafiya ta kasar Sin ta dauki matakan da za su sa marasa lafiya da ake zargi su zauna a gida, kuma sashen gaggawa zai ba da bututun samfurin ga mai haƙuri, su kuma yi musu allura, su amsa su kuma su samu sakamakon binciken daga baya. NHS ta Ingila tana shirin yin bincike a gida don gano yiwuwar kamuwa da cutar, ta hana masu kamuwa da cutar kamuwa da cutar daga asibiti, kuma ta yi amfani da motar asibiti don tsabtace mutane daga kamuwa da cutar.
Cibiyoyin da ake amfani da su wajen kula da marasa lafiya a Koriya ta Kudu sun ba da damar yin bincike mafi sauri da kuma zurfin bincike a kasar. A Jamus, likitoci na National Health Insurance Co-operation sun ce a ranar 2 ga Maris, an yi bincike 10,700 a makon da ya gabata a kan wani giwa mai iya yin bincike 12,000 a cikin asibiti a rana.
Injin lafiya ne ke biyan kuɗin lokacin da aka nemi likita ya yi bincike.
A cewar shugaban cibiyar Robert Koch, Jamus na da damar yin gwajin gwaji 160,000 a mako.
A ranar 19 ga Maris, an yi bincike a kan yadda ake tuƙi a manyan birane.
Ba a san yawan gwajin da aka yi a Jamus a ranar 26 ga Maris na 2020 ba, saboda an ba da rahoton sakamako mai kyau kawai.
"Binciken dakin gwaje-gwaje na farko ya nuna cewa an gwada aƙalla samfura 483,295 daga makon kalanda na 12/2020 zuwa 12/2020 kuma an tabbatar da samfurori 33,491 (6.9%) na SARS-CoV-2. Masu bincike a cikin Isra'ila sun gwada wata hanya don gwada samfurori daga marasa lafiya 64 a lokaci guda a asibitin Technion da Rambam, kawai idan an haɗa samfurori tare da tabbataccen tabbatacce.
Tare da gina da Wang Jian, wanda ya kafa BGI, ya sa ido sosai, da kuma ɗaukar kwanaki 5, aikin samfurin zai iya ƙaruwa da kashi 47% a Hubei, kuma farashin keɓewa zai ninka sau biyu idan ba a fara gwajin ba.
Bayan haka, an kafa dakin gwaje-gwaje na Wuhan a birane 12 a duk faɗin kasar Sin, ciki har da Shenzhen, Tianjin, Beijing da Shanghai.
A ranar 4 ga Maris, 2020, ana yin gwaji mai yawa na yau da kullun 50,000 a rana. An saki Open Source Multiplex Design ta Origami Assays, wanda ke ba da damar yin amfani da gwaji 93 kawai don bincika samfuran marasa lafiya 1122 na COVID-19. Waɗannan ƙirar masu daidaitawa za a iya yin su a ƙananan dakunan gwaje-gwaje kuma ba sa buƙatar robotic tanks na ruwa.
A watan Maris, ƙarancin kayan gwaji da ƙarancin su ya zama babban abin damuwa a cikin tsarin binciken da aka yi a cikin Tarayyar Turai, Burtaniya da Amurka.
Wannan ya sa wasu marubuta su yi bincike kan wasu hanyoyin gwaji, wato, sakin RNA da za a iya yin gwajin tare da sanyaya samfurori zuwa 98 °C (208 °F) na minti 5 da kuma yin ƙarin gwaji. A ranar 31 ga Maris, an sanar da cewa, Hadaddiyar Daular Larabawa tana yin gwajin mutum fiye da kowace ƙasa kuma tana kan layi don isar da yawancin jama'a.
"Wannan shi ne wucewa ta mota, kuma wannan shi ne gwajin daga Group 42 da BGI (wanda ke da tushen dakin gwaje-gwaje na gaggawa a "Huo-Yan" a China) wanda ya haɗa da dukan jama'a".
Labarin da aka gina cikin kwanaki 14 na iya yin dubban gwaje-gwajen RT-PCR a rana, kuma shi ne na farko a duniya da zai iya yin wannan ƙimar a waje da China.
Ana yin gwajin cutar korona a cikin kwayoyin halitta daban-daban, kuma an yi ta ne a China, Faransa, Jamus, Hong Kong, Japan da Amurka.
Hukumar Lafiya ta Duniya ta dauki tsarin samar da kayan aiki na Jamus a matsayin na kasashe masu karamin kudin shiga da ba za su iya yin aiki da kansu ba.
An gabatar da tsarin girke-girke na Jamus a ranar 17 ga Janairu, 2020, kuma an shirya yarjejeniyar da Cibiyoyin Kula da Cututtuka na Amurka suka tsara ba har zuwa ranar 28 ga Janairu, wanda ya haifar da jinkirin gwaji a cikin gwamnatin Sin ta Majalisar Dinkin Duniya, kuma Amurka ta sami matsala game da amincin kayan aikin gwaji yayin da annobar ta fara, kuma waɗannan ƙasashe da Ostiraliya ba su iya samar da isasshen kayan aikin gwaji da kuma ba da shawara ga ƙwararrun likitocin lafiya ba.
Akasin haka, masana sun ce, samun damar yin bincike a Koriya ta Kudu ya taimaka wajen rage yaduwar cutar Novel coronavirus.
Gwamnatin Koriya ta Kudu ta yi shekaru da yawa tana gina damar bincike a cikin dakunan gwaje-gwaje na masu zaman kansu.
A ranar 16 ga Maris, Hukumar Lafiya ta Duniya ta yi ta yin gargadin gaggawa game da gaggawa a gudanar da bincike don rage yaduwar cutar COVID-19. Ƙarin buƙatar kayan aikin bincike saboda yawan yaduwar cutar ya haifar da ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙyar ƙyar ƙyar ƙyar ƙyar ƙyar ƙyar ƙyar ƙyar ƙyar ƙyar ƙyar ƙyar ƙyar ƙyar ƙyar ƙyar ƙyar.
A watan Maris na shekarar 2020, kasar Sin ta sanar da cewa tana da matsaloli game da ingancin kayan aikinta na bincike.
A Amurka, binciken da CDC ta yi ya kasance da wuya, kuma gwamnati ta kawar da takunkumin da ke hana gudanar da gwaje-gwaje na sirri. Spain ta sayi gwaje-gwaje daga kamfanin Shenzhen Bioeasy Biotechnology Co Ltd na kasar Sin, amma sakamakon bai kasance daidai ba.
Kungiyar ta bayyana cewa sakamakon da ba daidai ba zai iya kasancewa saboda rashin tattara samfurori ko kuma rashin amfani da kayan aikin da kyau.
A cewar ma'aikatar kasar Spain, za a maye gurbin kayan aikin bincike na musamman da Shenzhen Bioeasy ta bayar domin dawo da kayan aikin bincike na kuskure. Jamhuriyar Czech ta sayi kashi 80% na kayan aikin bincike na kasar Sin da suka samar da sakamako na kuskure.
Firayim Minista Matović ya ba da shawarar a jefa su cikin Danube. A cewar Ateş Kara, ma'aikacin ma'aikatar lafiya ta Turkiyya, Turkiyya ta yi amfani da kayan aikin bincike daga China saboda yawan kuskuren da ke tattare da su.
Gwaji, gano masu cutar da suka kamu da cutar da kuma bin diddigin wadanda ke dauke da cutar SARS-CoV-2 ya haifar da sakamako mai kyau.
Masu bincike da ke aiki a birnin VÃ2 na Italiya, inda aka fara samun mutuwar COVID-19 a Italiya, sun yi gwaje-gwaje biyu a cikin kwanaki goma a kan yawan mutane 3,400.
Rabin mutanen da suka kamu da cutar ba su da wata alama kuma duk abubuwan da suka faru sun kasance a cikin keɓewa.
Saboda ƙuntatawa a kan tafiye-tafiye zuwa al'umma, an iya dakatar da sababbin cututtuka.
Ta hanyar neman babban layi, sanyawa da kuma sanya takunkumin tafiye-tafiye, annobar cutar coronavirus ta 2020 ta bazu a Singapore da sauri fiye da sauran ƙasashe masu tasowa, amma ba a ɗauki matakan da suka fi ƙarfin rufe gidajen abinci da shagunan sayar da kayayyaki ba.
An soke wasu bukukuwa, kuma Singapore ta fara ba da shawarar mazauna su zauna a gidajensu har zuwa 28 ga Maris, amma makarantu sun buɗe a ranar 23 ga Maris bayan hutu.
Yawancin sauran ƙasashe sun sami damar sarrafa cutar ta hanyar saka idanu kan taɓawa, iyakance tafiya, bincike, warewa, amma kaɗan ta hanyar iyakance ayyukan ƙasa kamar Iceland da Koriya ta Kudu.
Kasashen da suka yi bincike sosai game da yawan mutuwar, bisa ga binciken kididdiga, suna da ƙananan haɗarin kamuwa da cutar, wataƙila saboda waɗannan ƙasashe suna iya gano waɗanda ba su da alamun cutar.
WHO ta ba da shawarar cewa ƙasashe da ba su da damar yin gwaji da kuma gwaje-gwaje na ƙasa waɗanda ke da ƙwarewar gwaji na COVID-19 da yawa su aika da samfurin farko na COVID-19 guda biyar da samfurin COVID-19 guda goma masu ƙyama zuwa ɗayan cibiyoyin bincike 16 na WHO don yin gwajin tabbatarwa.
Akwai dakunan gwaje-gwaje guda 16 a Asiya, 5 a Turai, 2 a Afirka, 1 a Arewacin Amirka da 1 a Kudancin Amirka, da kuma 1 a Ostiraliya.
A cikin jadawalin da ke gaba, kashi na mutanen da aka bincika sun nuna cewa tsarin binciken kasar yana rinjayar shafi na tabbatacce.
Kasashen da ke bincika asibitoci ne kawai ke da kashi mafi girma na mutanen da ke cikin asibiti, wanda ke nufin cewa ba a canza wasu abubuwa ba, ko da sun sami alamun cutar ko a'a.
Wanke hannu, ko kuma tsabtace hannu, aikin wanke hannu ne don kawar da datti, man shafawa, ƙwayoyin cuta, ko wasu abubuwa marasa amfani.
Yin wanka da sabulu a lokatai masu muhimmanci a rana yana hana kamuwa da cututtuka da yawa, kamar zazzabi da kwalara, waɗanda aka watsa zuwa bakinka ba tare da wanke hannayensu ba.
Alal misali: Idan ba a wanke hannayensu kafin su taɓa idanu, hanci ko bakinsu ba (watau ƙwayar mucous), mutane za su iya kamuwa da cututtukan numfashi kamar mura ko mura.
Abubuwa biyar masu muhimmanci da ake bukatar a yi a wanke hannu da sabulu a ƙarshen rana sun haɗa da: kafin da bayan wanke gidan wanka, bayan wanke ƙananan jariri ko canza dipers, kafin a ciyar da jariri da kuma kafin cin abinci, da kuma kafin a shirya abinci ko kuma bayan ka taɓa nama mai naman kaza, kifi, ko kaza.
Idan babu ruwa da sabulu, za a iya wanke hannu da toka. Hukumar Lafiya ta Duniya ta ba da shawarar wanke hannu.
kafin, bayan da kuma lokacin da ake dafa abinci.
Kafin ka kula da mai ciwo da kuma bayan ka kula da shi.
Bayan sun canja tufafin tufafi ko kuma sun wanke jaririn da ke cikin gidan wanka.
bayan an yi wa hanci riga, an yi masa yanka ko kuma an yi masa yanka.
bayan an yi wa dabba aiki, ko kuma an ci dabba ko kuma an taɓa takardar dabba.
A cikin Littafi Mai Tsarki, ana iya kwatanta tsabtace hannu da tsabtace jiki.
Yin wanka kafin a sha magani ko kuma a yi magani zai iya hana ko rage yaduwar cututtuka.
Babban manufar wanke hannu shi ne don tsabtace ƙwayoyin cuta (kwayoyin cuta, ƙwayoyin cuta, ko kuma ƙwayoyin cuta) da kuma sunadarai da za su iya cutar da mutum.
Wannan ƙwarewa tana da mahimmanci ga masu dafa abinci ko ma'aikatan kiwon lafiya, amma kuma yana da amfani ga jama'a gaba ɗaya.
Wanke hannu yana da fa'idodi da yawa ga lafiyar jiki, gami da rage yaduwar mura, cutar korona da sauran cututtuka masu yaduwa; hana abubuwan da ke haifar da kamuwa da cutar kumburi; rage kamuwa da cutar numfashi;
kuma tana da shirin rage mutuwar jarirai a cikin haihuwa a gida.
Wani bincike da aka yi a shekara ta 2013 ya nuna cewa, yin wanka da hannu a cikin gida zai iya kawo ci gaba a kan yara masu shekaru biyar.
A ƙasashe masu tasowa, ana iya rage yawan mutuwar yara da ke tattare da cututtukan numfashi da kumburi ta hanyar gabatar da canje-canje masu sauƙi na halayyarsu, kamar wanke hannu da sabulu.
Wannan mataki mai sauƙi zai iya rage yawan mutuwar da ake samu daga waɗannan cututtuka da kashi 50%.
Hanyar da za ta inganta wanke hannu za ta iya rage yawan rashin ruwa da kashi ɗaya bisa uku, idan aka kwatanta da samar da ruwa mai tsabta ga yankunan da ba su da kuɗi sosai.
Rage yawan kumburi da kumburi da kuma shan numfashi da sauri (ARI) a gida, makaranta da kuma al'ummomi a duniya shine hanya mafi inganci da sauƙi don hana kamuwa da kumburi da kuma cututtukan numfashi na gaggawa (ARI) a gida, a makaranta da kuma a duniya.
Ciwon huhu shi ne babban ciwon da ke kashe yara miliyan 1.8 a shekara, kuma yana kaiwa ga mutuwar yara miliyan biyar a duniya.
Kimanin yara miliyan 3.5 ne ke mutuwa a kowace shekara saboda ciwon kumburi da kuma cutar sankara.
A cewar UNICEF, wanke hannu da sabulu kafin cin abinci da bayan amfani da gidan wanka na iya ceton rayuka fiye da kowane allurar rigakafi ko kuma maganin likita, rage kusan rabin mutuwar da ke faruwa daga kumburi da rage mutuwar da ke faruwa daga kamuwa da cutar numfashi da kashi ɗaya bisa huɗu.
Ana yin wanka da hannu a cikin tsarin ruwa, tsabtace muhalli da tsabtace mutum (WASH) tare da sauran matakan tsabtace jiki.
Yin wanka a hannu yana kāre mutum daga cututtukan fata da ake kamuwa da su ta hanyar yin magana da su kai tsaye.
Ƙananan lahani a wanke hannu zai iya sa mutum ya yi rauni sosai saboda ya bushe.
Wani bincike da aka yi a shekara ta 2012 a ƙasar Denmark ya nuna cewa yawan wanke hannu zai iya haifar da cututtukan fata da ake kira saurin saurin saurin sa hannu, wanda ya fi kowa a cikin ma'aikatan kiwon lafiya.
Yin wanka hannu sau da yawa yana ɗaya daga cikin alamun rashin lafiyar jiki.
Akwai muhimman lokatai guda biyar a rana da ake bukatar wanke da sabulu don rage yaduwar kamuwa da cuta: bayan amfani da wanka (urina, tsotsa), bayan wanke ƙananan jariri (canza tsabta), kafin ciyar da jariri, kafin cin abinci da kuma kafin yin abinci ko kuma kafin / bayan cin naman alade, kifi ko kaji.
Kafin ka yi maganin cututtukan jiki ko raunuka, kafin ka yi amfani da su, ko bayan ka yi wa wani rauni, ko bayan ka yi wa wani rauni, ko bayan ka yi wa wani mutum rauni, ko bayan ka taɓa takardar dabba, ko kuma bayan ka taɓa dabba, kana bukatar ka yi amfani da hanyar wanke hannu don hana kamuwa da cuta.
A ƙasashe da yawa, yawan wanke hannu da sabulu ya rage.
A shekarar 2015, wani bincike da aka yi a kasashe 54 ya nuna cewa a matsakaita, kashi 38.7% na iyalai suna wanke hannu a gida. A shekara ta 2014, wani bincike da aka yi a kasar Saudiyya ya nuna cewa, kasar ta Saudiyya ce ta fi yawan wanke hannu. A kusan tsakiyar kasar, Amurka ta kai kashi 77, kuma kasar Sin ta kai kashi 23%.
A cikin shirin kula da lafiya mai mahimmanci da ma'aikatar ilimi ta Philippines ta gabatar, ana amfani da shi azaman samfurin aiki don inganta lafiyar yara da ilimi.
Babban burin wannan shirin na kasa shi ne sanar da mutane sau biyu a shekara game da shawarar wanke hannu da sabulu a kai a kai, da kuma tsabtace hakora da fluoride a kai a kai.
An yi amfani da shi sosai a Indonesia.
Ana iya cire ƙwayoyin cuta daga fata ta ƙara ruwa a sabulu ko sabulu mai narkewa.
Babban aikin sabulu da wanke ruwa shine rage shinge na bayani da haɓaka narkewa.
Fats da furotin da ke cikin ƙasa ba su da sauƙi a cire su daga ruwa, saboda ruwa shi kaɗai ba ya isa ya tsabtace fata.
Amma, ana taimakawa wajen tsabtace ta ta hanyar samun ruwa mai kyau ..
Sabulu mai bushewa za a iya sake amfani da shi kuma zai iya ɗauke da ƙwayoyin cuta da aka yi amfani da su a dā.
Wasu bincike da suka bincika yadda kwayoyin cuta ke yaduwa da sabulu mai ƙarfi sun kammala cewa ba su da matsala sosai don kawar da ƙwayoyin cuta daga kumfa.
CDC ta ce sabulu mai ruwa ya fi dacewa don rarraba kayan sarrafawa marasa taɓa hannu.
An yi amfani da sabulu na antibacterial a cikin al'umma da ke taimakawa wajen yin rayuwa mai kyau.
Har zuwa yau, babu wata hujja da ta nuna cewa amfani da maganin rigakafi ko maganin rigakafi na halitta yana ba da damar ƙwayoyin da ke da ƙwayoyin cuta.
Amma sabulu na antibacterial suna dauke da wani abu mai dauke da kwayoyin cuta kamar tricone, wanda ke dauke da kwayoyin halitta masu yawa.
Saboda haka, ko da yake ba a zaɓi maganin rigakafi na maganin rigakafi ba, ba zai iya zama da tasiri kamar yadda aka yi tsammani ba.
Baya ga wakili mai kare fata, wasu nau'ikan kayan aiki masu ci gaba kamar su pH controller, antibacterial active benetic acid da ƙarin kayan sanyaya fata (aloevra, bitamin, mantoles, kayan lambu) da acid (acetic acid, ascorbic acid, lactic acid). Wani bincike daga Jami'ar Kiwon Lafiya ta Oregon ya nuna cewa sabulu masu tsabta suna da tasiri kamar sabulu na antibacterial don hana ciwo da kuma kawar da ƙwayoyin cuta daga wuta.
Ruwan da ke da zafi sosai don wanke hannuwanmu ba shi da zafi sosai don kashe ƙwayoyin cuta.
Kwayar cuta tana girma da sauri sosai a zafin jiki (37 °C).
Amma, ruwan zafi da sabulu sun fi ruwan sanyi da sabulu kyau wajen kawar da ƙwayoyin ƙwayoyin cuta da kuma man fetur da ke ƙunshe da ƙwayoyin cuta.
Amma, a kan abin da mutane suke tunani, binciken kimiyya ya nuna cewa ruwan zafi ba ya rage yawan kwayoyin halitta da ke hannayenmu.
Tsabtace hannu ko kuma wanke hannu, wani zaɓi ne na tsabtace hannu wanda ba a dogara da ruwa ba.
A ƙarshen 1990s da farkon karni na 21, zaɓuɓɓukan tsabtace hannu marasa giya da ruwa (wanda aka fi sani da wanke hannu mai amfani da giya, wanke hannu mai hana kamuwa da cutar, ko wanke hannu) sun sami karbuwa.
Yawancin su an kafa su ne don amfani da su a cikin gel, ko a matsayin ruwan glycerin, ko kuma a cikin turɓaya tare da wani abu mai ƙarancin nauyi kamar carbohydrate (acid ocular polymer) don rage tasirin amfani da bushewa da kuma rage amfani da barasa.
Ƙara hydrogen peroxide yana ƙara yawan maganin rigakafi. Ana amfani da maganin hana shan giya mai amfani da hannu don kashe ƙwayoyin cuta.
Kayan tsabtace giya suna kashe ƙwayoyin cuta, ƙwayoyin cuta masu ƙonewa (MRSA da VRE), cutar sankara da wasu ƙwayoyin cuta (HIV, herpes, RSV, rhinovirus, allurar rigakafi, mura da cutar hanta) da kuma naman gwari.
Bayan dakika 30 na yin amfani da wanke-wanke na giya da kashi 70% na giya, ana cire kwayar cutar daga hannayen mutum (ƙarancin ƙwayar cuta na 3.5 da 35 decibels) da kashi 99.97% kuma ana cire kwayar cuta daga kashi 99.99% zuwa 99.999% (ƙarancin ƙwayar cuta na 4 zuwa 5) a cikin minti 1.
Ana amfani da maganin hana shan giya ko kuma wanke hannu da giya don a bushe hannuwan biyu sosai ko kuma a rufe su.
Ana shafa gaba da baya na dukkan yatsunsu da ƙarshen yatsunsu na tsawon dakika 30 har sai ruwa, kumfa ko gel ya bushe.
Dole ne a wanke yatsunsu sosai, tare da rufe yatsunsu biyu. Cibiyar Kula da Cututtuka ta Amurka ta ba da shawarar yin amfani da kayan tsabtace hannu musamman idan an gano cewa an wanke hannayen hannu.
Yawan amfani da waɗannan wakilai ya dogara da sauƙin amfani da saurin kashe ƙananan abubuwa, amma ba za su maye gurbin wanke hannu ba sai dai idan akwai sabulu da ruwa.
Yin amfani da kayan wanke hannu da giya a kai a kai zai iya haifar da fata mai bushewa idan ba a haɗa man shafawa da / ko wanke fata a cikin kayan shafa ba.
Ana iya rage ko kawar da sakamakon bushewar giya ta ƙara glycerin da/ko wasu man shafawa zuwa ga kayan shafawa.
A cikin gwaji na asibiti, wanke hannu da giya ya haifar da saɓo ko sabulu na antibacterial da ke rage yawan haushi da bushewar fata.
Ba a yawan samun cututtukan fata, cututtukan ƙasusuwa ko rashin shan giya ko kuma abubuwan da ke cikin kayan wanke hannu.
A wasu lokatai, ana iya samun cututtukan fata da suka shafi jiki idan aka kwatanta da wanke hannu da sabulu da ruwa.
Ko da yake suna da tasiri, magungunan da ba su da ruwa ba ba ba za su tsabtace hannayenmu ba, amma suna iya lalata su.
Wannan shi ne dalilin da ya sa sabulu da ruwa ba su dace da maganin hana hannu daga kamuwa da ƙwayoyin cuta da yawa ba, saboda haka ƙwayoyin cuta suna iya kasancewa a hannunka.
Aikin tsabtace hannu mai tsabta da ba giya ba ya dogara ne da kayan abinci da kayan yaji, kuma yana da ƙarancin ƙarancin giya da ƙarancin giya.
A kwanan nan, an lura cewa yin amfani da sinadarin benzodiazepine ya ragu bayan sake yin amfani da sinadarin, kuma ba kamar yadda ake ganin giya ba, yin amfani da sinadarin benzodiazepine ya ragu bayan sake yin amfani da sinadarin.
Mutane da yawa a cikin al'ummomin da ba su da kuɗi sosai ba za su iya sayen sabulu kuma su yi amfani da mat ko ƙasa a maimakon haka.
Ƙura ko ƙasa za su iya yin aiki sosai fiye da ruwa, amma ba sa yin amfani da sabulu.
Abu daya da zai iya damun mu shi ne, ƙasa ko kuma ciyawa za su iya ƙara yaduwar cutar maimakon rage yawan cutar da ke tattare da ƙwayoyin cuta.
Kamar sabulu, toka tana kashe kwari, domin tana warware abubuwa masu ƙwayoyin cuta a cikin ruwa.
Hukumar lafiya ta duniya ta ba da shawarar yin amfani da safa a matsayin zaɓi idan babu sabulu.
Don hana yaduwar cutar, cibiyoyin kula da cututtuka na Amurka sun ba da shawarar yin wanka na hannu daidai ya haɗa da waɗannan matakan:
Ka wanke hannunka da ruwa mai zafi ko sanyi.
Ana ba da shawarar ruwa mai ruwan sama don ƙazanta wuraren waha, kuma a halin yanzu, ba za a iya ganin cewa zafin jiki na ruwa yana da bambanci ba.
Ka yi amfani da sabulu a hannuwanka sau da yawa, har da a bayan hannu, tsakanin yatsunsu da kuma ƙarƙashin ƙusa.
Sabulu yana kawar da ƙwayoyin cuta a fata, kuma bincike ya nuna cewa mutane suna wanke hannu sosai a lokacin da sabulu yake a cikin jiki maimakon a cikin ruwa.
Ka bincika na akalla dakika 20.
Yin shafawa yana sa a yi amfani da shi sosai don kawar da ƙwayoyin cuta a fata kuma yana kawar da ƙwayoyin cuta da yawa idan an yi masa masa masa masa masa masauki na dogon lokaci.
Ka wanke su da ruwa mai kyau.
Wanke hannu a cikin tafki zai iya sake gurɓata hannayensu.
Ka wanke su da tawul mai tsabta ko kuma ka bar su su bushe da iska.
Hannun da suka yi ruwa da kuma waɗanda suka yi gurgu suna da sauƙi su sake kamuwa da cutar.
Ƙafafun mutum da kuma ƙusa masu launin ƙusa za su iya haifar da ƙwayoyin cuta.
Ana ba da shawarar yin amfani da maganin wanke hannu don hana bushewa, saboda fata mai bushewa na iya haifar da lalacewar fata wanda zai iya haifar da cutar.
"Ana iya yin zaɓuɓɓuka masu ƙarancin kuɗi don sauƙaƙe wanke hannu a wuraren da babu ruwa na famfo da / ko sabulu, misali: karɓar ruwa daga rami mai ɗorewa ko rami mai kyau da kuma / ko amfani da ruwa idan ya cancanta a ƙasashe masu tasowa. A cikin yanayin rashin ruwa (kamar makarantu ko yankunan karkara a ƙasashe masu tasowa), akwai zaɓuɓɓukan tanadi kamar ""TPI-Taps"" da sauran zaɓuɓɓukan ƙananan-ɓatarwa".
TPE-Tap fasaha ce mai sauƙi ta hannu ta amfani da igiyar waya da ƙaramin ruwa da famfo na sabulu.
Ko da yake bushewa da kyau na hannu yana da muhimmanci a tsabtace hannu, akwai wasu muhawara game da yadda za a bushe hannu a cikin wanka na jama'a.
Ƙara yawan bincike ya nuna cewa tawul ɗin takarda sun fi tsabta fiye da na'urorin bushewa na hannu na lantarki da ke cikin gidajen wanka da yawa.
A shekara ta 2008, an gudanar da wani bincike a Jami'ar Westminster a London, wanda aka yi ta hanyar masana'antar takarda ta Tasis ta Turai, wanda aka tallafa wa masana'antar takarda ta iska don kwatanta matakan tsabtace da ke samar da tawul na takarda, bushewar hannu mai zafi da kuma iska mai iska mai iska mai iska mai zamani.
Bayan wanke hannu da kuma bushewa a cikin iska mai zafi, adadin kwayoyin ya karu da kashi 194% a yatsunsu da kuma 254% a hannayensu.
Drying a cikin jet-air dryer ya nuna karuwar kashi 42% na yawan kwayoyin cuta a kan matsakaita a kan takalma na kwari da kuma 15% a cikin shinge.
Bayan wanke hannu da kuma bushewa da tawul ɗin takarda, adadin kwayoyin ya ragu da kashi 76% zuwa matsakaiciyar yatsunsu da kuma kashi 77% a hannunsu. Masana kimiyya sun gudanar da bincike don tabbatar da yiwuwar wasu masu amfani da gidan wanka da kuma gidan wanka sun gurɓata saboda kowane irin bushewa.
Dryer na iska, da saurin iska mai gudu 180 m/h (650 km/400 mph) na iya cire ƙwayoyin cuta daga hannayensu da na'urar kuma ya gurɓata sauran masu amfani da gidan wanka da kuma yankin wanka har zuwa mita 2.
Yin amfani da iska mai zafi yana sa ƙwayoyin cuta su yada daga cikin matattarar zuwa mita 0.25.
A shekara ta 2005, wani bincike da aka yi a TÃœV Produkt und Umwelt ya nuna cewa ba a samu karuwar kwayoyin cuta a cikin kayan bushewa na takarda.
Bayan an bushe hannu, an lura da canje-canje a ƙididdigar ƙwayoyin cuta kamar haka:
Akwai masana'antun bushewa da yawa, kuma ana gwada bushewa da na'urorin bushewa da na'urorin wanka.
Wani zaɓi kuma shi ne wanke kayan wanke hannu a lokacin tafiya, idan babu sabulu da ruwa.
Dole ne a yi amfani da kayan wanke hannu da giya aƙalla kashi 60% na giya.
Magungari Ignaz Semmelweis ya yi amfani da taimakon hannu na gaggawa tun bayan ya gano cewa yana da tasiri wajen hana cututtuka a asibiti (a 1846).
Akwai na'urorin lantarki da ke tunatar da ma'aikatan asibiti su amsa da cewa idan sun manta su wanke hannu, su wanke.
A wani binciken da aka yi, an gano cewa yawan kamuwa da cutar ya ragu sosai.
Ana yin wanke hannu a cikin magani na tsawon dakika 15 kuma ana amfani da sabulu da ruwa ko gel don shafa da kuma shafa kowane ɓangaren hannu.
Dole ne a shafa hannayensu tare da yatsunsu.
Idan akwai ƙazanta a cikin yatsunsu, za a iya amfani da goga don kawar da shi.
Yana da muhimmanci a wanke hannayenmu da kyau kuma a bushe su da tawul mai tsabta domin ƙwayoyin cuta suna iya kasancewa a hannayenmu.
Bayan ya bushe, rufe ruwa ta amfani da tawul na takarda (kuma buɗe kofa ta fita idan ya cancanta).
Wannan zai hana hannuwanmu sake gurɓata daga waɗannan abubuwa.
"A cikin tsarin kiwon lafiya, ana yin wanka da hannu don hana kamuwa da ƙwayoyin cuta da ke tattare da su".
Jaridar New England Journal of Medicine ta ruwaito cewa a yawancin wuraren kiwon lafiya, ana yawan yin wanka da hannu, kuma hakan ya sa likitoci da ma'aikatan jinya da yawa suka manta da wanke hannuwan marasa lafiya kafin su yi wanka, don haka suka rarraba ƙananan ƙwayoyin cuta.
Wani bincike ya nuna cewa wanke hannu da kuma wasu ayyuka masu sauƙi suna rage yawan jini da ke tattare da cututtuka da kashi 66 cikin ɗari. Hukumar Lafiya ta Duniya ta wallafa wani labarin da ya nuna yadda ake wanke hannu da kuma canja hannu a fannonin kiwon lafiya.
Za a iya samun tsarin tsabtace hannu na ƙungiyar a shafin yanar gizonmu don amsar jama'a.
Wani muhimmin bita ya faru ne a shafin yanar gizo na Whitby et al.
Idan ana buƙatar bayanin bin ƙa'idodin kulawa, kayan aikin kasuwanci na iya auna da tabbatar da tsabtace hannu.
"Ƙungiyar Lafiya ta Duniya ta ce akwai "Lokaci Biyar" na wanke hannu".
Bayan sun fuskanci jini ko kuma ruwa da ke fitowa daga jiki
Kafin a yi aiki da ba tare da gurɓataccen yanayi ba, kuma
Bayan kula da marasa lafiya. Ƙara sinadarai masu ƙwayoyin cuta zuwa sabulu (sabulu na marasa lafiya ko na antibacterial) yana nuna cewa akwai wakili mai wanke hannu.
Don yin aikin tiyata, ana bukatar 'masha' hannunka, a buɗe da kuma rufe famfo na wanka, a wanke hannunka da tawul mai bushe, a wanke hannunka da wasu kayan aiki masu tsabta don wankewa, a wanke da chlorhexidine ko iodine, da kuma wanke goga mai bushe, da kuma tsabtace yatsunsu.
Ya kamata kowa ya saka kayan ado.
Wannan aikin yana bukatar a wanke hannuwanmu da kuma hannayenmu na tsawon minti 2 zuwa 6.
Ba a bukatar dogon lokaci na gwaji (minti 10) ba.
Idan aka yi amfani da igiya, dole ne a hana ruwa daga hannun.
Bayan an gama wanke hannayensa, sai a bushe hannunsa da tufafi masu tsabta kuma a saka rigar tiyata.
Don rage yaduwar kwayoyin cuta, ya fi kyau a wanke hannu kafin a kula da mai haƙuri ko kuma bayan an yi masa magani.
Don sarrafa cututtukan stephilococcal a asibitoci, an gano cewa mafi kyawun amfani daga wanke hannu shine 20% na wanke hannu na farko, kuma yana da ƙananan ƙarin amfani idan yawan wanke hannu ya ƙaru fiye da 35%.
Yin wanka da sabulu mai tsabta yana haifar da ƙaruwa fiye da sau uku na kamuwa da cututtukan cuta na abinci idan aka kwatanta da wanke da sabulu mai ƙonewa. A matsakaita, wanke hannu da giya na tsawon dakika 30 ya rage gurɓatawar kwayoyin cuta da kashi 26% fiye da wanke hannu da sabulu mai ƙonewa.
Amma sabulu da ruwa sun fi amfani da su wajen rage cutar H1N1 da kuma cutar Clostridium difficile a hannu fiye da sabulu da ruwa. Tsayar da hannu a wuraren kiwon lafiya don inganta tsabtace hannu na iya haɗa da koyar da ma'aikatan wanke hannu, ƙara wanke hannu da giya, da kuma rubutaccen rubutu da rubutu ga ma'aikatan.
Ana bukatar ƙarin bincike don sanin wane daga cikin waɗannan hanyoyin ya fi tasiri a fannoni daban-daban na kiwon lafiya.
A cikin ƙasashe masu tasowa, ana ganin wanka da sabulu a hannu a matsayin kayan aiki mai tsada, ingantaccen kiwon lafiya da ingantaccen abinci mai gina jiki.
Amma, rashin isasshen ruwa, sabulu ko kayan wanka na hannu a gidaje, makarantu da wuraren aiki ya sa ya zama ƙalubale a cimma halaye na wanke hannu a duniya.
Alal misali, duk da cewa akwai zaɓuɓɓukan da ba su da tsada don gina wuraren wanke hannu, a yawancin yankunan karkara na Afirka, akwai ƙananan wuraren wanke hannu kusa da kowane gidan wanka na sirri ko na jama'a.
Amma, ba sabulu ko ruwa ba ne zai iya sa a yi wanka a hannu sosai.
Tallafawa da koyarwa game da wanke hannu da sabulu na iya tasiri ga yanke shawara na siyasa, haɓaka wayar da kan jama'a game da fa'idodin wanke hannu, da haifar da canjin halin jama'a na dindindin.
Domin wannan ya yi aiki, dole ne a yi nazari da kuma lura.
Binciken tsarin bincike na 70 ya gano cewa hanyoyin da ke kan al'umma suna da tasiri wajen ƙara wanke hannu a cikin LMICs, kuma kamfen ɗin talla na zamantakewa ba su da tasiri. Misali ɗaya na tallata wanke hannu a makarantu shine tsarin tauraro uku na UNICEF wanda ke ƙarfafa makarantu su ɗauki matakai masu sauƙi, marasa tsada don tabbatar da cewa ɗalibai suna wanke hannayensu da sabulu, a tsakanin sauran ƙa'idodin tsabta.
Idan aka cika ƙananan ƙa'idodi, makarantu za su iya girma daga taurari ɗaya zuwa uku.
Gina wuraren wanka na hannu na iya zama wani ɓangare na kamfen na tallata wanka na hannu don rage cututtuka da mutuwar yara.
Wani misali kuma shi ne yakin neman wayar da kan jama'a na duniya na kokarin kawo sauyi a halayyar wanke hannu. Saboda annobar coronavirus daga 2019-2020, UNICEF ta karfafa fadada emojis na wanke hannu.
Wasu binciken sun duba yawan kudin wanke hannu a kasashe masu tasowa dangane da DALYs.
Amma, wani bincike ya nuna cewa ƙarfafa wanke hannu da sabulu ya fi tasiri fiye da sauran hanyoyin ruwa da tsaftacewa.
A tsakiyar karni na 19, an fara sanin muhimmancin wanke hannu ga lafiyar ɗan adam, musamman ga waɗanda ke cikin mawuyacin yanayi, kamar uwaye masu ciki ko kuma waɗanda ke cikin asibiti, ta hanyar masu gabatar da tsabtace hannu biyu: Ignaz Semmelweis, likitan Hungary da Florence Nightingale, na Ingila, wanda ya kafa aikin jinya na zamani a Vienna, Hungary.
A lokacin, mutane da yawa sun yi imani cewa miyagun ƙwayoyi ne suke sa mutane su kamu da cutar.
A cikin shekarun 1980, annoba ta abinci da cututtukan da ke tattare da kula da lafiya sun sa Cibiyoyin Kula da Cututtuka da Rigakafin Amurka su inganta tsabtace hannu a matsayin babbar hanyar hana yaduwar cutar.
Cutar kumburi ta 2009 da annobar COVID-19 a 2020 sun haifar da karuwar fahimta a cikin ƙasashe da yawa game da buƙatar wanke sabulu don kare kansu daga irin waɗannan cututtukan cututtuka.
Alal misali, a Jamus, ana saka hotunan da ke dauke da fasahar wanke hannu a bayan gida a bayan gida da kuma a wuraren wanke hannu a filin jirgin sama.
A cikin Littafi Mai Tsarki, an yi amfani da kalmar nan "ɓata hannu" don a nuna cewa ba ka son ka ɗauki alhakin wani abu ko kuma ka yi aiki tare da shi.
A cikin Linjilar Matta, an samo ayar Littafi Mai Tsarki inda Bilatus na Fentikos ya wanke hannayensa bayan yanke shawarar giciye Yesu Kristi, amma ya zama sanannen magana a wasu al'ummomin Turanci.
A cikin Shakespeare's Macbeth, Mrs. Macbeth ta fara wanke hannayenta da ƙarfi don tsabtace launi mai kyau don wakiltar lamirin ta na laifi game da laifukan da ta aikata da kuma abin da ya sa ta kashe mijinta.
Ya kuma lura cewa bayan mutane sun tuna ko kuma sun yi bimbini a kan ayyukan lalata, sukan fi daraja wanke hannu da kuma kayan wanke hannu fiye da wasu.
Bugu da ƙari, bayan yin tunani, ba su da wata damar yin wasu ayyukan gyara kamar su aikin sa kai da ake ba da izinin wanke hannu.
Addinai suna ba da umarni game da wanke hannu don dalilai na tsabta da alama. Yin wanke hannu na alama, amfani da sabulu ba tare da ruwa ba don wanke hannu, tsarin wanke hannu ne a cikin addinai da yawa, wanda ya haɗa da Baha'i, Hindu, Tewilah da Netilayi a addinin Yahudanci, Lavooba a addinin Kirista da kuma Wudu a addinin Musulunci.
Hindu, Yahudawa da Musulmai sun umarci wanke hannu bayan yin amfani da gidan wanka.
Kuma: addinin Hindu, Buddha, Sikh, Yahudanci da Musulunci sun tilasta wanke hannu kafin da bayan kowane cin abinci.
Kula da haɗarin wurin aiki don COVID-19
Kula da haɗarin wurin aiki don COVID-19 yana ba da damar kiyaye matakan aminci a wurin aiki don hana kula da cutar coronavirus 2019 (COVID-19).
Tabbatar da ingantaccen kula da haɗari a wurin aiki ya dogara da wurin aiki da nau'in aiki, wanda zai dogara ne akan binciken haɗarin tushen haɗari, rashin yaduwar COVID-19 a cikin al'umma da yanayin haɗarin mutum.
A cewar Hukumar Kula da Lafiya da Lafiya ta Aiki ta Amurka (OSHA), ayyukan da ke da ƙananan haɗari sune ayyukan da ke da ƙarancin alaƙa da al'umma da abokan aiki, kuma don haka dole ne a ci gaba da matakan rigakafin kamuwa da cuta na asali kamar wanke hannu, kiyaye ma'aikata a gida idan suna rashin lafiya, aiwatar da numfashi da kuma tsabtace da kamuwa da cuta na yau da kullun.
Ayyukan da ke da haɗarin haɗari na matsakaici sune waɗanda ke aiki kai tsaye tare da mutanen da ba a san ko ake zargin suna da COVID-19 ba amma waɗanda za su iya kamuwa da cutar ta hanyar ci gaba da kamuwa da cutar ko tafiya ta duniya.
Wannan ya ƙunshi mutanen da suka fito daga al'umma, kamar su makarantu, wuraren da ke da yawan jama'a da kuma wuraren sayar da kayayyaki.
Don wannan rukunin, masu kula da hatsari dole ne su sami kayan aiki na iska mai tsabta da na sirri wanda ke amfani da matattarar iska mai ƙarfi don matakan rigakafin kamuwa da cuta na asali, idan mutum yana fuskantar COVID-19.
OSHA ta dauki haɗarin haɗari mai tsanani ga waɗanda aka gano ko ake zargi da COVID-19 a matsayin haɗari mai ƙarfi, idan ma'aikata suka tattara samfurori daga waɗanda aka sani ko ake zargi da COVID-19 yayin aiwatar da aikin samarwa a cikin iska, zai ƙara haɗarin haɗari.
Kula da haɗari da suka dace da waɗannan ma'aikatan sun haɗa da kulawar injiniya, kamar su iska mai iska mai iska mai iska da kayan kariya na sirri waɗanda suka dace da aikin.
Cutar COVID-19 na iya haifar da tasiri mai yawa a wurin aiki.
Ana iya sallama ma'aikata daga aiki saboda rashin lafiya, kula da wasu, da kuma tsoron haɗari.
Za a iya canza tsarin kasuwanci, wanda ya haɗa da abin da ake buƙata da kuma yadda ake sayen waɗannan kayayyakin (watau ta hanyar yin layi a lokacin da babu layi ko ta hanyar mai kawowa ko ta hanyar wucewa ta mota).
A ƙarshe, ana iya hana jigilar kaya zuwa wuraren da COVID-19 ke da haɗari sosai. Ana iya amfani da shirin shirye-shiryen annobar da shirin amsawa don ɗaukar matakan kariya.
Akwai shirye-shirye da yawa da suka shafi wuraren aiki da nau'ikan aiki, wanda ke da haɗarin albarkatu, tushen haɗari daga gida da al'umma, da kuma tushen haɗarin kowane ma'aikaci don shekarunsu da kuma matsalolin kiwon lafiya masu tsanani.
Za su kuma bayyana matakan da ake bukata don kauce wa waɗannan haɗarin da kuma shirye-shiryen yanayin da za a iya kamuwa da cutar.
Shirye-shiryen shirye-shiryen cututtuka masu yaduwa na iya zama na shawarwari na ƙasa ko na yanki.
Don magance cutar, ana buƙatar rage rarraba tsakanin ma'aikata, hana mutanen da ke da haɗarin cututtukan lafiya, kare kasuwancin da rage tasirin tasiri ga sauran ɓangarorin sarkar samarwa.
A wurin da ake kasuwanci, yanayin da ake ciki zai iya sa a yi maganin cutar.
Tsarin tsarin kula da haɗari ana amfani dashi bisa ga inganci a cikin kula da haɗari ga aminci a wurin aiki da haɗarin haɗari ga ƙungiya.
A wuraren da ba za a iya kawar da haɗarin COVID-19, ingantattun hanyoyin sarrafawa sune sarrafa injiniya, wanda a ƙarshe ana tallafawa da kayan kariya ta mutum ta hanyar kula da gwamnati.
Kulawa ta injiniya na iya gano ma'aikata daga haɗarin aiki, wanda ba ya dogara da halayyar ma'aikaci, wanda zai iya zama hanya mai tsada.
Gudanar da gudanarwa shine canje-canje a cikin manufofin aiki ko hanyoyin aiki, wanda ke sa ma'aikaci ko mai aiki su ɗauki matakan.
Ko da yake kayan aikin kariya na mutum ba su da tasiri fiye da aikin injiniya da kuma kula da gwamnati, yana taimakawa wajen rage wasu haɗarin.
Duk nau'ikan kayan kariya na mutum dole ne a zaɓa su dace da ma'aikaci, kamar yadda ake buƙata, a zaɓi su yadda ya kamata (misali: tacewa), a daidaita da kuma yadda ya kamata, a bincika su akai-akai, a gyara su kuma maye gurbin su, kuma a cire su yadda ya kamata, a tsabtace su da adana su ko kuma su hana gurɓataccen yanayi.
A cewar Hukumar Kula da Lafiya da Lafiya a Aikin Amurka (OSHA), ayyukan da ke da ƙananan haɗari suna da alaƙa da ƙananan al'umma da sauran abokan hulɗa.
Ana ba da shawarar matakan rigakafin kamuwa da cuta na asali ga duk wuraren aiki: maimaitawa da motsa hannu mai zurfi, ba da shawarar mutane su zauna a gida idan suna rashin lafiya, matakan da suka shafi numfashi kamar tari da numfashi, shirya kayan aiki da shara, kasancewa a shirye don aiki ta waya da kuma nisantar da canji, ƙarfafa ma'aikata kada su yi amfani da kayan aikin wasu, da kuma yin aikin tsabtace wuraren aiki na yau da kullun.
Ganowa da sauri da kuma gano mutanen da za su iya kamuwa da cutar mataki ne mai mahimmanci don kare ma'aikata, abokan ciniki da sauran mutane a wurin aiki.
Cibiyoyin Kula da Cututtuka na Amurka (CDC) na Amurka, cibiyoyin kula da cututtuka na Amurka) na bukatar mutane da ke fama da matsalar numfashi na musamman su zauna a gida har tsawon sa'o'i 24 har sai an gano zazzabi, alamun wuta ko wasu alamun cutar, amma kada su yi amfani da wani magani da zai rage zazzabi ko kuma ya sauya wasu alamun cutar, kuma dole ne a sauya manufofin hutu na rashin lafiya, wanda zai ba ma'aikata damar kasancewa a gida, kuma ma'aikata su san wannan.
A cewar OSHA, ayyukan da ke da matsakaiciyar haɗarin haɗari suna buƙatar kusanci mai yawa, har zuwa ƙafa shida (1.8 m) na mutanen da aka sani ko ba su da COVID-19, duk da haka, idan mutane ne waɗanda ke iya zama sananne saboda ci gaba da watsawar jama'a na SARS-CoV-2 ko kuma waɗanda suka yi tafiya kwanan nan zuwa ƙasashen da ke da yawan yaduwar COVID-19.
Wannan ya haɗa da ma'aikata masu alaƙa a makarantu, yankunan da ke da yawan jama'a, da sauran manyan shagunan sayar da kaya. Don wannan kuma ga ƙungiyoyin haɗari mai girma, kulawar injiniya ta ƙunshi ingantaccen iska, ƙara yawan numfashi, shigar da shinge na jiki, kamar su hana fashewar filastik, da kuma kare sabis na abokin ciniki a windows na mota. Kulawa ta gudanarwa don wannan da kuma sauran ƙungiyoyin da ke da haɗari mai ƙarfi ya haɗa da ƙarfafa ma'aikata masu aminci su zauna a gida, yin tarurruka na fuska a kan taron a kan Wurin, ƙaddamar da haɗarin yanayi na yau da kullun, ba da izinin yin balaguro na sirri, ba da izinin yin balaguro na sirri a kan alamun ci gaba da COVID-19, ba da izinin yin amfani da hannu da hannu ko kuma ba da izinin shiga cikin gidajen aiki da kuma haɗarin haɗari da ke tattare da haɗari da haɗari da haɗari da haɗari da ke tattare da haɗari da haɗari da haɗari da haɗari da haɗari da haɗari da COVID-19, ƙarfafa hanyoyin da za a iya magance COVID-19, ba da izinin tuntuɓar mutane da kuma tuntuɓar abokan aiki da ke tattare da yanayin da yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin, da kuma haɗari da yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin aiki, da yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin COVID-19.
Sau nawa ne ma'aikatan wannan rukunin haɗari ke amfani da numfashi?
Kulawa mai kyau don kare mutum daga ma'aikatan jirgin sama da sauran fasinjoji daga masu rashin lafiya ya ƙunshi ware mai haƙuri da nisan ƙafa 6, bauta wa mai haƙuri da sanya abin rufe fuska a gaba. ko kuma neman rufe bakinsu da hancinsu da kayan shafa yayin da suke rashin lafiya ko kuma suna shan wahala.
Ma'aikatan jirgin sama suna bukatar su saka safofin hannu na lokaci ɗaya a lokacin da suke kula da wani mai tafiya mai rashin lafiya ko kuma suna taɓa ruwa ko kuma abubuwa masu ƙazanta, kuma idan mai tafiya yana da zazzabi, tari ko kuma rashin numfashi, dole ne su yi amfani da na'urar kāre kansa.
Dole ne a jefa safofin hannu da sauran abubuwa masu cirewa a cikin jakar kayan aiki na halitta, sannan a tsabtace su da kuma gurɓata abubuwa masu ƙazanta. Ga jiragen ruwa da sauran jiragen ruwa masu jigilar kaya, ya haɗa da jinkirta tafiya da keɓewa da sanar da lokacin da aka yi amfani da matakan kula da haɗari, gami da jiragen ruwa da sauran jiragen ruwa masu fasinjoji. Idan za a sami zazzabi ko wasu alamun cutar a jirgin, sanar da cibiyar likitanci a jirgin nan da nan.
Mafi kyawun hanya ita ce a sanya ido kan lafiyar mutum a cikin ɗakin da aka keɓe. CDC ta ba da shawarar rufe makarantu da cibiyoyin kula da yara na ɗan lokaci da tsaftacewa ko kuma tsabtace cutar idan mutumin da ke da cutar ya shiga cikin ginin makaranta kuma babu yadda jama'a ke yadawa.
A lokacin da akwai watsa shirye-shiryen zamantakewa na matsakaici zuwa matsakaici, ana iya aiwatar da dabarun nisantar jama'a kamar soke shirye-shiryen tafiya, soke taro da sauran abubuwa kamar koyo a makaranta, dakatar da manyan taro a ɗakunan masu sauraro ko kantin abinci, faɗaɗa nesa tsakanin mazauna, rarraba lokutan shiga da fita, hana baƙi marasa dole da kuma ware ofisoshin da keɓewa don bincika yara masu nuna alamun.
Idan akwai yaduwar jama'a, ban da tsarin nisantar jama'a, ana iya ganin tsawaita rufe makarantu a matsayin zaɓi. CDC ta yi la'akari da cewa haɗarin kiwon lafiya na ma'aikatan da ke bin doka da ke aiki a yau da kullun yana da ƙasa.
Jami'an tsaro da ke da alaƙa da mutanen da suka kamu da COVID-19 ko kuma waɗanda ake zargi da su, an ba da shawarar cewa su bi irin wannan jagororin kamar masu aikin likita na gaggawa, gami da kayan kariya na sirri.
Idan akwai kusanci a lokacin damuwa, kafin a sake amfani da su ko kayan gida, ma'aikata dole ne su tsabtace belun su da kayan aikin su da ƙwayoyin cuta ta hanyar fesawa ko wankewa, kuma su ajiye da cire PPE da kayan aiki da kayan wanka da kayan aiki da aka yi amfani da su ta hanyar amfani da tsarin aiki da aka adana.
OSHA ta nuna cewa wasu ma'aikatan kiwon lafiya da masu kula da gawawwaki suna fuskantar haɗarin haɗari mai yawa ko kuma mai girma.
Ayyukan da ke da haɗari mai yawa suna fuskantar kula da lafiya, tallafi, dakin gwaje-gwaje da kuma waɗanda aka sani ko waɗanda ake zargi da cutar COVID-19.
Wannan babban haɗari ne idan ma'aikata suna aiki tare da ma'aikatan da ke aiki a kan ayyukan samar da Aerosol ko kuma suna aiki tare da marasa lafiya masu cutar COVID-19 da ake zargi da samfurori.
Tsarin samar da kwayoyin a cikin iska, shigar da bututu a cikin numfashi, aiwatar da fara kwayar halitta, yin bronchoscopy wasu hanyoyin hakora da kuma gwajin ko tattara samfurin rigakafi.
Ayyuka a cikin rumbun gawawwakin da ke da haɗari mafi girma sun haɗa da aikin mutanen da ke shirya gawawwakin waɗanda ake zargi da COVID-19 a lokacin mutuwar su, wanda ke nufin cewa idan aka yi autopsy, waɗannan mutane za su zama mutanen da ke da haɗari mafi girma. Ƙarin aikin injiniya don sanya waɗanda ake zargi da ko sanannun COVID-19 a cikin ɗakin keɓewa don waɗannan ayyukan idan ana yin ayyukan da ke fitar da ƙwayoyin cuta a cikin iska.
Za a iya amfani da wani na'urar numfashi ta musamman don yin amfani da shi a wasu wuraren kiwon lafiya ko kuma wajen ajiye gawawwakin.
Ana buƙatar ɗaukar samfuran a matakin 3 na kiyaye lafiyar jiki.
Hukumar Lafiya ta Duniya (WHO) ta ba da shawarar cewa marasa lafiya masu zuwa su zauna a cikin wani wuri mai iyakance saboda shakkar COVID-19. Baya ga PPE, ana ba da shawarar cewa a yi amfani da masu numfashi na OSHA daga nisan ƙafa 6 don waɗanda ake zargin suna aiki kuma suna aiki tare da mutanen da ke fama da SARS-CoV-2 da kuma waɗanda ke aiki da ƙwayoyin iska.
A Amurka, NIOSH ta ba da izinin yin amfani da abin rufe fuska na N95 don numfashi ko kuma a yi amfani da shi a cikin tsarin tsarin rigakafin numfashi wanda ya haɗa da gwaji, horo da gwajin lafiya.
Sauran nau'ikan kayan numfashi suna ba da kariya mai yawa kuma suna haɓaka kwanciyar hankali. WHO ba ta ba da cikakken tallafi ga rufewa, saboda COVID-19 cuta ce ta numfashi, ana watsa ta ta hanyar ruwan jiki.
Hukumar ta WHO ta ba da shawarar cewa ma'aikatan da ke yin bincike a ƙofofin shiga su sa abin rufe fuska na tiyata kawai.
WHO ta ba da shawarar cewa waɗanda ke kula da marasa lafiya na COVID-19 ko kuma waɗanda ke jigilar marasa lafiya ba tare da fitar da sinadarai ba su yi amfani da abin rufe fuska na tiyata, abin rufe idanu ko kuma rigar fuska da safofin hannu.
Idan an aiwatar da aikin sarrafa iska, za a maye gurbin abin rufe fuska na tiyata da N95 ko FFP2 na numfashi.
Dangane da rashin wadatar PPE a duniya, WHO ta ba da shawarar rage bukatar PPE ta hanyar telemedicine, ta hanyar iyakance jiki, ta hanyar windows mai tsabta, ta hanyar shigar da waɗanda kawai ke buƙatar kulawa ta kai tsaye, ta hanyar amfani da kayan kariya na sirri don iyakantaccen aiki, ta hanyar kula da mutane da yawa ba tare da ɗaukar numfashi ɗaya ba, ta hanyar kula da sarkar samar da kayan kariya na sirri da kuma haɗa kai da mutanen da ba su da alamar.
Daga: Katherine Maher, Shugaba na Gidauniyar Wikimedia
B: Duk ma'aikatan Wikimedia Foundation
Matsalar: [Covid-19] Rage matsa lamba da shirya don gaba
Ranar isarwa / Sa'a: 14/2020, 00:24 UTC
Mai ba da lasisi: CC0: Babu haƙƙin doka
A wannan watan, mun sami kanmu a cikin yanayi na musamman.
Cutar COVID-19 ta duniya ta bayyana alaƙarmu da mutane kuma ta bayyana alhakinmu ga juna.
Ko da yake ba mu da misali na kalubalen, amsarmu mafi kyau ita ce fahimtar juna, haɗin kai da kuma gina al'umma a tsakiyar wannan shirin.
Abokanmu da kuma kulawar da muke gani a imel, tarho da tattaunawa tsakanin ma'aikatanmu sun nuna cewa muna fama mu yi aiki tare da mutane masu ban mamaki.
Na yi farin cikin sanin ku duka a matsayin abokin aiki.
A makon da ya gabata, wani ya ce yana godiya da aikinmu.
Wannan babban alama ce ta yadda duniyarmu take da ma'ana da dawowa Wikipedia, kuma cewa wannan muhimmin taimako ya zama na kan layi da kuma na kowa.
Wannan zai sa aikinka ya kasance daidai, ko kana da matsayi, ko abokan aikinmu suna samun kuɗi, ko kuma al'ummarmu ta kasance cikin aminci.
Duniya tana bukatar bayanan da Wikipedia ke bayarwa yanzu fiye da kowane lokaci.
Wannan shi ne lokacin da muke da tasiri mai kyau a kan abin da muke yi da kuma yadda muke yi.
Wannan aikin da kuma rawar da kuke takawa suna da mahimmanci, saboda haka, za mu iya yin wasu manyan canje-canje game da yadda za mu yi aiki tare daga mako mai zuwa.
A lokacin, an yi amfani da wannan hanyar wajen yin wa'azi.
Kamar yadda Robyn ta bayyana a baya, kungiyar C ta hadu a daren jiya don tattauna tsarinmu da jadawalinmu na kwanaki da watanni masu zuwa.
A wannan jawabin, mun yi tunani game da abin da zai zama amsar da ta dace ga abin da muke fuskanta da kuma abin da za mu yi don ci gaba da ƙungiyarmu a wannan lokacin.
Muna son mu kawar da damuwa sosai kuma mu ci gaba da hidimarmu na dogon lokaci.
Idan kana son ka sake kira, babu matsala.
Ga dukan ma'aikata, masu hutu da ma'aikata na wucin gadi:
Za mu yi aiki na sa'o'i 4 a rana ko 20 a mako har sai an bayyana a gaba.
Ba wai yana nufin hutu ba ne - idan za ka iya yin karin sa'o'i a lokacin aikinka na yau da kullum, aikin zai iya amfanar ka.
Amma ba za mu iya tunanin inda duniyarmu za ta je ba, kuma lafiyarka ita ce abin da ya fi muhimmanci a gare mu, ko kana bukatar ka kula da iyalinka, ka je shagon ko ka je asibiti.
Ba mu lura da sa'o'inku ba.
Idan ka gaskata da shi, kada ka yi aiki.
Ba lallai ba ne a ce haka, amma muna da tabbaci.
Babu ranar rashin lafiya ko buƙatar PTO - kawai kuna buƙatar sanar da ma'aikacin gudanarwa da kuma duba kalandarku da jadawalin ƙungiyar ku don tabbatar da cewa suna da mahimman wuraren aiki.
(Idan kun sami sakamako mai kyau na gwajin COVID-19, don Allah ku sanar da Brian don ya taimaka muku kuma ya tabbatar da cewa an kula da batun ku ta hanyar hukuma).
Ana biyan mutane cikakken kuɗin awa ɗaya.
Mun riga mun samu, kuma za mu ci gaba da ba da abin da muke da shi ga 'yan kwangila da ma'aikatanmu.
Ana biyan kowa a lokacin aikinsa.
Wannan ya haɗa da rashin iya aiki saboda rashin lafiya.
Idan kana son yin aiki, za mu taimake ka.
Mutane da yawa suna amfani da aiki don bayyana damuwarsu ga duniya.
A lokacin da muke yin hakan, aikinmu zai iya kawo sakamako mai kyau.
Wannan kuma game da kula da kanka ne.
Tambayarmu ita ce yin magana da ku ta hanyar gudanarwa don mu san abin da za mu jira kuma mu shirya.
Wasu ayyuka suna da muhimmanci.
Amma, akwai wasu abubuwa da za mu ci gaba da yi.
SRE, ayyukan HR, amintattu da kungiyoyin tsaro da kuma tara kuɗi (a tsakanin sauran) suna yin aiki mai mahimmanci wanda zai iya buƙatar ƙarin tallafi.
A kowane bangare, za mu fara aiki don samun manufa da kuma mayar da hankali a yanzu a kan abin da yake da muhimmanci ga burinmu.
Muna da aiki da yawa, kuma dukanmu muna mai da hankali ga abin da muke bukata sosai.
Ba a yi amfani da jinkiri a yanzu ba.
Ba mu da shirin ninka lokacin aiki don kammala ayyukan da suka yi jinkiri bayan an kammala annobar.
A halin yanzu ba za a bukaci ku yi aiki na karin sa'o'i don cimma ƙuntatawa ba.
Mun yarda cewa yanayi ya canza, kuma muna aiki don kafa sababbin manufofi da jadawalin lokacin da ake buƙata.
Menene za a ƙirƙiri a kan APP (shirin shekara-shekara)?
Don daidaitawa da sabon gaskiyarmu da kuma sa'o'inmu na yau da kullun, muna buƙatar daidaita lokacin da shirinmu na shekara-shekara na 2020-2021 zai ci nasara.
Manufarmu ita ce mu tsawaita shirinmu na 2019-2020, wanda zai sa ma'aikata su sami damar yin aiki da kansu da kula da iyalansu ta hanyar tsara ayyukan da suka dace, kuma hakan zai biya bukatun mutanen da suke son rage lokacin aiki.
Wannan tsawaita lokaci zai rage matsin lamba da matsin lamba a kan tsarin da ke yanzu a duk faɗin ƙungiyar.
A mako mai zuwa za mu sanar da ma'aikatanmu ga hukumar kuma za mu sanar da wakilan da kungiyoyi abin da ke gaba da sauri idan muka samu bayanai.
Godiya ga jagorar ku na ƙungiyar APP mai ƙarfi a wannan lokacin.
A cikin shekara ta 1950, an yi amfani da kayan ado da kayan ado da kuma kayan ado.
A makon da ya gabata, mun gano cewa ɗayan abokan aikinmu na SF na iya kamuwa da cutar COVID-19.
Amma, saboda yawan matakan da muka ɗauka, mun ɗauki ma'aikatan kashe ƙwayoyin cuta don ofishin San Francisco.
Sun yi amfani da kayan maganin kashe kwayar cutar da ake amfani da su a asibiti don kawar da kamuwa da cuta a kowane bene, gami da karɓar ƙuƙwalwa da kuma bankunan ɗagawa da ke zuwa saman mu.
Ginin yana da tsarin kula da kansa ta amfani da kayayyakin da ke kare lafiyar mazauna.
Muna da tabbaci cewa za a shirya ofishin sosai sa'ad da muka yanke shawarar komawa.
Ofishinmu na DC yana cikin WeWork kuma sun raba mana hanyar COVID-19 tare da ma'aikatanmu a DC.
A makon da ya gabata, ofishinmu na D.C. ya bi umurnin San Francisco don yin aiki daga gida gaba ɗaya.
Kamar yadda wasu ma'aikatanmu a NYC suka sani, muna kuma yin jawabi don haya a Brooklyn.
Ana ci gaba da tattaunawar amma ana iya jinkirta.
Wasu abokan aikinmu suna aiki daga gida a karon farko.
Abokan aikinmu na dogon lokaci sun san cewa zai iya zama gyara, kuma suna so su ba ku wasu shawarwari:
Ka rage tsawon taron zuwa awa ɗaya ko biyu.
Idan ana buƙatar zaman lokaci mai tsawo, la'akari da yadda za a iya raba ƙananan zaman zuwa kwanaki da yawa.
Ka bayyana taron a fili, ka yi shiri kuma ka aika da littattafan da za a karanta a gaba.
Sa bidiyon ta zama tsoho, wanda ya haɗa da kayan aiki kamar Google Docs da Zoom, wanda ke ba da haɗin kai tsaye da sadarwa.
Ka sami wanda zai duba kowane taro, wanda zai lura da tattaunawar da kuma jerin masu jawabi, kuma ya taimake ka ka rubuta (ko kuma ka rubuta bayanin da aka yi da juna).
Idan kana son kayan ji na kunne mai kyau, ka aika da imel don taimakon fasaha.
Za su yi amfani da kuɗin tsaro don yin karar.
Ka shiga shafin #remoties don tattaunawa da abokan aikinka game da ayyukan da aka watsa
Ƙungiyar HR tana neman hanyoyin da za ta gudanar da aikin da ake rarrabawa a cikin tushe ta hanyar samar da jagororin ergonomics bisa ga Webinar.
A makon da ya gabata, mun nemi masu karɓar taimakon jama'a su soke ayyukan Wikimedia Foundation, wanda ke aiki a matsayin editators, har sai WHO ta ce annobar ta ƙare.
Mun sanar da su cewa muna fahimtar cewa neman sokewa zai iya sa ya yi musu wuya su cika yarjejeniyar tallafi da aka riga aka yi, kuma ba za a hukunta kowa ba saboda jinkirin ko canjin waɗannan manufofin.
Za mu yi ƙarin jagora a Wikimania da sauran taron yanki da na yanki a mako mai zuwa.
Halin da ke fitowa daga al'ummar duniya ba kawai baƙin ciki bane, amma kuma ta'aziyya saboda ra'ayoyin da suka ba da don mayar da hankali ga al'ummarsu, Wikimedia da sauransu saboda rashin kwanciyar hankali da ya haifar.
A nan gaba, CRT tana aiki don ƙirƙirar shafi a Meta-Wiki, da nufin sarrafa matsin lamba ga al'umma da kuma ci gaba da hulɗa da su.
Ana saka idanu sosai kan al'amuran da suka shafi COVID-19
A ranar Alhamis mai zuwa 14:00 UTC/07:00 PT za mu aika da gayyata zuwa taron ma'aikata na musamman.
Muna amfani da wannan lokacin don raba ƙarin sabon bayani, amsa tambayoyinku, da kuma ɓata lokaci a cikin dangantakarmu.
Muna cikin wannan kuma muna taimaka wa juna a duk hanyar da za mu iya.
A wannan lokacin, zaku iya samun bayanai daga wannan imel ɗin da sauran bayanan da suka shafi COVID-19 a kan Office Wiki.
CRT ta sabunta waɗannan shafuka kuma ta sa duk bayanan su kasance a wuri ɗaya.
Bugu da ƙari, muna aiki don ci gaba da sadarwa tare da ma'aikata, waɗanda ke aiki a ƙasashe masu rauni.
Idan kuna buƙatar taimako game da tafiya, yanayi, babban layi na aiki ko ƙalubalen rufewa, ko kuma kuna buƙatar taimako game da kowane irin abu, don Allah kada ku yi jinkirin sanar da CRT kuma kuyi aiki tare da su.
Muna nan don tallafawa da kuma aiwatar da shi kamar yadda ake buƙata.
Idan akwai batun da ke buƙatar kulawa da ruwan inabi mai ɓoye, aika imel zuwa Bryan Judan - Daraktan Ayyukan Gudanar da Ayyukan Human Resources na Duniya.
Babu wani daga cikin waɗannan canje-canjen da ya kamata a ɗauka cewa mun yi watsi da aikinmu.
Amma a wannan lokacin, an yarda cewa dole ne a gyara ayyukanmu da kuma abubuwan da muke da su a hanyar da ba mu taɓa gani ba.
Muna bukatar mu tallafa wa juna, kuma muna bukatar mu yi aiki tare, mu tallafa wa ayyukanmu, kuma mu ba da sabis don tallafa wa duniya.
Za mu iya yin aiki a kan lokaci.
Yanzu lokaci ne da za mu goyi bayan juna kuma mu samar da sarari don ayyuka masu mahimmanci a makonni da watanni masu zuwa.
Dukkanku suna da mahimmanci don wannan ya zama gaskiya, kuma muna son ku kula da kanku da danginku don ku kasance mafi kyau a lokacin da ake buƙata.
Yanzu - Ka Wanke Hannunka Kuma Ka Guji Shafarka!
Catherine ta kasance a cikin CRT (Amanda K, Amy V, Bryan J, Doreen D, Gregory V, Jaime V, Joel L, Lynette L, Ryan M, da Tony S), da kuma ƙungiyar jagoranci (Grant I, Heather W, Jaime V, Janeen U, Lisa S, Robyn A, Ryan M, da Toby N).
b'Angiotensin - enzyme na 2 (ACE2) wanda ke aiki a cikin huhu, jijiyoyin jini, zuciya, koda da hanji.
ACE2 yana da kyakkyawan manufa don magance cututtukan jijiyoyin jini ta hanyar rage matakan angolistin-II da haɓaka Ang (1-7) da keɓaɓɓen aiki na angolistin-transforming enzyme (ACE). ACE2 yana aiki azaman hanyar shiga cikin ƙwayoyin cuta don wasu coronavirus.
Ana kiran enzyme a cikin mutum hACE2.
Angrosthitin-enzyme 2 zinc ne wanda ke dauke da ironloenzyme wanda ke cikin endothelial da sauran kwayoyin halitta.
An sanya furotin na ACE2 zuwa yankin N-terminal peptidase M2 da kuma yankin C-terminal collectrin renal amino acid transducer.
ACE2 wani nau'i ne na nau'i na I wanda yake da cutar, wanda yake a saman samfurori da sauran sassan jiki saboda yana da yankin aiki.
ACE2 wani enzyme ne da ake kira shedase na waje wanda aka yanke daga cikin ƙwayoyin halitta, kuma sakamakon ya zama furotin mai narkewa wanda aka saki zuwa jini kuma daga ƙarshe ya shiga cikin fitsari.
ACE2 yana cikin yawancin kwayoyin halitta: ACE2 yana da alaƙa da ƙwayoyin cuta na huhu na nau'in II, ƙwayoyin cuta na ƙananan hanji, jijiyoyin jini da jijiyoyin jini a cikin yawancin kwayoyin halitta.
Ana samun bayanin ACE2 mRNA a cikin ƙwayar cuta, strattrum, hypothalamus da ƙwayoyin kwakwalwa.
Babban aikin ACE2 shine kasancewa daidaitaccen daidaito ga ACE.
ACE angiotensin I hormone yana haɗuwa zuwa vasoconstricting angiotensin II.
ACE2 kuma yana yanke amino acid din phenylalanine, wanda yake fitowa daga carboxylic terminal na angiotensin II (Asp-Arg-Val-Tyr-Ile-His-Pro-Phe) a cikin furotin kuma ya mai da shi mai ruwa zuwa vasodilator angiotestin (1-7), (H-Asp-Arg-Val-Tyr-Ile-His-Pro-OH).
ACE2 na iya lalata wasu peptides, ciki har da [des-Arg9]-bradykinin, apelin, neurotensin, dynorphin A da ghrelin.
ACE2 kuma yana sarrafa membrane SLC6A19, mai ɗaukar amino acid mara kyau, wanda aka sani yana da alaƙa da cutar Hartnap.
A matsayin furotin na transmembrane, ACE2 yana aiki a matsayin babban hanyar shiga wasu ƙwayoyin cuta na corona, wanda ya haɗa da HCoV-NL63; SARS-CoV (virus da ke haifar da SARS); da SARS-CoV-2 (virus da ke haifar da COVID-19).
Musamman, sun haɗa furotin S1 na SARS-CoV da SARS-CoV2 zuwa ƙwayoyin halitta na ACE2 kuma suna ba da damar ƙwayoyin cuta da enzymes zuwa endosomes da kuma watsawa a cikin sel.
Wannan aikin shigarwa yana buƙatar yin gwajin S a kan mai karɓar bakuncin TMPRSS2, wanda zai iya zama magani na yanzu. Wannan ya sa wasu suka yi tunanin cewa zai iya taimakawa wajen yaki da kamuwa da cuta ta hanyar rage matakan ACE2 a cikin sel.
Koyaya, yawancin al'ummomin ƙwararru da hukumomi suna ba da shawarar ci gaba da maganin ACE inhibitor da ARB na yau da kullun.
A ranar 11 ga Yuli, 2012, wani bita da kuma nazarin meta-analysis da aka buga ya nuna cewa amfani da magungunan ACE ya rage yawan ciwon huhu da kashi 34% idan aka kwatanta da masu kula.
Hakanan, haɗarin kamuwa da cutar ta huhu ya kasance iri ɗaya ga marasa lafiya da ke da cutar ta ACE mai haɗari, musamman a cikin kwakwalwa da ciwon zuciya.
An kuma yi amfani da maganin ACE wajen magance mutuwar da ke tattare da cutar huhu, kuma sakamakon ya kasance ƙasa da haɗarin cutar huhu gaba ɗaya.
Ana ganin cewa ƙwayoyin ACE2 (rhACE2) na mutum sabon magani ne na cutar kumburi mai saurin kamuwa da cutar, cutar numfashi da ke haifar da rashin numfashi saboda cutar lipossaccharide, wanda ke inganta haemodynamics da oxygenation na kumburi a cikin aladu.
RHACE2 rabin rai a cikin mutum yana da kusan awanni 10 kuma farkon aikinsa yana da minti 30 ban da sa'o'i 24 na aiki (lokacin aiki).
Yawancin binciken sun nuna cewa rhACE2 na iya zama magani mai kyau ga cututtuka masu dauke da masu hana tsarin renin-angiotensin (RAS inhibitors) na yau da kullun ko kuma na cutar da ke dauke da cutar angiotensin II. An gwada rhACE2 a cikin gwaji na asibiti don magance cutar ta shan numfashi mai tsanani.
Aikace-aikacen COVID-19 aikace-aikacen wayar hannu ne waɗanda aka tsara don taimakawa bin diddigin ko gano tsarin gano mutane (Contacts) waɗanda zasu iya haɗuwa da mutumin da ke da cutar.
A wasu ofisoshin gwamnati da kuma jihohi, an shirya ko kuma an gabatar da aikace-aikace da yawa da taimakon gwamnati.
An tsara tsarin da yawa don gina aikace-aikacen bin diddigin taɓawa.
Musamman ma, masu amfani da aikace-aikacen sun sami damuwa game da sirrin sirri game da tsarin da aka kafa don bin diddigin yanayin ƙasa.
Zaɓuɓɓukan ƙananan tsangwama sun haɗa da amfani da siginar Bluetooth don yin rikodin kusanci ga mai amfani zuwa sauran wayoyin hannu.
A ranar 10 ga Afrilu, 2020, Google da Apple sun sanar da cewa suna aiki tare don daidaita aikin na'urorin da ke aiki da Bluetooth zuwa tsarin aiki na Android da iOS.
A kasar Sin, gwamnatin kasar Sin, tare da Alipay, ta kirkiro aikace-aikacen waya don sanar da 'yan ƙasa idan sun tuntuɓi mutanen da ke da COVID-19.
Ana amfani da shi a birane sama da 200 a kasar Sin. A Singapore ana amfani da app mai suna TraceTogether.
An kirkiro app ɗin ne ta hanyar ƙungiyar IT ta gida wanda aka saki a matsayin tushen buɗe kuma ana ba shi ga gwamnati. A Arewacin Macedonia, ya ƙaddamar da aikace-aikacen Bluetooth na StopKorona! 2 don saka idanu da kuma amsawa cikin sauri ga waɗanda ke da cutar.
Ma'aikatar Sadarwa da Fasaha da Ma'aikatar Kiwon Lafiya ne suka kirkiro wannan app din.
Tun daga 14 ga Afrilu, 2020, aikace-aikacen yana jiran izini don ajiya a cikin Google Play Store da Apple App Store.
"A ranar 12 ga Afrilu, gwamnatin UAE ta bayyana cewa aikace-aikacen bincike na tuntuɓar yana cikin babban ci gaba. Kuma ana shirin yin irin wannan aikace-aikacen a Ireland da Faransa (""StopCovid"") wanda zai fara aiki a cikin makonni. "
Dukansu Ostiraliya da New Zealand suna la'akari da aikace-aikace dangane da aikace-aikacen TraceTogether da yarjejeniyar BlueTrace a Singapore. Rasha na shirin gabatar da aikace-aikacen Geofencing ga marasa lafiya da ke zaune a Moscow waɗanda ke da cutar COVID-19 don hana su barin gidajensu.
Farfesa Ross Anderson na Jami'ar Cambridge, mai ilimin kimiyyar tsaro, ya lissafa matsaloli da yawa, gami da yiwuwar sakamako mai kyau na karya wanda za'a iya amfani dashi akan tsarin da aka yi amfani da shi da kuma amfani da aikace-aikacen idan an iyakance shi ga ƙaramin ɓangare na jama'a.
"Domin magance barazanar yaduwar aikace-aikacen ""coronavirus"" masu yaudara ko cutarwa, Apple ya sanya takunkumi kan irin kamfanonin da za su iya ƙara aikace-aikacen da suka shafi coronavirus zuwa Shagon App, wanda zai iyakance ga kamfanonin da ke da sunan WiFi ko kuma sanannun suna".
Google da Amazon sun sanya irin wannan takunkumin.
Masu kare hakkin dan adam sun nuna damuwa game da tasirin saka idanu da yawa ta amfani da aikace-aikacen coronavirus, musamman ma saboda ɓangarorin leken asiri da aka kirkira don magance annobar coronavirus ta duniya za su lalace da zarar an kawar da barazanar.
Amnesty International da wasu kungiyoyi sama da 100 sun yi kira da a takaita irin wannan sa ido kan leken asiri.
Kungiyoyin sun sanar da sharuɗɗa takwas game da ayyukan gwamnati.
Dole ne a yi amfani da allurar rigakafi ta hanyar doka, dole ne a yi amfani da ita kuma a biya ta yadda ya kamata.
Dole ne tsawon lokacin kulawa da kulawa ya zama sakin layi na sanet;
Dole ne a iya amfani da bayanan don dalilai na COVID-19 kawai;
Tsaron bayanai da ɓoyewa suna buƙatar karewa da bayyanawa bisa ga hujja;
Dole ne a hana sarrafa dijital haɓaka nuna bambanci da tsaka tsaki;
Duk wani bayani da aka raba ga wasu ya kamata a bayyana shi ta hanyar doka;
Dole ne a sami kariya don hana cin zarafin da ake yi da kuma kare hakkin ɗan ƙasa;
"Ana buƙatar "haɗin kai mai ma'ana" na "duk masu ruwa da tsaki masu mahimmanci", gami da ƙwararrun likitocin kiwon lafiya na jama'a da ƙungiyarmu. Kungiyar Kwamfuta ta Keus ta Jamus (CCC) da 'yan jarida (Reporter Ohne Grenz) (RSF) sun ba da jerin abubuwan bincike ba tare da iyakancewa ba".
Idan ba a buƙatar shirin Google / Apple don magance matsalar sa ido na yau da kullun ba, za a iya cire sa ido daga dandamali.
Wasu ƙasashe sun yi amfani da bin diddigin ƙasa na hanyar sadarwa maimakon aikace-aikace, suna kawar da ikon saukar da aikace-aikace da hana bin diddigin.
A Isra'ila, an amince da saka idanu ta hanyar sadarwa.
Maganin yanar gizo don samun bayanai a cikin yanayin bushe yana da matsaloli masu yuwuwa.
Koyaya, ba duk tsarin da ke da sabar tsakiya bane dole ne su sami damar samun bayanan sirri na gida, an ƙirƙiri tsarin tsare sirri da yawa waɗanda ke amfani da sabobin tsakiya don sadarwa kawai (duba sashin da ke ƙasa).
A Koriya ta Kudu, an yi amfani da tsarin da ba na aikace-aikace ba don bincika lambobin sadarwa.
Maimakon amfani da aikace-aikacen da aka tsara don dalilai guda ɗaya, tsarin yana tattara bayanan waƙa daga tushe daban-daban, gami da bayanan bin diddigin wayar hannu da bayanan kasuwancin katin, kuma yana haɗa saƙonnin rubutu zuwa waɗannan mutanen da ke da cutar.
Baya ga amfani da wannan bayanan, gwamnati ta ba da damar samun bayanan wurare ga kowa, saboda canje-canje a cikin dokokin tsare sirri na bayanai saboda annobar MERS a wannan ƙasar.
Wannan bayanin yana buɗe ga jama'a ta hanyar aikace-aikace da shafukan yanar gizo da yawa. An yi la'akari da cewa ƙasashe ciki har da Jamus suna amfani da tsarin tsakiya da tsare sirri.
Tun daga 6 ga Afrilu 2020 har yanzu ba a saki cikakkun bayanai ba.
Tunani na girmama sirri da bin hanyoyin sadarwa ya kasance tun da wuri tare da tarihin bincike na ɗan adam, aƙalla tun daga 2013. A ranar 7 ga Afrilu, 2020, sun yi amfani da mafita mai girmama mutum, wanda shine Bluetooth low-power (BLE) wanda ke nuna yadda yake kusa da sauran wayoyin.
Duk da haka, PPT-PT haɗin gwiwa ne wanda ke da duka hanyoyin tsakiya da na tsaka-tsaki kuma ya ƙunshi yarjejeniya guda ɗaya, tare da haɗin yarjejeniya don bincika kariya ta sirri ta kusa da yankin (DP-PPT / DP-3T), lambobin tuntuɓar lokaci, (TCN, fka lambobin taron tuntuɓar, CEN), yarjejeniyar sirrin sirri da kuma binciken don sadarwa ta hannu (PACT) da sauransu.
Bayanan sirri da aka gano a cikin waɗannan ladabi ba za su bar na'urar ba, kuma duk abin da ya dace zai shafi na'urar.
Kungiyar Sirri a cikin MIT Media Lab, dandamali wanda ke amfani da fasahar tsare sirri yayin tattara da amfani da bayanan muhalli ko hanyar wucewa don bin diddigin yaduwar COVID-19, tana haɓaka SafePaths.
An saki Apps Gone Rogue: Tsaron Tsaro na Mutum a cikin Cutar a ranar 6 ga Maris, 2020. Wani irin wannan yunƙurin shine dandamali na SafeTrace, wani kamfani mai haɓaka fasahar tsare sirri na Ingma MPC wanda aka kafa a MIT Media Lab. "
SafeTrace ingantacciyar fasahar kayan aiki ce da ke ba masu amfani damar raba wuraren sirri da bayanan kiwon lafiya ga sauran masu amfani da hukumomi ba tare da keta sirrin bayanan ba.
A ranar 5 ga Afrilu, 2020, ƙungiyar TCN ta duniya ta kasance ta hanyar daidaitaccen tsari kuma an rarraba su tsakanin ƙungiyoyi masu haɗa ladabi, waɗanda ke ƙayyade ƙarancin sarari da ƙirƙirar ƙungiyar da za ta ba da damar daidaita aikace-aikacen da kuma faɗakarwa ta duniya.
A ranar 9 ga Afrilu, 2020, gwamnatin Singapore ta sanar da bude yarjejeniyar BlueTrace, wanda ke amfani da aikace-aikacen gwamnati na hukuma.
A ranar 10 ga Afrilu, 2020, Google da Apple, masu kula da dandamali na wayar hannu na Android da iOS, sun sanar da shirin sadarwa na kiyaye sirri bisa haɗin gwiwar fasaha mai ƙarancin ƙarfi da bayanan sirri.
Sun kuma bayyana cikakken bayani game da manyan fasahohin da aka yi amfani da su a cikin tsarin.
A cewar Apple da Google, ana shirin sakin tsarin a matakai uku:
Jerin aikace-aikacen da ke ba gwamnatoci damar ƙirƙirar aikace-aikacen bin diddigin cutar coronavirus don kiyaye sirrin sirri
Wannan aikin yana aiki kai tsaye zuwa iOS da AndroidGoogle da Apple Plan don sauƙaƙe haɗakarwa da kuma kawar da ci gaba da matsalolin sa ido ta hanyar rarraba sabuntawar tsarin aiwatarwa na farko bayan haɗarin ya wuce ta hanyar da ta dace.
Maganin magani (wanda kuma ake kira sake amfani da magani, sake rarrabawa, sake amfani da shi, ko sake kunna magani) magani ne da aka yarda da shi don sake amfani da shi daga magani na farko.
Wannan shine layin binciken kimiyya wanda ake gudanarwa a halin yanzu don samar da lafiya da ingantattun hanyoyin magance COVID-19.
Sauran fannonin bincike sun haɗa da allurar COVID-19 da kuma watsa jini. SARS-CoV-2 yana da sunadarai 66 da za su iya zama magunguna, kowannensu yana da manyan wuraren da ke da alaƙa da ligand.
Binciken waɗannan wuraren dole ya haɗa da samar da maganin rigakafin cutar mai tasiri ga furotin COVID-19.
Abubuwan da suka fi dacewa da SARS-CoV-2 sune sunadarai kamar papine, RNA mai dogaro da RNA polymers, helicyse, S-protein da ADP ribophosphatase.
Hussein A, et al sun yi nazarin wasu gungun masu neman shiga, kuma daga baya an daidaita su kuma an bincika su tare da magungunan da aka amince da su na inganci don hanzarta ci gaban magungunan rigakafin SARS-CoV-2 da aka ba da shawarar binciken asibiti.
Chlorokine magani ne na rigakafin zazzabin cizon sauro da ake amfani da shi wajen hana wasu cututtuka.
A ranar 18 ga Maris, Hukumar Lafiya ta Duniya ta sanya chlorokoquine da kuma hydrochlorokoquine da ke da alaƙa a matsayin ɗayan magunguna huɗu da ake gwadawa a cikin gwajin asibiti na haɗin gwiwa.
Gwamnan New York, Andrew Cuomo, ya sanar da cewa, za a fara gwajin chlorine da hydrochloroquine a ranar 24 ga Maris. A ranar 28 ga Maris, FDA ta amince da amfani da sulfate na hydrochloroquine da chloroxine phosphate a ƙarƙashin lasisin gaggawa (USA).
Ba a amince da maganin ba ta hanyar gwajin asibiti na FDA, kuma an yarda da shi a cikin Tarayyar Turai don amfani da shi azaman magani na gaggawa ga marasa lafiya waɗanda ba za su iya samun magani a cikin gwajin asibiti ba, duk da haka.
CDC ta ce ba a riga an ƙaddara amfani da Hydroxychloroquine don maganin prolapse ba, sashi da tsawon lokacin da za a yi amfani da shi ko maganin SARS-CoV-2.
"Ma'aikatan likitanci sun ce za su yi amfani da maganin idan "babu wani zaɓi".
Kungiyar bincike ta Turkiyya da ke birnin Istanbul na gudanar da wani karamin bincike kan amfani da sinadarin chlorine tare da zinc, bitamin A, bitamin C da bitamin D.
Ana gudanar da manyan bincike a Jami'ar Duke da Jami'ar Oxford.
Makarantar Likitancin NYU Langone tana gudanar da bincike kan amfani da ingancin aikin rigakafin hydroxychloroquine.
Gwaje-gwajen asibiti na kasar Sin a Wuhan da Shenzhen sun nuna cewa favipiravir yana da tasiri sosai.
A cikin kwanaki 4 da suka gabata, marasa lafiya 35 a Shenzhen sun sami sakamako mara kyau na gwaji, kuma daga cikin marasa lafiya 45 da ba a ba su tsawon lokacin cutar ba, kwanaki 11 ne.
A cikin binciken da aka yi a Wuhan, an yi wa mutane 240 da ke fama da cutar huhu, rabin su sun karɓi favipiravir, kuma rabin su sun karɓi umifenovir.
Hukumar Magunguna ta Italiya ta gaya wa jama'a cewa shaidar da ke yanzu game da tallafin magani ba ta da yawa kuma ba ta farko ba.
A ranar 2 ga watan Afrilu, Jamus ta ce za ta sayi maganin daga Japan kuma ta yi amfani da sojojin ta don isar da shi zuwa asibitocin jami'a don kula da marasa lafiya na COVID-19.
Shinzo Abe ya ce zai sayi maganin don tallafawa gwamnatin Trump, a cewar jaridar Morning Post ta Kudu ta kasar Sin.
Ba shi da kyau a yi amfani da shi ga mata masu ciki ko kuma waɗanda suke ƙoƙarin yin ciki.
"Bincike na maganin rigakafi na lopinavir da ritonavir / lopinavir / ritonavir (Kaletra) ya kammala cewa ""ba a sami amfani ba".
An tsara magungunan don hana cutar ta kamuwa da cutar HIV ta hanyar haɗa ta da prostate.
Kungiyoyin bincike a Jami'ar Colorado suna ƙoƙarin haɓaka magunguna don ƙirƙirar mahaɗin da ke da alaƙa da ƙwayar cutar SARS-CoV-2. Akwai zargi da yawa a cikin al'ummar kimiyya saboda kawar da hanyoyin canza magunguna da aka yi don cutar HIV/AIDS.
Hukumar Lafiya ta Duniya ta gwada Lopinvir a gwajin hadin gwiwar duniya.
Masana kimiyya sun gano cewa cutar Remdesvir tana da tasiri sosai a cikin bitro, multiple phylloxera, pneumonia, parmecto-corona da kuma kwayar cutar corona.
Wani batu na maganin rigakafi shine ci gaban juriya ta hanyar juyin halitta wanda zai haifar da cutar da ta fi tsanani da kuma yaduwar cutar.
Wasu bincike na farko sun nuna cewa Redisvir yana da iyakacin iyaka a yadda ake daidaitawa. Ana gudanar da gwaje-gwaje na asibiti da yawa, biyu a asibitocin Cleveland, ɗaya don marasa lafiya na matsakaiciyar ciwon kirji, ɗayan kuma don marasa lafiya na musamman.
Akwai jerin gwaje-gwaje na asibiti guda uku don asibitoci da marasa lafiya masu tsanani da ke da COVID-19: biyu masu sarrafawa na placebo (China, Kanada) da ɗaya mara sarrafawa (Italiya).
Gwajin maganin rigakafi azithromycin na jihar New York ya fara ne a ranar 24 ga Maris, 2020.
Cibiyar Kula da Lafiya da Lafiya ta Duniya ta Japan (NCGM) tana gudanar da gwaji na asibiti na Tejin Alvisco (Sicelsonide), wani ƙwayar cuta mai cutar asma da ke shiga cikin hanci, don kula da marasa lafiya waɗanda ba su da alamun cutar coronavirus.
Ana gudanar da gwajin ingancin magani na mataki na 2 a cikin asibitoci a Denmark, Jamus da Austria a cikin gwajin gwajin cutar na 2 na marasa lafiya 200 a cikin kulawar ciwo mai tsanani.
Masu bincike daga Cibiyar Zuciya ta Montreal, Kanada a halin yanzu suna nazarin rawar colchicine wajen rage kumburi da cututtukan huhu a cikin marasa lafiya masu fama da COVID-19.
Binciken COLCORONA ya shafi manya 6000 masu shekaru 40 zuwa sama, waɗanda aka tabbatar da cewa suna da COVID-19 kuma ba su buƙatar asibiti don samun magani.
Idan mata masu ciki ko masu shayarwa ba su da maganin hana haihuwa mai kyau, ba za su cancanta ba.
Ana gwada magungunan kashe kwayoyin cuta da yawa a Italiya.
Ana amfani da ƙananan ƙwayar ƙwayar ƙwayar cuta don magance marasa lafiya, saboda Hukumar Magunguna ta Italiya ta nemi umarni game da amfani da shi.
An sanar da yawan maganin maganin rigakafi da magungunan magani a Italiya a ranar 14 ga Afrilu, a cikin binciken da aka yi da marasa lafiya 300 da ke amfani da Enosafarin Sodium.
A matsayin cutar SARS-CoV-2, an ba da babban hankali ga kimiyya game da sake amfani da magungunan rigakafin da aka amince da su don cututtukan cututtuka kamar MERS, SARS da West Nile Virus.
Ana ba da shawarar yin amfani da ribarvirin a cikin tsarin COVID-19 na fitowar 7 na kasar Sin
Umifenovir: An ba da shawarar umifenovir don maganin COVID-19 bisa ga jagororin fitowar 7 na kasar Sin
Wasu daga cikin magungunan rigakafin da aka gano cewa za a iya sake amfani da su a matsayin maganin COVID-19 sune:
Tocilizumab (mai karɓar maganin IL-6): An amince da shi a China.
Hakanan an gudanar da gwaje-gwaje a Italiya da China. Duba Tocilizumab#COVID-19.
allurar rigakafin COVID-19 allurar rigakafin cutar coronavirus 2019 (COVID-19) ce.
Ko da yake ba a ce duk wani rigakafin da aka yi amfani da shi ya kammala gwajin asibiti ba, akwai gwaje-gwaje da yawa da ake yi don samar da irin wannan rigakafin.
A ƙarshen Fabrairu 2020, Hukumar Lafiya ta Duniya ta ce ba a tsammanin za a kai ga allurar rigakafin cutar SARS-CoV-2 watanni 18 kafin wannan cutar ta shiga ba.
'Yan takara biyar na allurar rigakafi sun kasance a cikin binciken tsaro na matakin a watan Afrilu.
An gano COVID-19 a watan Disamba na 2019.
A shekarar 2020, za a yi wani babban annoba a duniya wanda zai haifar da babban saka hannun jari da bincike don samar da allurar rigakafi.
Yawancin kungiyoyi suna amfani da kwayoyin halittar da aka buga don haɓaka alluran rigakafin SARS-CoV-2.
Rahoton CEPI, wanda aka kammala a watan Afrilu na shekarar, ya nuna cewa ci gaban sa ido yana da ƙwazo, saurin gudu, ƙarfin samarwa, daidaitawa da samun dama a duniya.
A farkon watan Afrilu na shekarar 2020, masana kimiyyar CEPI sun ruwaito cewa dandamali daban-daban na fasaha 10 suna kan bincike da ci gaba don samar da allurar rigakafi mai tasiri akan COVID-19.
Babban burin dandamali wanda aka inganta zuwa Nazarin Tsaro na I ya haɗa da:
Nucleic acid (DNA da RNA) (mai haɓaka matakin I da mai neman allurar rigakafi Moderna, mRNA-1273)
Nau'in ƙwayar cuta (nau'in I na haɓakawa da rigakafi: Cancinobiology, nau'in adenovirus 5 vector)
A watan Afrilu na shekarar 2020, masana kimiyya sun ruwaito cewa, 'yan takarar allurar rigakafi 115 suna cikin matakai na farko na ci gaba, 78 sun bayyana cewa ayyukan suna aiki (79, a cewar Cibiyar Milken), kuma 37 sun bayyana, amma an kiyasta cewa bayanan da ke cikin jama'a ba su da yawa (a matakin shiri ko zane).
Gwajin Mataki na I-II yana gudanar da gwajin rigakafi na farko da amintacce, wanda galibi ana yin saurin kai, ana bincika shi a wuri kuma ana amfani da shi a wurare da yawa don ƙayyade mafi inganci da inganci.
Gwaje-gwaje na III sun haɗa da ƙarin mahalarta, waɗanda suka haɗa da ƙungiyoyin kulawa, tasirin maganin rigakafi, kuma sakamakon mummunan sakamako saboda an ba da sashi mai yawa.
Daga cikin alluran rigakafi 79 da ake ci gaba (kamar yadda aka tabbatar a watan Afrilu na 2020), 74 ba a gwada su a kan mutum ba (har yanzu suna cikin binciken preclinical).
A ranar 24 ga Janairu, 2020, Jami'ar Queensland ta sanar da cewa, a Ostiraliya, ta yi bincike kan samar da allurar rigakafin kwayoyin cuta mai canza kwayoyin cutar don karfafa rigakafin.
A ranar 24 ga Janairu, 2020, Cibiyar Hoto ta Duniya (VIDO-InterVac) ta Jami'ar Saskatchewan ta sanar da fara aikin allurar rigakafi tare da niyyar fara gwaji a kan ɗan adam a 2021.
An bude ayyukan ci gaban allurar rigakafi a ranar 26 ga Janairu, 2020 a Cibiyar Kula da Cututtuka da Rigakafin China da Jami'ar Hong Kong a ranar 28 ga Janairu.
Kamfanonin Pharmaceutical na Janssen sun sanar da fara aikin samar da allurar rigakafi da Hanneke Schuitemaker ke jagoranta a ranar 29 ga Janairu 2020.
Johnson ya kirkiro allurar rigakafi ta baki tare da abokin aikinsa na fasaha ta zamani Vaxart.
A ranar 18 ga Maris, 2020, Emergent BioSolutions ta sanar da kafa haɗin gwiwa tare da Vaxart don samar da allurar rigakafi.
A ranar 8 ga Fabrairu, 2020, dakin gwaje-gwaje na OncoGen a Romania, ya buga wani bincike don samar da maganin rigakafi na irin wannan fasaha don maganin cutar kansa.
A ranar 25 ga Maris, cibiyar bincike ta sanar da cewa sun kammala samar da allurar rigakafi kuma sun shirya don fara gwajin su.
A ranar 27 ga Fabrairu, 2020, wani kamfanin Generex / NuGenerex Immuno-Oncology ya sanar da ƙaddamar da aikin samar da allurar peptide Ii-Key na COVID-19.
Suna son samar da gwajin allurar rigakafi wanda za a iya gwadawa a cikin kwanaki 90 a kan mutane.
A ranar 5 ga Maris, 2020, Jami'ar Washington a St. Louis ta sanar da ayyukan samar da allurar rigakafi.
A ranar 5 ga Maris, 2020, kamfanin A.A. ya sanar da cewa, a Fort Detrick, Medical Research and Materiel Command na rundunar sojin Amurka da Walter Reed Army Institute of Research a Silver Spring, duka suna yammacin Maryland, suna aiki don samun allurar rigakafi.
A ranar 10 ga Maris, 2020, Emergent Biosolutions ta sanar da fara haɗin gwiwa tare da Novavax Inc.
A cikin ci gaba da samar da allurar rigakafi.
Abokan hulɗarsu sun sanar da ƙarin bayani game da cikakken bincike da gwajin asibiti na aji na 1 na shekara ta 2020 zuwa Yuli, 2020.
A ranar 12 ga Maris, 2020, Ma'aikatar Lafiya ta Indiya ta sanar da cewa tana aiki tare da sassauƙa 11. Duk da haka, ta sanar da cewa zai ɗauki aƙalla shekara ɗaya da rabi zuwa shekaru biyu don samar da allurar rigakafi cikin sauri.
A ranar 12 ga Maris, 2020, kamfanin kimiyyar halittu mai suna Mediggo, da ke birnin Quebec, Quebec, ya ba da rahoton ƙaddamar da wani shiri na kama da cutar coronavirus wanda aka tallafawa daga cibiyoyin kiwon lafiya na Kanada.
Za a yi gwajin mutum a cikin dakin gwaje-gwaje a watan Yuli ko Agusta 2020.
A farkon wannan makon, jaridar The Guardian ta ruwaito cewa Shugaba Donald Trump ya ba da babbar kudade ga Kurvak don allurar rigakafin Covid-19, kuma gwamnatin Jamus ta yi watsi da hakan.
A ranar 17 ga Fabrairu, 2020, kamfanin magunguna na Amurka Pfizer ya sanar da cewa ya yi aiki tare da kamfanin Jamus BioNTech don yin aiki tare don yin allurar da ta dogara da mRNA.
BNT162, wanda ya zama mai neman allurar rigakafi bisa mRNA, yana cikin gwajin gwaji na farko a halin yanzu, tare da gwaji na asibiti wanda aka sa ran farawa a watan Afrilu 2020.
Kamfanin fasahar kere kere na Italiya, Italy A.A. ya sanar a ranar 17 ga Maris, 2020, cewa za a samu sakamakon gwajin asibiti na farko a watan Afrilu na shekarar 2020 kuma za su iya fara gwajin gwajin rigakafin su na karshe a kan mutane.
A Faransa, a ranar 19 ga Maris, 2020, Cibiyar Innovation for Prepared Immunity (CEPI) ta saka hannun jari na dala miliyan 4.9 don bincike kan allurar COVID-19, wanda ya haɗa da Institut Pasteur, Thames Biosciences (Vienna, Austria) da Jami'ar Pittsburgh.
Sauran abokan haɗin gwiwar CEPI don haɓaka allurar rigakafin COVID-19 sune Moderna, Curacao, Inovacio, Novavax, Jami'ar Hong Kong, Jami'ar Oxford da Jami'ar Queensland.
A ranar 20 ga Maris, 2020, masu binciken Rasha sun sanar da cewa sun fara bincike kan alluran rigakafi daban-daban guda shida a kan dabbobi.
Masu binciken Kwalejin Imperial na London sun sanar da cewa a ranar 20 ga Maris, 2020 A.A., za su ci gaba da samar da allurar RNA don COVID-19.
An shirya takarar rigakafi a cikin kwanaki 14 bayan an karɓi umarnin daga China.
A ƙarshen Maris, Gwamnatin Kanada ta sanar da cewa za ta tallafawa ayyukan bincike 96 na C$275 miliyan na Kanada don gwajin likita akan COVID-19, gami da masu neman allurar rigakafi da yawa a kamfanoni da jami'o'i na Kanada kamar su Medicago da Jami'ar Saskatchewan gwaje-gwaje.
A daidai wannan lokacin, gwamnatin Kanada ta sanar da cewa ta ba da C$192 miliyan don haɓaka allurar rigakafin COVID-19 kuma Bankin Allurar rigakafi na kasa zai yi aiki don alluran rigakafi daban-daban, don hana wani barkewar cutar coronavirus.
"A ranar 2 ga Afrilu, 2020, masu binciken Jami'ar Pittsburgh School of Medicine sun ba da rahoton gwajin rigakafin PittCoVacc wanda zai iya faruwa a cikin beraye, suna ba da sanarwar cewa ""akwai maganin rigakafin cutar da aka gano a cikin beraye bayan makonni 2 na allurar rigakafin SARS-CoV-2 S1 bayan makonni 2 na allurar rigakafin".
A ranar 16 ga Afrilu, 2020, Jami'ar Waterloo ta Kamfanin Magunguna a Kanada ta sanar da ƙirar allurar rigakafin da ke dogara da kwayoyin halitta wanda za a iya amfani da shi a hanci.
Ana amfani da kwayoyin cuta don yin amfani da DNA a cikin kwayoyin mutum don samar da ƙwayoyin cuta masu kama da kwayar cuta waɗanda ba su da lahani waɗanda ke kunna tsarin rigakafin jiki don samar da rigakafi ga cutar SARS-CoV-2.
A watan Maris na 2020, gwamnatin Amurka, masana'antu da jami'o'i uku sun haɗa kudaden da suka samu don siyan manyan kwamfutoci daga IBM, wanda ya kawo kayan aikin sarrafa kwamfuta daga Hewlett Packard Enterprise, Amazon, Microsoft da Google.
Wasu alluran rigakafi suna da iyakantaccen sakamako, wanda ake kira sakamako mara iyaka.
Wannan yana nufin cewa suna da amfani fiye da rigakafi.
A Ostiraliya, ana neman ƙarin bincike na bazuwar don yin rajistar ma'aikatan kiwon lafiya 4,170.
Magungunan da ake ci gaba da yi na iya zama marasa aminci ko kuma marasa tasiri.
Bincike game da ingancin allurar rigakafi na samfurin dabba da ke da alaƙa da COVID-19, kamar su beraye masu canzawa na ACE2, sauran dabbobi na gwaji, da sauran tsutsotsi waɗanda ba mutane ba, ya nuna cewa akwai buƙatar lokaci don amfani da ƙwayoyin cuta masu aminci na Tier 3 da kuma haɗin gwiwar duniya don amfani da matakan tsaro na yau da kullun.
An gwada alluran rigakafin SARS da MERS a cikin samfuran dabbobi waɗanda ba na mutum ba.
A shekarar 2020, babu magani ko rigakafin cutar SARS, wanda aka yi la'akari da cewa yana da lafiya da tasiri ga mutane.
A cewar takardun bincike da aka buga a 2005 da 2006, UAE ta kasance a gaba ga gwamnatoci da hukumomin kiwon lafiya a duniya don ganowa da haɓaka sabbin alluran rigakafi da magunguna don magance SARS.
A lokacin da cutar ta MERS ta fara, an yi imanin cewa binciken SARS na yanzu zai iya samar da allurar rigakafi mai amfani da kuma samar da magani ga MERS-CoV.
A watan Maris na shekarar 2020, allurar rigakafin MERS guda ɗaya (wanda ya dogara da DNA) ta kammala gwajin asibiti a cikin mutane, kuma wasu uku suna kan aiki, dukansu allurar rigakafin da ke dauke da cutar, biyu masu daidaitawa (ChAdOx1-MERS, BVRS-GamVac) da kuma wanda aka tsara MVA (MVA-MERS-S).
Sakonnin kafofin sada zumunta sun haifar da ka'idar da ke haifar da kwayar cutar a bayan COVID-19 da kuma tunanin cewa akwai riga an riga an sami allurar rigakafi.
Labarai a shafukan sada zumunta daban-daban sun nuna cewa akwai takardun mallaka na wasu nau'ikan coronavirus kamar SARS coronavirus da alluran rigakafi.
Cutar Coronavirus 2019 (COVID-19) cuta ce mai yaduwa da ke haifar da cutar ta hanyar cutar ta hanyar numfashi mai tsanani ta hanyar cutar ta hanyar cutar ta hanyar numfashi ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar ta hanyar ta hanyar ta hanyar ta hanyar ta hanyar ta hanyar ta hanyar ta hanyar ta hanyar ta hanyar ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta
Alamomin da aka fi sani sun haɗa da zazzabi, tari da rashin numfashi.
Sauran alamun sun haɗa da gajiya, ciwon tsoka, ciwon ciki, ciwon wuya, rashin wari, da kuma ciwon ciki.
A lokacin da aka fara bayyanar cututtuka, ana iya ɗaukar kwanaki biyu zuwa goma sha huɗu zuwa kwanaki biyar.
Ko da yake yawancin cututtuka suna haifar da alamun bayyanar cututtuka, an sami wasu ci gaba a cikin cutar kumburi da kuma yawan kwayoyin halitta.
Tun daga ranar 17 ga Afrilu, 2020, an ba da rahoton fiye da shari'o'i miliyan 2.24 daga kasashe da yankuna sama da 210 kuma an kashe sama da 153,000.
Fiye da mutane 568,000 ne suka warke daga cutar. Ana iya samun kamuwa da ita ta hanyar yin magana da mutane, kamar ta hanyar yin magana da mutane ko kuma ta hanyar yin magana da su.
A lokacin da aka numfasa, waɗannan saukad da sukan sauka a ƙasa ko a jikin mutum maimakon su yi nisa.
Hakanan mutane na iya auna su ta hanyar taɓa ƙasa mai ƙazanta sannan ta taɓa idanunsu, hanci ko bakinsu.
A wurare masu bushe, cutar tana iya wucewa har zuwa awanni 72.
Yana da matukar yaduwa a cikin kwanaki uku na farko bayan bayyanar cututtuka, kodayake ana iya watsa shi kafin bayyanar cututtuka da kuma bayan matakan cutar (rRT-PCR) daga nasopharyngeal cuta.
Ana ba da shawarar cewa waɗanda suke da tabbacin cewa suna da cutar da kuma masu kula da su su yi amfani da abin rufe fuska.
Shawarwarin amfani da abin rufe fuska ga jama'a na iya bambanta, wasu hukumomi suna ba da shawarar yin amfani da shi, wasu suna son yin amfani da shi, wasu kuma suna son yin amfani da shi.
A halin yanzu babu allurar rigakafi ko magani na musamman na COVID-19.
An samu yaduwar cutar a yankin a mafi yawan yankuna shida na Hukumar Lafiya ta Duniya.
Mutane da suka kamu da cutar za su iya nuna alamun kamuwa da cutar kamar zazzabi, tari, gajiya, da kuma rashin numfashi.
Alamu na gaggawa sun haɗa da rashin numfashi, ciwon kirji ko matsa lamba, rikicewa, rashin jin daɗi, da kuma launin shuɗi a fuska ko a lebe.
Sau da yawa, alamun numfashi na sama suna bayyana kamar fashewa, hanci ko rauni a wuya.
A cikin kashi daban-daban na alamun cututtukan ciki, kamar kumburi, ƙwanƙwasawa da kuma ciwon baya.
A kasar Sin, an fara gabatar da wasu lokuta ne kawai game da rufe ƙirjin da kuma cututtukan jiki.
A wasu, cutar tana iya kaiwa ga ciwon huhu, ƙwayar cuta da mutuwa.
Wannan lokaci ne da ake kira lokacin da ake nuna alamun cutar.
Lokacin haifuwa na COVID-19 yawanci kwanaki biyar zuwa shida ne amma zai iya kaiwa kwana biyu zuwa 14.
Kashi 97.5% na mutanen da ke nuna alamun cutar suna nuna alamun a cikin kwanaki 11.5 daga ranar kamuwa da cutar.
Ba a san cikakken matsayin masu dauke da cutar ba, amma an gano cewa suna iya taimakawa wajen yaduwar cutar.
Yawan mutanen da ba su da alamun cutar a halin yanzu ba a san su ba kuma ana nazarin su, kamar yadda Cibiyoyin Kula da Cututtuka da Rigakafin Koriya (KCDC) suka ruwaito, kashi 20 cikin dari na shari'o'in da aka tabbatar sun kasance ba a san su ba yayin da suke asibiti.
Hukumar Lafiya ta kasar Sin ta hada da cututtuka na farko a cikin al'amuran da suka faru a ranar 1 ga Afrilu, ciki har da na mutum. 130 (78%) na kamuwa da cututtuka 166 a wannan ranar sun kasance iri ɗaya a lokacin gwajin.
Dukansu acta da albasa na iya ɗaukar nauyin ƙwayoyin cuta masu yawa.
Sautin da aka yi da ƙarfi ya fi yawan sautin da aka yi.
Wani bincike da aka yi a Singapore ya nuna cewa idan ba a rufe su ba, za su iya sa ruwa ya yi tsayi har zuwa mita 4.5 (15).
Ko da yake cutar ba ta cikin iska ce gaba ɗaya ba, an sami damar watsa ta ta hanyar BioAerosol na National Academy of Sciences kuma masu tattara iska suna ba da sakamako mai kyau ga RNA na cutar a cikin hanyar wucewa a waje da ɗakunan mutane.
Wasu hanyoyin magani kamar su ma'auni da kuma bugun jini na zuciya (CPR) na iya sa numfashi ya shiga iska kuma ya bazu cikin iska.
Ko da yake akwai barazanar yaduwar cutar ta hanyar cutar, ana ganin cewa wannan haɗarin ba shi da yawa.
Cibiyar Tsaro da Kula da Cututtuka ta Turai (ECDC) ta ce ba a san yadda cutar za ta iya yaduwa ba, amma mutum ɗaya yakan kamu da mutane biyu zuwa uku. Kwayar tana rayuwa na awanni da kwanaki a wuraren da ba su da ruwa.
Musamman, an gano cutar a cikin kwali na tsawon awanni huɗu, tare da filastik (polypyllinine) da bakin karfe (AISI 304) da 99% jan ƙarfe.
Duk da haka, wannan ya bambanta dangane da zafi da zafin jiki.
Sabulu da kuma tsabtace ruwa suna da tasiri idan aka yi amfani da su yadda ya kamata. Samfurori na sabulu suna lalata, lalata, da kuma kawar da fata da sauran abubuwa.
Sauran magunguna kamar benzodiazepine chloride da chlodehydrine gluconate (mai hana tiyata) ba su da tasiri. A cikin binciken Hong Kong, an ɗauki samfurin samfurin matsakaici kwanaki biyu bayan fara asibiti.
Na farko daga cikin marasa lafiya shida ya nuna mafi girman nauyin kwayar cutar, na shida kuma ya nuna mafi girman nauyin kwayar cutar a ranar biyu da aka bincika mai haƙuri.
Cutar huhu mai tsanani Coronavirus 2 (SARS-CoV-2) sabon cuta ce ta huhu mai tsanani, wanda aka fara gano mutane uku a cikin ruwa tare da cututtukan huhu masu tsanani.
Dukkanin halaye na kwayar cutar SARS-CoV-2 na Novel suna faruwa ne a cikin yanayin coronavirus.
A waje da jikin mutum, ana kashe kwayar ta da sabulu na gida, wanda ke karya rigakafinta. SARS-CoV-2 yana da alaƙa da SARS-CoV na farko.
Fushi sune mafi yawan abubuwan da COVID-19 ke shafa, saboda kwayar cutar tana samun ƙwayoyin mai karɓar baƙi ta hanyar enzyme angostine enzyme 2 (ACE2), wanda yake da yawa a cikin ƙwayoyin alveolar II a cikin huhu.
Kwayar cutar tana amfani da wani nau'i na musamman na peplomer (mai ƙwayoyin cuta) don yin hulɗa da ACE2 da shiga cikin ƙwayoyin mai masaukin.
A cikin asibitocin Wuhan, China, kashi 12 cikin 100 na mutanen da suka kamu da cutar sun kamu da ciwon zuciya na gaggawa.
A yayin ci gaban cutar, alamun jijiyoyin zuciya suna da girma saboda amsawar kumburi da matsalolin tsarin rigakafi, amma mummunan lalacewar zuciya yana da alaƙa da masu karɓar ACE2 a cikin zuciya.
Ana nuna masu karɓar ACE2 sosai a cikin zuciya kuma suna shiga cikin aikin zuciya.
A cikin marasa lafiya na ICI da ke da kamuwa da COVID-19, an gano babban jijiyar jini (31%) da kuma jini mai zubar da jini (25%) kuma yana iya kasancewa tare da prostate. An gano cewa mutuwar mutane da COVID-19 ta haifar da cutar alveolar ta atomatik (DAD), da kumburi a cikin huhu.
Kodayake SARS-COV-2 yana da mahimmanci ga ƙwayoyin numfashi waɗanda ke bayyana ACE2 don bayyana numfashi, marasa lafiya masu fama da COVID-19 suna da alamun hawan jini na yau da kullun.
Musamman, an gano cewa kwayoyin cuta na GM-CSF-t-cell suna da alaƙa da ɓoyewar ƙwayar cuta na IN-6 da kuma mummunan cututtukan huhu a cikin marasa lafiya na COVID-19.
An kuma bayar da rahoton kamuwa da cutar lymphocytic a cikin binciken gawawwakin.
Hukumar lafiya ta duniya ta wallafa wasu takardun gwaji don magance cutar.
Hanyar gwaji ta yau da kullun ita ce amsa sarkar polymerase mai ɗaukar hoto (rRT-PCR).
Ana gwada shi a kan samfurori na numfashi da ke cikin nasopharyngeal swab.
Sakamakon zai kasance cikin 'yan sa'o'i kaɗan zuwa kwanaki biyu.
Ana iya amfani da gwajin jini, amma ana buƙatar samfuran jini biyu na makonni biyu a gefe kuma sakamakon ba shi da mahimmanci.
Masana kimiyya na kasar Sin sun gano cutar coronavirus kuma sun buga jerin zuriya don haka dakunan gwaje-gwaje a duk duniya za su iya ci gaba da gwajin polymerase chain reaction (PCR) daban-daban don nazarin kamuwa da cutar.
A ranar 4 ga Afrilu, 2020, gwajin rigakafin cutar (wanda zai iya gano kamuwa da cuta mai tsanani kuma idan mutum ya kamu da cutar a baya) yana ci gaba, amma har yanzu ba a amfani da shi sosai ba.
Kwarewar da 'yan kasar Sin ke da ita a kan bincike ta nuna cewa kashi 60 zuwa 70% ne kawai ke da gaskiya.
FDA a Amurka ta amince da gwajin farko na kulawa a ranar 21 ga Maris, 2020. Jagoran gwajin da aka fitar a asibitin Zhongnan na Jami'ar Wuhan sun nuna hanyoyin gano kamuwa da cuta bisa ga halaye na asibiti da haɗarin mura.
Abubuwan da aka yi amfani da su a cikin gilashin ƙasa na biyu na biyu suna da yawa tare da yaduwar baya, asali da baya kafin kamuwa da cuta.
Ana iya ganin ƙananan girman kai, kumburi (ciki na lobular septal tare da cika alveolar mai canzawa), da kuma karfafawa yayin da cutar ta ci gaba.
Akwai wasu bayanai game da ƙananan raunuka da kuma canje-canjen da ke faruwa a cikin cutar COVID-19.
Babban binciken da aka samu a jikin mutum:
Ƙarƙashin ƙwayar cuta, ƙwayar pericarditis, ƙuntatawa da kumburi
Ana iya gano nau'ikan cutar sankara guda huɗu:
Ƙaramin ƙwayar cuta: ciwon huhu, ciwon huhu, ciwon kumburi, ƙwayar lymphoma, da kuma ciwon daji mai girma a tsakiyar
Rashin ƙwayar huhu: Rashin ƙwayar ƙwayar cuta (DAD) yana yadawa tare da yaduwar ƙwayar cuta.
DAD shine tushen cutar ta hanyar numfashi mai tsanani (ARDS) da kuma matsanancin hyposemia.
Warkar da huhu: Bayyanawa a cikin cibiyar fibrosis tsakanin rami na alveolar da huhu
jini: rarraba jini na intravascular coagulation (DIC); amsa ta leukoerythroblastic
Don rage haɗarin kamuwa da cutar, matakan kariya sun haɗa da kasancewa a gida, kauce wa wuraren da ke da mutane da yawa, wanke hannuwanku da sabulu da ruwa na akalla sakan 20, kula da tsabtace numfashi da kuma guje wa taɓa idanu, hanci ko hanci da hannaye marasa wanka.
CDC ta ba da shawarar yin amfani da murfin da hanci a lokacin da ake yin sutura ko kuma yin sutura, kuma a cikin ɗakin da ba a yi sutura ba.
Bayan duk wani tari ko kuma numfashi, ana bada shawara a tsabtace hannayenmu sosai.
CDC ta ba da shawarar yin amfani da sutura a wuraren taron jama'a don rage yaduwar mutum idan mai ɗaukar cutar ne. Dabarun nisantar zamantakewa dabarun rage hulɗa da masu cutar a cikin manyan ƙungiyoyi ta hanyar rufe makarantu da wuraren aiki, iyakance tafiya da soke manyan tarurruka.
Dokokin nesa sun haɗa da kiyaye mutane aƙalla mita 6.
"Babu magani da aka sani yana da tasiri wajen hana COVID-19". Kamar yadda ba a sa ran allurar rigakafi ba har zuwa 2021, wani muhimmin ɓangare na gudanar da COVID-19 yana ƙoƙarin rage barkewar cutar da ake kira ""rage yaduwar cutar".
CDC ta kuma ba da shawarar cewa mutane su wanke hannayensu da sabulu da ruwa na akalla dakika 20, musamman bayan sun shiga gidan wanka ko idan hannayensu sun bayyana a fili, kafin su taɓa hanci da kuma wanke ko kafin da kuma bayan cin abinci.
WHO ta ba da shawarar yin amfani da wanke hannu da giya a cikin akalla kashi 60% na giya, idan sabulu da ruwa ba su da sauƙi. A wuraren da ba a iya samun kayan tsabtace hannu a kasuwa, WHO ta ba da takardu biyu don samar da muhalli.
A cikin waɗannan ƙwayoyin, maganin rigakafi ya fito ne daga ethanol ko isosopropanol.
Hydrogen peroxide shine maganin kashe kwayoyin cuta a cikin giya; ba shine mai aiki na maganin hana kwayar cutar hannu ba.
An ƙara glycerol a matsayin mai ƙonawa.
Mutane suna ba da gudummawa ta hanyar taimakon kuɗi, wanda zai iya haɗa da magani na ruwa, taimakon oxygen, da sauran sassan jiki da kuma tallafawa waɗanda suka ji rauni.
CDC ta ba da shawarar cewa mutanen da suka yi imanin cewa suna da kwayar cutar su sa abin rufe fuska mai sauƙi.
An yi amfani da maganin oxygenation na artificial (ECMO) don magance matsalar numfashi, amma har yanzu ana ganin fa'idodi.
Ana ba da shawarar tsabtace mutum da salon rayuwa mai kyau da abinci mai gina jiki don inganta rigakafin cututtuka.
Maganin tallafi na iya zama da amfani ga mutanen da ke da alamun bayyanar cututtuka a farkon matakin cutar. Hukumar Lafiya ta Duniya da Hukumar Lafiya ta Kasa ta China sun ba da shawarwari don kula da mutanen da ke asibiti a cikin COVID-19.
Likitoci da likitocin huhu a Amurka sun amince da shawarwarin likita daga hukumomi daban-daban don amfani da IBCC, tushen bayanan kyauta.
A.A. Har zuwa Afrilu 2020, babu wani magani na musamman don COVID-19.
Don gwaji, wasu likitoci suna ba da shawarar yin amfani da paputamol (acuminanone) don amfani da layi na farko dangane da ibuprofen.
Ya kamata a yi hankali don rage haɗarin yaduwar kwayar cutar yayin aiwatar da ayyukan samar da iska kamar numfashi na ciki ko na hannu.
Kwararrun likitocin kiwon lafiya da ke kula da mutanen da ke fama da COVID-19 CDC sun ba da shawarar cewa ban da yin amfani da matakan tsaro na yau da kullun, matakan tsaro da kuma kulawar iska, a shigar da mutumin a cikin Rukunin Tserewa na Cutar Cutar Cutar (IRR). CDC ta ba da umarnin amfani da kariya ta sirri.
Kayan aikin da aka ba da shawarar: PPE tufafi, kayan numfashi ko fuska, kayan kariya ga idanu da safar hannu. Idan an samu, ana fi son numfashi (a maimakon rufe fuska).
An amince da kayan numfashi na N95 don saitunan masana'antu amma FDA ta amince da su a matsayin abin rufe fuska don amfani a ƙarƙashin lasisin Amfani da Gaggawa (EUA).
An tsara su don kare su daga ƙwayoyin iska kamar ƙura, amma ba a ba da tabbacin inganci a kan takamaiman wakili na halitta don sabis ɗin da ke waje da bayanin samfurin ba.
Idan babu abin rufe fuska, CDC ta ba da shawarar yin amfani da abin rufe fuska ko amfani da abin rufe fuska na gida a matsayin zaɓi na ƙarshe.
Yawancin cutar COVID-19 ba ta da tsanani kamar yadda take buƙatar motsa iska na inji ko zaɓuɓɓuka, amma ƙananan lalacewar suna da tsanani.
Ana nazarin nau'in numfashi na mutane masu fama da matsalar numfashi da ke da alaƙa da COVID-19 a cikin asibiti, ana iya kawar da ciwon ta hanyar babban numfashi ko matsin iska mai kyau na biyu.
Ba a san ko waɗannan abubuwa biyu sun amfane shi a irin wannan yanayin ba.
Wasu likitoci suna amfani da na'urar numfashi mai ƙarfi a lokacin da suke wurin, domin iska mai sarrafawa tana rage yawan kwayoyin halitta fiye da na'urar numfashi mai tsawo.
Kasashe da yawa masu tasowa ba su da isasshen gadajen asibiti a kowane mutum, wanda yawan marasa lafiya masu cutar COVID-19 da ke buƙatar kula da su a asibiti ya rage ikon tsarin kiwon lafiya.
Wani bincike a kasar Sin ya nuna cewa kashi 5 cikin 100 na mutanen da ke cikin gidajen kula da marasa lafiya sun shiga cikin dakunan kula da marasa lafiya, kashi 2.3 cikin 100 na mutanen da ke bukatar taimakon iska, kuma kashi 1.4 cikin 100 sun mutu.
Kashi 30% na mutanen da ke asibiti a China da ke dauke da COVID-19 za su shiga ICU.
Rashin damuwa na numfashi mai saurin gaske (ARDS) zai zama mai rikitarwa yayin da COVID-19 ke ci gaba da zama mai wahala kuma iska ta zahiri ta zama mai rikitarwa yayin da oxygen ke ƙara wahala.
Ana buƙatar haɓaka isar da iskar oxygen yayin da iska mai iska mai ƙara yanayin kula da matsin iska da kuma PEEP mai girma ke rage haɗarin cutar huhu da cutar huhu da ke tattare da numfashi.
A cikin iska mai iska mai ƙarfi, ba za a iya samun PEEP mai yawa ba.
An fara binciken hanyoyin da za a iya magance su a watan Janairun 2020, kuma ana gwada magungunan rigakafin cutar da yawa a asibiti.
Remdesivir yana da ban sha'awa sosai.
Ko da yake ana iya ɗaukar sabbin magunguna har zuwa 2021, yawancin magungunan da ake gwadawa sun riga an amince da su don wasu ayyuka ko kuma suna cikin gwaji na gaba.
Ana iya gwada maganin rigakafi a kan waɗanda suke da ciwo mai tsanani.
Hukumar Lafiya ta Duniya ta ba da shawarar cewa a yi aiki da yardar rai da kuma shiga cikin gwajin inganci da aminci na hanyoyin magani waɗanda zasu iya zama masu tasiri. FDA ta ba da izinin gwajin FDA na wucin gadi idan rayuwar mutum ta kasance cikin haɗari mai tsanani ko kuma cikin haɗari nan take.
Bai bincika nazarin asibiti da ake buƙata don tabbatar da cewa cutar tana da lafiya da tasiri ba.
A watan Fabrairun shekarar 2020, kasar Sin ta kaddamar da wani aikace-aikacen wayar hannu don magance annobar.
Ana buƙatar masu amfani su shigar da sunayensu da lambar ID.
Aikace-aikacen na iya samun 'taɓawa ta kusa' ta amfani da bayanan leken asiri, don haka ya bambanta yiwuwar kamuwa da cutar.
Kowane mai amfani zai iya bincika yanayin wasu masu amfani uku.
Idan aka gano wani hatsari, app ɗin ba kawai yana gargadin keɓewa ba, har ma da hukumomin kiwon lafiya na gida. Ana amfani da bayanan fuska a kan bayanan wayar hannu, fasahar gano fuska, bin diddigin wayar hannu da kuma hankali na wucin gadi don bin diddigin waɗanda suka kamu da cutar da su da kuma su. An samo su a Koriya ta Kudu, Taiwan da Singapore.
A watan Maris na shekarar 2020, hukumomin tsaro na gwamnatin Isra'ila sun ba da damar bin diddigin wayar salula na mutanen da ake zargi da kamuwa da cutar coronavirus.
An dauki matakai don ganowa da kare wadanda zasu iya tuntuɓar 'yan ƙasa da suka kamu da cutar.
A watan Maris na shekarar 2020, kamfanin dillancin labarai na Deutsche Telekom ya kuma ba da bayanan da aka inganta na wayar tarho ga Cibiyar Robert Koch ta Jamus, wata hukumar gwamnatin tarayya don bincike da hana yaduwar cutar.
Rasha ta yi amfani da fasahar gano fuska don gano wadanda ba a keɓe su ba.
Kwamishinan lafiya na yankin Italiya Giulio Gallera ya ce, kashi 40 cikin dari na mutane sun ci gaba da motsawa ta kowace hanya, in ji masu amfani da wayoyin hannu.
Gwamnatin Jamus ta gudanar da binciken na tsawon sa'o'i 48 a karshen mako tare da masu halarta sama da 42,000.
Shugaban Estonia Kersti Kaljulaid ya kuma yi kira ga kasashen duniya da su kirkiro hanyoyin magance yaduwar cutar korona.
Mutane suna iya fuskantar haɗarin kasancewa a waje, ƙuntatawa a tafiya, cututtukan da ake samu daga magani ko kuma kamuwa da cutar.
BBC ta yi magana da Rory O'Connor, yana cewa: "Kasuwanci, kadaici, damuwa game da lafiya, damuwa da koma bayan tattalin arziki sune cikakkiyar raƙuman ruwa wanda ke lalata lafiyar hankali da lafiyar mutane".
Sauran cututtukan da suka fi kama da cututtukan numfashi, kamar mura, suna iya zama marasa ƙarfi kuma ba su da alamun bayyanar cututtuka.
Sau da yawa, ana warkar da marasa lafiya a cikin makonni biyu, amma ana iya ɗaukar makonni uku zuwa shida kafin a warke idan an sami ciwo mai tsanani ko kuma na tsanani.
Dangane da sauran irin wannan ƙwayoyin cuta kamar SARS da MERS, mata masu ciki na iya samun haɗarin kamuwa da COVID-19 mai tsanani, amma ba tare da bayanai game da COVID-19 ba. A wasu mutane, COVID-19 na iya haifar da cutar sankara ta hanyar kai wa shamfu hari.
A cikin mutanen da suka fi fama da COVID-19, COVID-19 na iya haifar da matsalar numfashi mai sauri, barazanar mutuwa ko rashin ƙarfi zuwa cututtukan numfashi na gaggawa (ARDS).
Matsalolin da ke tattare da COVID-19 sun haɗa da cutar sepsis, rashin lafiyar hanji da kuma lalacewar zuciya, koda da hanta.
Rashin lafiyar koda, musamman karuwar lokacin furotin, ya shafi kashi 6% na mutanen da aka kwantar da su asibiti dangane da COVID-19, kuma an sami aikin koda mara kyau a cikin kashi 4% na wannan rukuni.
Kimanin kashi 20 zuwa 30% na mutanen da aka yi wa COVID-19 cutar suna da ƙwayoyin cuta na hanta (transaminases).
A cewar wannan rahoton, matsakaicin lokacin da ake tsakanin alamun farko da mutuwa ya kasance kwanaki goma, daga cikinsu kwana biyar suna cikin asibiti.
Duk da haka, marasa lafiya da aka tura zuwa ICU suna da matsakaici na kwanaki bakwai tsakanin rashin lafiya da mutuwa.
A cikin shari'o'in da suka gabata, binciken ya kasance kusan kwanaki 14 a cikin yanayin kwanaki shida zuwa 41 daga tsakiyar bayyanar alamun farko zuwa mutuwa.
A wani bincike da Hukumar Lafiya ta Kasa ta kasar Sin (NHC) ta gudanar, mace-mace sun yi kashi 1.7% na mace-mace, maza kuma sun yi kashi 2.8%.
Binciken tarihi na samfurori na huhu na bayan mutuwa ya nuna lalacewar fiber na hannu a cikin huhu biyu.
An lura da canje-canje na cytopathic na kwayar cuta a cikin ƙwayoyin cuta.
Hoto na huhu yana kama da ciwon hanzari na numfashi (ARDS).
Hukumar Lafiya ta kasar Sin ta ce kashi 11.8 cikin 100 na mutuwar da aka samu, cutar zuciya ce ta fi tsanani.
A cewar wani rahoto na watan Maris a Amurka, kashi 89 cikin dari na mutanen da aka kwantar da su a asibiti suna da yanayin da ya kamata.
Yanayin mutuwa ya bambanta dangane da yanayin, saboda bambancin yankuna, amma zai iya zama saboda matsalolin tsarin.
Idan aka ƙidaya ƙananan abubuwa, zai iya ƙara yawan mutuwar.
Amma, an yi la'akari da cewa mutuwar ta ragu sosai domin an yi amfani da su a dā.
Masu shan sigari suna da damar samun alamun COVID-19 mai tsanani sau 1.4 kuma suna buƙatar kulawa mai yawa ko kusan sau 2.4 idan aka kwatanta da masu shan sigari.
Jami'an asibitin Hong Kong sun tabbatar da cewa an rage yawan maganin samba daga kashi 20 zuwa 30% a wasu mutanen da suka warke daga cutar, kuma an gano cewa sun sami rauni a jikin su ta hanyar binciken.
Wannan zai iya haifar da alamun cutar bayan an sake dawowa.
A watan Maris na shekarar 2020, ba a san ko kamuwa da cutar ta baya zai ba da damar yin nasara da tsayayya da cutar ga waɗanda suka tsira daga cutar ba.
Ana ganin yanayin kamuwa da cutar dangane da halayen sauran coronavirus, amma daga baya an ba da rahoton cewa an gwada tabbataccen kwayar cutar bayan an dawo da COVID-19.
An yi imanin cewa waɗannan cututtukan suna daɗa muni maimakon sake warkewa.
Ana ganin cewa kwayar cutar ta samo asali ne daga halitta da dabba ta hanyar kamuwa da cutar da aka yi ta halitta da kuma ta hanyar kamuwa da cutar.
Ba a san ainihin asalinsa ba, amma har zuwa Disamba 2019, cutar za ta bazu gaba ɗaya daga mutum zuwa mutum.
Janairu 2020 na farko da aka buga a Lanet, binciken farko na COVID-19 41 da aka tabbatar sun nuna cewa ranar 1 ga Disamba, 2019 ita ce ranar fara bayyanar cututtukan.
Hukumar lafiya ta duniya ta ruwaito cewa an fara nuna alamun cutar tun daga ranar 8 ga watan Disamba na 2019.
An yi amfani da matakan da suka dace don auna yawan mutuwar.
Waɗannan lambobin suna bambanta ta yanki da lokaci kuma suna shafar halayen al'umma kamar girman gwaji, ingancin tsarin kiwon lafiya, zaɓuɓɓukan magani, farkon annobar, da shekaru, jinsi da lafiyar gaba ɗaya.
A ƙarshen 2019, an ba da lambar U07.1 don mutuwar gaggawa na ICD-10 don cutar SARS-CoV-2 da aka daidaita a cikin dakin gwaje-gwaje da lambar U07.2 don gwajin COVID-19 wanda ke nazarin asibiti ko cututtuka masu alaƙa da cutar SARS-CoV-2 da aka tabbatar ba tare da dakin gwaje-gwaje ba.
Dangane da kididdigar Jami'ar Johns Hopkins, A.A. ya kai kashi 6.9% na mutuwar duniya tun daga ranar 17 ga Afrilu, 2020 (153,822/ 2,240,191).
Sauran matakan sun haɗa da yawan mutuwar mutum (CFR) da yawan mutuwar kamuwa da cuta (IFR), wanda ke nuna yawan mutanen da suka mutu daga cutar (mai magani da waɗanda ba a yi musu magani ba) da ke mutuwa daga cutar.
Kuma ba a da iyakanceccen lokaci ba, har sai an yanke shawarar yin allurar rigakafi ga wasu mutane.
Ko da yake duk waɗanda ke da cutar suna da tsarin rigakafi, kasancewa da tsarin rigakafi na iya ba da bayani game da yawan mutanen da ke da cutar.
A wani karamin gari da ke Castiglione d'Adda, inda mutane 4,600 ke zaune, a Italiya, mutane 80 (1.7%) sun mutu a tsakiyar annobar.
A Gangelt, cutar ta bazu a shirye-shiryen Carnival, kuma ta bazu cikin matasa, tana haifar da ƙananan mutuwar, saboda haka duk mutuwar COVID-19 ba za a iya rarraba su ba a wannan yanayin.
Bugu da ƙari, tsarin kiwon lafiya na Jamus bai wuce ƙarfinsa ba.
A cikin Netherlands, kashi 3 cikin 100 na masu ba da jini sun kiyasta cewa suna da maganin rigakafi.
69 (0.004% na yawan jama'a) sun tabbatar da mutuwar COVID-19.
Sakamakon annobar da kuma yawan mutuwar ta bambanta ga maza da mata.
A cikin binciken da aka yi a China da Italiya, yawan mutuwar ya fi girma.
Mafi yawan haɗarin ga maza a cikin shekaru 50 ne, kuma rata tsakanin maza da mata kawai ta kusa da 90.
A kasar Sin, yawan mutuwar maza ya kai kashi 2.8 cikin dari, mata kuma kashi 1.7 cikin dari.
Ba a san ainihin dalilan wannan bambancin jinsi ba, amma ƙabilar da kuma halayyar mutum na iya zama ɗaya daga cikinsu.
A cikin cututtukan da ke tattare da jima'i, shan taba yana iya haifar da yawan mutuwar mata fiye da maza, kamar ƙananan hawan jini.
A Turai, maza ne ke da kashi 57% na waɗanda suka kamu da cutar, kuma maza ne ke da kashi 72% na waɗanda suka mutu daga COVID-19.
Kamar yadda na Afrilu 2020, Gwamnatin Amurka ba ta bin diddigin bayanan jima'i da ke da alaƙa da kamuwa da cutar COVID-19 ba.
Bincike ya nuna cewa maza da mata kamar Ebola, HIV, mura da SARS suna nuna bambanci daban-daban.
Yawancin ma'aikatan kiwon lafiya, musamman ma mata masu jinya, suna da mafi yawan haɗarin kamuwa da cutar.
Hukumar Lafiya ta Duniya ta bayyana cewa, a ranar 11 ga Fabrairu, 2020, babban sunan cutar zai zama COVID-19.
A cewar babban darektan Hukumar Lafiya ta Duniya, Theodore Adhanom Gebre Allah, an fara gano cutar ta coronavirus, cutar, da kuma kamuwa da cutar a cikin mutane 19 a ranar 31 ga Disamba, 2019.
Don hana nuna bambanci, an zaɓi sunan don kauce wa ƙididdigar wani yanki na ƙasa (misali China), nau'in dabbobi ko rukuni na mutane, daidai da shawarwarin duniya. An kira cutar da ke haifar da COVID-19 cutar ta respiratory acute respiratory syndrome 2 (SARS-CoV-2).
Hukumar Lafiya ta Duniya ta kuma yi amfani da kalmar COVID-19 da kuma cutar da ke haifar da COVID-19 a kafofin watsa labarun.
"Ana kiran cutar da kwayar cutar "Corona Virus".
An fara gano cutar a Wuhan, China, inda aka fi sani da cutar coronavirus  da Wuhan coronavirus .
A watan Janairun 2020, Hukumar Lafiya ta Duniya ta ba da shawarar cewa a yi amfani da sunayen lokaci don cutar da cutar a matsayin jagora na shekarar 2015 dangane da amfani da wurare a cikin sunayen cutar da cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar ta hanyar ta hanyar ta hanyar ta hanyar ta hanyar ta hanyar ta hanyar ta hanyar ta hanyar ta hanyar ta hanyar ta hanyar ta hanyar ta hanyar ta hanyar ta hanyar ta hanyar ta hanyar ta hanyar ta hanyar ta hanyar ta hanyar ta hanyar ta hanyar ta hanyar ta hanyar ta hanyar ta hanyar ta hanyar ta hanyar ta hanyar ta hanyar ta hanyar ta hanyar ta hanyar ta hanyar ta hanyar ta hanyar ta hanyar ta hanyar ta hanyar ta hanyar ta hanyar ta hanyar ta hanyar ta hanyar ta hanyar ta hanyar ta hanyar ta hanyar ta hanyar ta hanyar ta hanyar ta hanyar ta hanyar ta hanyar ta hanyar ta hanyar ta hanyar ta hanyar ta hanyar ta ta hanyar ta hanyar ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta
An sanya sunayen COVID-19 da SARS-CoV-2 a ranar 11 ga Fabrairu, 2020.
Saboda iyakancewar iyawa a cikin sarkar samarwa ta yau da kullun, wasu masana'antun dijital suna buga kayan kiwon lafiya kamar su na'urorin numfashi da sassan iska.
A misali, asibitin Italiya yana buƙatar bawul na iska mai gaggawa kuma mai ba da sabis na iya samar da shi a cikin adadin lokacin da ake buƙata, inda aka buga bawul 100 a rana ɗaya don buƙatar dare ɗaya na mai aikin jinya na gida.
Tun lokacin da COVID-19 ya fara, asalin cutar, daidaitawa, rigakafi, magani da sauran fannoni da bayanai sun bazu cikin sauri akan Intanet.
Da alama mutane suna da ikon watsa kwayar cutar zuwa wasu dabbobi.
Binciken bai gano wani tabbacin karuwar cutar a alade, ducks da kaza ba.
Babu magani ko allurar rigakafi don magance cutar.
Binciken duniya game da alluran rigakafi da magunguna akan COVID-19 ana gudanar da su ta hanyar hukumomin gwamnati, ƙungiyoyin ilimi da masu bincike na masana'antu.
A watan Maris, Hukumar Lafiya ta Duniya ta kafa gwajin Solidarity don kimanta tasirin maganin sinadarai huɗu na riga-kafi, wanda ke da babban alkawarin tasiri.
Babu allurar rigakafi amma hukumomi daban-daban suna aiki sosai don haɓaka masu neman allurar rigakafi.
SARS-CoV da SARS-CoV-2 sun riga sun yi amfani da su ta hanyar SARS-CoV saboda dukansu suna amfani da mai karɓar ACE2 don shiga cikin ƙwayoyin halitta.
Akwai hanyoyi uku na rigakafi da ake bincike.
Na farko, masu bincike suna da burin samar da allurar rigakafin cutar gaba ɗaya.
Ana amfani da wannan nau'in kwayar cutar, ko tana aiki ko ta mutu, don magance sabon haɗarin COVID-19 ga tsarin rigakafin mutum na mummunan cuta.
Hanyar ta biyu ita ce allurar rigakafi, wanda ake nufi da samar da allurar rigakafi da ke lura da tsarin rigakafin wasu ƙananan kwayoyin cutar.
A cikin yanayin SARS-CoV-2, irin wannan binciken ya mai da hankali kan furotin S-spike wanda ke taimakawa kwayar cutar ta dauki mai karɓar enzyme ACE2.
Hanyar uku ita ce yin allurar rigakafin nucleic acid (DNA ko RNA) don yin allurar rigakafi.
Dole ne a gwada alluran rigakafi na gwaji don aminci da inganci a cikin waɗannan hanyoyin. A ranar 16 ga Maris, 2020, an fara gwajin asibiti na farko na allurar a Seattle akan masu sa kai huɗu.
Allurar rigakafi tana da lambar halittar jini mara lahani daga kwayar cutar. An gabatar da shi a matsayin ingantaccen maganin rigakafin mutum don shirya rigakafin SARS-COV-2, amma wannan abu ne mai ban mamaki.
Tun daga watan Afrilu na 2020, an gudanar da gwajin asibiti sama da 300 a aiki.
A yanzu haka, ana nazarin hanyoyin da aka amince da su na cutar zazzabi, ciki har da bincike huɗu da aka amince da su, ciki har da bakwai na hydrochloroquine ko chloroquine.
Yawancin magungunan rigakafin da aka sake amfani da su suna gudanar da bincike na kasar Sin, wanda aka ruwaito a ƙarshen Afrilu a cikin gwaje-gwaje na Babi na III tara a cikin ƙasashe da yawa.
A watan Afrilu na shekarar 2020, an gudanar da bita mai canzawa kan ci gaban asibiti na allurar rigakafi da masu neman magani don COVID-19. Reflovir, chloroquine da hydrochlorokine, Lopeavia / Rutanavir da Lopenavir / Rudonavir tare da interferon beta suna nazarin yawancin magungunan riga-kafi na yanzu don maganin COVID-19 .
Akwai tabbaci na gaske game da tasirin rage farashin har zuwa Maris 2020.
A cikin asibiti, an sami ci gaba a cikin marasa lafiya da aka yi amfani da maganin jinƙai.
Ana gudanar da gwaje-gwaje na asibiti na mataki na III a Amurka, China da Italiya. An fara nazarin chloroquine a China a watan Fabrairun 2020.
Duk da haka, an yi kira ga masu bincike don yin nazarin.
Hukumomin kiwon lafiya na Koriya da na kasar Sin sun bada shawarar yin amfani da chloroquine.
Ko da yake, Cibiyar Kwayar cuta ta Wuhan ta ba da shawarar shan gram ɗaya a kowace rana, amma sau biyu na iya zama haɗari da kisa.
A ranar 28 ga Maris, 2020, Likitocin da ke kula da mutane da COVID-19 sun ba da izinin gaggawa don amfani da hydrochloroquine da chloroxine. Jagorar fitowar 7 ta kasar Sin ta kara da amfani da Interferon, ribavarin ko umfenovirine a kan COVID-19.
Bayanai na farko sun nuna cewa babban adadin ribavarin yana da mahimmanci don hana SARS-CoV-2 a cikin vitro.
Bayan nuna ƙananan matakan matsa lamba ga SARS-CoV-2, an ba da shawarar yin amfani da Nitazoxanide a cikin nazarin vivo. Nazarin ya nuna cewa, yana da mahimmanci don shigar da SARS-CoV-2 ta hanyar haɗuwa da babban amfani da furotin na trans-tissue protease serine 2 (TMPRSS2) tare da mai karɓar ACE2.
Nazarin da aka yi na chloroquine da hydrochloroquine tare da ko ba tare da arthromycin ba yana da manyan ƙuntatawa waɗanda ke hana al'ummar likitanci ɗaukar waɗannan magunguna ba tare da ƙarin bincike ba. Oseltamivir ba ya haifar da SARS-CoV-2 a cikin vitro kuma ba shi da wani muhimmin matsayi a cikin maganin COVID-19.
A cikin matakan COVID-19 na ƙarshe, hadari mai suna Cytoquin na iya zama mai rikitarwa.
Akwai hujja cewa hydroxychloroquine na iya samun halayen anti-cytocin. Tocilizumab an haɗa shi a cikin jagororin likita na Hukumar Lafiya ta Kasa ta China bayan an kammala ƙaramin bincike.
A Italiya, ana gudanar da gwajin mataki na biyu a matakin ƙasa bayan ya nuna sakamako mai kyau a kan mutane da ke fama da mummunan cuta.
An yi amfani da shi don gano hadarin yutocin tare da gwajin jini na Sam Freistine, don hana irin wannan ci gaban da ake zaton zai haifar da mutuwar mutane da aka cutar.
An amince da FDA don interleukin-6 mai karɓar karɓa dangane da nazarin da aka buga a cikin CAR T cell therapy, a cikin 2017 dangane da amsawa ga maganin cututtukan fitowar isotonin steroidal.
Har zuwa yau, babu wani bayani na bazuwar da aka bincika game da yadda Tocalizim ke magance CRS.
Ana yin bincike kan yadda ake ba da allurar rigakafi ga mutanen da suka warke daga COVID-19 don neman maganin rigakafi da aka tace da kuma adanawa.
Wannan dabarar ta haifar da sakamako mara kyau ga kwarewar SARS.
Magungunan kashe ƙwayoyin cuta masu zaman kansu / masu zaman kansu sune matakan da aka tsara waɗanda zasu iya zama matsakaiciyar kariya akan SARS-CoV-2.
Duk da haka, akwai wasu hanyoyin da za a iya amfani da su, kamar su cytotoxic anti-addictive cell and / or phingyotosis.
Sauran hanyoyin magance rigakafin rigakafi na kai tsaye, kamar amfani da kwayoyin rigakafin monoclonal, suna da ƙarancin gaske.
Ana iya ƙara yawan ƙwayar cuta daga marasa lafiya da suka dawo daga cutar don saurin samar da ƙwayar cuta mai ƙwayoyin cuta na jini wanda ke ƙunshe da rigakafin cutar.
A cikin shekara ta 1914, an yi amfani da maganin cutar coronavirus a duniya.
Likita Li Wenliang, wanda ya kamu da COVID-19 bayan ya sanar da yaduwar cutar a asibitin Wuhan na tsakiya.
